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Abstract 
 
Mild Generation and Novel Reactivity of Nitroso Compounds 
 
by 
 
Charles Patrick Frazier 
 
 
The development of efficient methods for the formation of carbon-nitrogen bonds is 
of great interest in organic chemistry. While traditional approaches to C-N bond formation 
are well developed and have found widespread use, approaches utilizing an electrophilic 
source of nitrogen are vastly underdeveloped. Although a number of electrophilic sources of 
nitrogen have been developed, the efforts of our research have centered on the use of 
nitrosocarbonyl compounds. Due to their high reactivity, nitrosocarbonyl intermediates can 
only be generated in situ and are classically obtained from the oxidation of hydroxamic acid 
  x 
derivatives using periodate salts. However, this in situ oxidation protocol, which is 
commonly used in the hetero-Diels-Alder (HDA) reaction, is incompatible with the other 
reactions because the initially formed adduct is highly susceptible to decomposition. While 
this has significantly limited the development of chemistry utilizing nitrosocarbonyl 
compounds, we postulated that if the oxidation conditions were mild enough to circumvent 
product decomposition, nitrosocarbonyls could be utilized in a wide variety of C-N bond-
forming reactions. 
Recently, we reported the first example of the aerobic generation of nitrosoformate 
intermediates for use in the nitroso ene reaction. The aerobic oxidation method, which relies 
on the use of catalytic amounts of CuCl (5 mol %) and uses air as the terminal oxidant, 
proved mild enough to avoid decomposition of the ene adducts, affording the allylic 
hydroxylamines in up to quantitative yields. Additionally, the oxidation protocol is highly 
general for a wide variety of N-substituted hydroxylamines; the Diels-Alder reaction can be 
carried out in up to quantitative yields employing an array of nitroso compounds. Moreover, 
by switching to photoredox conditions using Ru(bpy)3Cl2, the nitrosocarbonyl intermediates 
can be efficiently generated with temporal and spatial control.  
As proposed, the mild oxidation conditions allowed the expansion of nitrosocarbonyl 
chemistry into new areas, such as the nitroso aldol reaction. Through the synergistic 
combination of our aerobic oxidation with known Lewis acid activation of β-ketoesters, the 
α-amination and α-oxygenation of carbonyl compounds was achieved for the first time using 
nitrosocarbonyl compounds. All of the reactions are operationally simple to perform, utilize 
reagent grade solvents and air as the terminal oxidant, and the only byproduct is water.  
  xi 
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1. Historical Background and Reactivity of Nitroso Compounds 
1.1 Stability and Reactivity Patterns of Nitroso Compounds. 
1.1.1 Varied Stability of Nitroso Compounds 
Nitroso compounds are reactive electrophiles use widely in the synthesis of complex 
molecules.
1
 Since the first reported synthesis of nitrosobenzene by Baeyer in 1874,
2
 a vast 
number of nitroso compounds have been synthesized, which vary widely in their reactivity.
3
 
Although a comparative study of the reactivity of different families of nitroso compounds 
has not been conducted, nitroso reactivity can generally be characterized by the extent of 
adjacent electronic effects. For example, in the context of nitroso compounds with adjacent 
heteroatoms, N-nitroso 1 and S-nitroso 2 compounds are particularly unreactive toward 
typical dienes in Diels–Alder reactions. This lack of reactivity can be attributed to the lone 
pair resonance donation of the attached heteroatom, which can be tempered if the lone pairs 
are not available for π-electron donation.1a For example, while N-nitrososulfonamide 3 is 
still unreactive toward dienes,
4
 metastable P-nitrosophosphine oxide
5
 4 and S-
nitrososulfonyl compounds
6
 5 readily engage in Diels–Alder reactions with dienes (Figure 
1).  
Figure 1. Relative Stabilities and Reactivities of Hetero-Nitroso Compounds 
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Like hetero-nitroso compounds, the reactivity of C-nitroso compounds are innately 
dependent on the associated electronic environment of the N-substitution. For the sake of 
this dissertation, nitroso compounds will be classified by their stability relative to “nitroxyl” 
10, a metastable nitroso compound widely studied in the context of biological systems. As 
with hetero-nitroso compounds, the reactivity of these stable nitroso compounds can be 
modulated by adjusting the electronics of the nitroso. For example, due to the electron 
withdrawing nature of the substituents, α-chloro-7 and α-acetoxy8 nitroso compounds 9 are 
substantially more reactive toward dienes than other simple aliphatic nitroso compounds 5, 
which are unreactive. Similarly, while substitution plays a large role in stability and 
reactivity, nitrosoarenes
9
 and nitrosoheteroarenes
10
 8 are generally more reactive toward 
dienes than vinylnitroso compounds 7.
11
 Notably, stable nitroso compounds often need 
additional activation by Lewis acids in order to achieve efficient reactivity.
12
 In every case 
(5-9), the nitroso compound can be readily isolated and characterized (Figure 2a). 
Figure 2. Relative Stabilities and Reactivities of C-Nitroso Compounds  
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In contrast, nitrosocarbonyls and related compounds are transient, highly reactive 
intermediates in synthesis.
1
 While acylnitroso compounds 14 are the only member of the 
class whose lifetime has been measured,
13
 the transient nature of the other nitrosocarbonyls 
can be inferred based on lack of reported isolability and similarity of reactivity toward dienes 
in Diels–Alder reactions. The comparative reactivity of each can be inferred based on the 
amount of π-donation into the carbonyl, with the nitrosoformimidamide 11 likely the least 
reactive and nitrosoformaldehyde 15 likely the most reactive (Figure 2b).
1a
  
Because nitrosocarbonyl compounds are not bench top stable species, efforts have been 
made to observe these transient intermediates spectroscopically. Schwarz and co-workers 
studied both the acylnitroso 14 and nitrosoformaldehyde 15 using neutralization-reionization 
mass spectrometry. In their study, they found that both compounds could be detected in the 
gas phase after thermo-retro-cleavage from 9,10-dimethylanthracene HDA adducts.
13b
 
Toscano and co-workers studied nitrosocarbonyl compounds in solution using time-resolved 
infrared spectroscopy. In their study, acylnitroso compounds 14 in solution were estimated to 
have a lifetime of approximately 10 ms at infinite dilution.
13a
  
Unlike their stable counterparts, nitrosocarbonyls and related compounds need no 
additional activation by Lewis and Brønsted acids to achieve efficient reactivity. 
Unfortunately, this makes asymmetric induction using a chiral catalyst extremely 
challenging, evidenced by the limited number of reported catalyst-controlled asymmetric 
reactions with nitrosocarbonyls and related compounds.
14
 Therefore, inducing asymmetry in 
this manner remains the “holy grail” of nitrosocarbonyl chemistry and would likely induce a 
paradigm shift in the field of electrophilic hetero-functionalization reactions.  
  4 
1.1.2 Characterization of Ambident Reactivity of Nitroso Compounds  
Nitroso compounds are ambident electrophiles with a number of reports of reactivity at 
the corresponding nitrogen, oxygen, or adjacent carbons of the molecule, dramatically 
complicating the rational design of new reactions. The ambident reactivity of nitrosoarenes 
has been well characterized in the context of the aldol reaction,
15
 and a number of predictive 
models have been developed to aid in designing highly selective reactions.
16
 In contrast, the 
ambident reactivity of nitrosocarbonyl compounds has been only minimally explored. The 
earliest reports postulating the existence of nitrosocarbonyl compounds (see section 1.2.1), 
exploited reactivity at the carbonyl to form the corresponding carboxylic acid or amides, 
subsequently releasing nitroxyl as a byproduct.
17
 Beginning in the 1970’s, pioneering work 
by Kirby
18
 and Keck
19
 ushered in a renaissance of C-N bond forming reactions with 
nitrosocarbonyl compounds, including reports of ene and Diels–Alder all showing 
preference for nitrogen reactivity (see section 1.2). In contrast to arylnitroso compounds, 
reactivity on oxygen has only recently been discovered,
20
 and efforts to better understand the 
principles governing this reactivity pattern have only been minimally explored (Figure 3).
20b
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Figure 3. Ambident Reactivity of Arylnitroso and Nitrosocarbonyl Compounds 
 
1.1.3 Common Decomposition Pathways of Nitroso Compounds. 
In addition to the complications of reaction development due to the ambident reactivity, 
nitroso compounds readily undergo decomposition reactions. Nitrosoarenes 22 are known to 
dimerize in solution to form either the Z- or E-dimer (21 and 23, respectively), depending on 
the nature of the substitution on the aryl ring.
21
 While some nitroso compounds such as p-
methoxy nitrosobenzene show little to no dimerization in solution, nitrosoarenes bearing 
electron withdrawing substituents such as p-nitro nitrosobenzene rapidly dimerize.
21b
 
Notably, dimerization is often reversible, which preserves the reactivity of nitrosoarenes 
(Figure 4).  
  6 
Figure 4. Dimerization of Nitrosoarene Compounds 
 
In contrast, nitrosocarbonyl compounds exhibit a lack of stability due to dimerization 
events which lead to decomposition. Acylnitroso compounds dimerize in solution to form a 
similar azoxy-dimer to nitrosoarenes (24), however these intermediates undergo rapid 
decomposition, irreversibly forming the corresponding anhydride (27).
22
 Additionally, due to 
the enhanced reactivity of hydroxylamines due to the α-effect, nitrosocarbonyls generated 
through the oxidation of N-substituted hydroxylamines often undergo trans-esterification 
reactions to liberate nitroxyl and form the N,O-disubstituted hydroxylamine (29).
17b, 23
 
Alternatively, the nitrogen of the N-substituted hydroxylamine can also add to the carbonyl 
of the nitroso to form the N,N-disubstituted hydroxylamine (30),
24
 with the subsequent 
liberation of nitroxyl. These pathways are destructive to the nitrosocarbonyl, and therefore, 
contribute to the overall reduction in reaction efficiency and lead to complicated mixtures of 
products (Figure 5). However, we felt if we could better understand how to circumvent the 
decomposition, the reactivity of nitrosocarbonyl compounds could be harnessed for a wide 
variety of C-N and C-O bond-forming reactions. 
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Figure 5. Decomposition Pathways of Nitrosocarbonyl Compounds 
 
1.2. The Discovery of Nitrosocarbonyl Compounds 
1.2.1 Early Postulation of the Existence of Nitrosocarbonyl Compounds 
Early efforts in generating nitrosocarbonyl compounds focused on the oxidation of 
hydroxamic acids with periodate,
17
 silver(I) or manganese(IV) oxides,
23
 iodine,
23b
 or N-
bromosuccinimide.
17c
 Building on the discovery that N-alkylhydroxylamines formed the cis-
nitroso dimer, early researchers were surprised to find that the oxidation of N-
acylhydroxamic acids did not follow the same trend. Instead, depending on the reaction 
conditions, the carboxylic acid 31,
17a
 N,O-bisacylated hydroxylamine 29,
17b
 or amide
17c
 32 
were isolated. Each of these products were formed through the loss of the N-O moiety under 
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the oxidative conditions. While the nitrosocarbonyl compound 14 was not directly observed, 
these early experiments reinforced the possible existence of a nitrosocarbonyl intermediate 
(Figure 6). 
Figure 6. First Evidence of the Existence of Nitrosocarbonyl Compounds 
 
The first direct evidence supporting the formation of nitrosocarbonyl compounds from 
the oxidation of hydroxamic acids was the reported trapping of the nitrosocarbonyl moiety as 
a Diels–Alder adduct by Kirby in 1973.18a In this pioneering report, the nitrosocarbonyl 
intermediate was trapped with the diene thebaine (35) and compared to Diels–Alder adducts 
previously isolated with stable nitroso compounds. Moreover, it was shown that the 
nitrosocarbonyl could be regenerated through the thermo-retro-cleavage of 9,10-
dimethylanthracene HDA adduct 37 and effectively transferred to another diene, an approach 
that was expanded on in subsequent communications.
18c, 18e
 This was the first example of the 
retention of the hydroxylamine moiety, providing the direct evidence of the existence of 
nitrosocarbonyl compounds and laying the foundation for the next 40 years of 
nitrosocarbonyl research (Figure 7).  
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Figure 7. First examples of the Nitrosocarbonyl Hetero-Diels-Alder Reaction 
 
1.2.2 Rendering Nitrosocarbonyl Compounds Useful in Synthesis 
Based on Kirby’s pioneering discovery, Keck expanded on the thermo-retro-cleavage 
approach to generating nitrosocarbonyl compounds by further exploring reactivity of the 
dienophile-transfer.
19a
 While Kirby’s work demonstrated that nitrosocarbonyl compounds 
are formed in the oxidation of hydroxamic acids, Keck was the first to consider the utility of 
nitrosocarbonyl compounds in synthesis. In particular, Keck reported the intramolecular 
nitrosocarbonyl Diels–Alder by functionalizing HDA adducts of acetohydroxamic acid with 
9,10-dimethylanthracene. Through the thermo-retro-cleavage of the functionalized adducts, 
Keck generated fused ring systems that could be further elaborated into important lactam 
building blocks 40 (Equation 1).  
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Equation 1. Dienophile-Transfer via the Thermo-Retro-Cleavage of HDA Adducts 
 
Additionally, Keck exploited the intermolecular nitrosocarbonyl HDA to access a model 
system for the lycoridine family of alkaloids (44 and 45),
19b
 showcasing the potential utility 
of nitrosocarbonyl compounds for the synthesis of complex molecules (Figure 8). 
Figure 8. The Intermolecular HDA Reaction: Accessing the Lycoricidine Family 
 
Shortly following his work on the intramolecular HDA reaction, Keck and co-workers 
reported the first example of a nitrosocarbonyl ene reaction.
19c, 19d, 19f
 Generating the 
nitrosocarbonyl through the thermo-retro-cleavage of HDA adduct 46, this work displayed 
the reactivity of nitrosocarbonyl compounds, as the transient intermediates readily undergo 
ene reactions in the absence of catalyst at moderate reaction temperatures. Moreover, this 
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reaction provided direct access to a wide range of allylic amines (47), which proved useful 
for the synthesis of complex natural products 48–50 (Figure 9).19e, 19g Kirby followed Keck’s 
reports with his own example using nitrosoformate intermediates for the inter- and 
intramolecular ene reaction.
18f, 22a
 Notably, in every example, direct oxidation of the N-
substituted hydroxylamine in the presence of the olefin led to a complex mixture of 
products, presumably due to over-oxidation of the resultant allylic amine. Therefore, it was 
necessary to proceed through the two step thermo-retro-cleavage approach, a limitation that 
was targeted by a number of research groups attempting to improve on Keck and Kirby’s 
methodology. 
Figure 9. Two-Step Nitrosocarbonyl Ene Reaction and Natural Product Targets 
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1.3 Modern Methods of Nitrosocarbonyl Generation  
1.3.1.Recent Development for the Generation of Nitrosocarbonyl Intermediates 
Since Keck and Kirby’s pioneering work, a number of research groups have developed 
novel methods for the oxidation of N-substituted hydroxylamines, including lead(IV) and 
silver(I) oxides,
25
 Dess-Martin periodinane,
26
 Swern–Moffat  conditions,27 a variety of 
transition metal – peroxide complexes,28 BPO & TEMPO,29 manganese(II) oxide,20a, 30 and 
Rh(II) complexes with Ag2CO3,
31
 and copper–catalyzed aerobic oxidations,20b, 32 among 
others.
33
 Additionally, non-oxidative methods have been developed from alternative starting 
materials, such as N-methylmorpholine-N-oxide addition to nitrile oxides,
22c, 34
 and the 
photo– or thermal–degradation of 1,2,4-oxadiazole-4-oxides.22b, 35 While these methods have 
been used for the Diels–Alder,25-28, 32a, 32b ene,28d, 32c aldol,20, 29-30, 32d and C-H activation 
reactions,
31
 the ene reaction is an effective tool for evaluating the mildness of the conditions, 
due to the known product decomposition issues. Therefore, methodologies that can be 
utilized for a single-pot ene reaction we consider the most mild. 
1.3.2 Non–Oxidative Methods for Single Pot Generation for Nitrosocarbonyl Ene 
The first example of a single-pot nitrosocarbonyl ene reaction was reported by Caramella 
and co-workers.
34
 The non-oxidative protocol, relying on the rearrangement of nitrile oxides 
with N-methylmorpholine-N-oxide, yielded the ene adduct 54 in high yield, reinforcing the 
assessment that there is no inherent instability of nitrosocarbonyl ene adducts under non-
oxidative conditions. Caramella and co-workers followed up shortly after with another non-
oxidative method which, again produced the nitrosocarbonyl ene adducts in high yield from 
1,2,4-oxadiazole-4-oxide 52 (Figure 10).
22b, 35
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Figure 10. Non-Oxidative Generation of Nitrosocarbonyl Compounds. 
 
1.3.3 Single-Pot Oxidative Nitrosocarbonyl Ene Using Hypervalent Iodine 
While the work of Kirby
36
 and Keck
19f
 laid the foundation for the future development of 
nitrosocarbonyl chemistry, their two-step protocol proved cumbersome and limited the 
development of the field. Therefore efforts to render the nitrosocarbonyl ene reaction 
accessible in a single pot were undertaken by a number of research groups. Taking 
inspiration from Kirby and Keck’s use of hypervalent iodine, the first example of a single-
pot oxidative generation of nitrosocarbonyl compounds for the ene reaction was reported by 
Adam and co-workers in 1999 and utilized phenyliodoso diacetate (PIDA) as the 
stoichiometric oxidant.
37
 The method involves the slow addition of the hydroxamic acid to 
PIDA and 3 equiv of the olefin. The reaction is high yielding for simple dienes with a variety 
of hydroxamic acids (Table 1, 58 and 59), however the yield suffered when an olefin bearing 
a more sensitive functional group was employed (Table 1, 60).  
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Table 1. First Single-Pot Nitrosocarbonyl Ene Reaction under Oxidative Conditions 
 
In addition to the work of Adam and co-workers, one example of the single-pot 
nitrosocarbonyl ene reaction utilizing iodine(V) was carried out by Kibayashi and co-
workers in the context of the synthesis of  key natural product core 62.
38
 This is the first 
example of a diastereoselective intramolecular single-pot nitrosocarbonyl ene reaction and 
was used in the context of a formal total synthesis of both (±) halichlorine 63 and (±) pinnaic 
acid 64 (Figure 11).
39
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Figure 11. Single-Pot Intramolecular Nitrosocarbonyl Ene Using Hypervalent Iodine 
 
1.3.4 Non-Iodine Based Single-Pot Oxidative Methods 
Recently a number of research groups have reported examples of the catalytic oxidation 
of hydroxamic acids employing transition metals and stoichiometric peroxides for both the 
DielsAlder 28a-c and the ene reaction.40 The first reported example for the catalytic 
nitrosocarbonyl ene reaction was reported by Iwasa and co-workers in 2004.
41
 While a 
number of transition metal catalysts were used, the highest yields were achieved using CuI 
(Table 2, 67–69). In addition to the work of Iwasa, Malkov recently demonstrated that FeCl3 
is an efficient catalyst for the intramolecular nitrosocarbonyl ene reaction.
28d
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Table 2. Transition Metal Catalyzed Nitrosocarbonyl Ene (Iwasa)  
 
In a departure from previously developed methodology, Tan and co-workers reported the 
use of photoredox catalysis for the oxidation of hydroxamic acids. Under the optimized 
reaction conditions (3 mol % rose Bengal, 10 mol % pyridine, MeCN, 35 ˚C, 11 W lamp), 
the nitrosocarbonyl ene adducts were isolated in high yield.
42
 
1.3.5 Concluding Remarks 
Despite the exceptionally high reactivity, modern methods of generation have enabled 
the development of nitrosocarbonyl chemistry to where the transient intermediates are 
effective reagents for C-N and C-O bond–forming reactions. The duration of this dissertation 
will detail our contributions to the pantheon of modern generation methods of nitroso 
compounds and will highlight our subsequent advances based on these discoveries. 
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2. Aerobic Oxidation of N-Substituted Hydroxylamines: Ene and Diels–
Alder Reactions. 
2.1 The Nitrosocarbonyl Ene Reaction: Development of an Aerobic Oxidation to 
Generate Nitrosoformate Intermediates 
2.1.1 Background and Early Reaction Development with Metal Peroxides 
Prior to the genesis of our research, methods that permitted the ene reaction between a 
nitrosocarbonyl compound and a functionalized alkene partner, and the development of an 
asymmetric manifold were notably absent from the literature. In addition, excess olefin was 
frequently utilized in order to obtain high yields of the ene product. A possible reason for the 
slow advance of nitrosocarbonyl ene reactions was the inability to identify a general and 
practical oxidant. We sought to rectify these limitations by developing a new catalytic 
system for the transformation  
The recent work of Iwasa,
1
 Whiting,
2
 and others
3
 led us to initially focus on oxidation 
methods that relied on transition metals and stoichiometric peroxides as the terminal 
oxidant. A preliminary screen revealed that copper salts in combination with hydrogen 
peroxide were optimal for the intramolecular ene reaction of N-hydroxycarbamate 1 (Table 
3, entries 1-5). Treatment of 1 with 5 mol % copper (II) chloride and hydrogen peroxide 
gave the intramolecular ene product 2 in up to 79% yield (Table 3, entry 4). Unfortunately, 
it was critical to stop the reaction as soon as the starting materials were consumed, because 
complete ene product decomposition was observed within 30 minutes of the completion of 
the reaction. Moreover, the rate of decomposition varied depending on the nature of the 
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substrate, which made obtaining consistent isolated yields problematic. Consequently, an 
alternative, milder method to oxidize the hydroxamic acids was sought. 
Table 3. Screening Metal-Peroxide Reaction Conditions for the Nitrosocarbonyl Ene 
 
Entry Catalyst Additive Oxidant Time
 
% Yield
b
 
1 FeCl3 – HOOH 3 h 25 
2
 
 RuCl3 Et3N HOOH 6 h 53 
 3
c
 NiCl2 – HOOH 6 h 0 
4 CuCl2 – HOOH 20 min 79 
5 CuCl – HOOH 30 min 78 
a 
All reactions were performed with reagent grade THF containing 250 ppm BHT 
inhibitor. The following amounts of reagents were used according to Table 1: 5 mol % 
catalyst, 120 mol % peroxide, 1.25 mol % pyridine and 1.25 mol % DTBMP. 
b
 Isolated 
yields. 
c Reaction was run at 70˚C. 
 
2.1.2 Motivation for Exploring the Aerobic Oxidation of Hydroxylamines 
From both an economical and environmental viewpoint, molecular oxygen represents the 
ideal oxidant due to its low cost and lack of toxic by-products,
4
 and aerobic oxidations have 
the potential to replace hazardous classical oxidation protocols.
5
 However, aerobic oxidation 
methodologies have largely focused on the oxidation of alcohol-based systems, despite the 
important role oxidation chemistry plays in other functional group transformations.
6
 The 
analogous aerobic oxidation of hydroxylamines to nitroso compounds has remained 
underdeveloped, despite its potential synthetic utility and environmental impact.  
 Hydroxylamines not only represent an important structural motif prevalent in natural 
products and biologically active molecules but they also serve as an attractive precursor to 
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nitroso compounds. During the last four decades, nitroso compounds have been utilized as 
synthetically useful intermediates for organic synthesis.
7
 In spite of the significant 
achievements, methods used for preparation of nitroso compounds still rely on the use of 
stoichiometric oxidants, which leads to issues of functional group incompatibility, limits 
new reaction development, and require the removal of potentially toxic oxidation by-
products.
8
 In an effort to circumvent these limitations, we shifted our attention toward an 
alternative oxidation protocol.  
2.1.3 Discovery of Aerobic Oxidation Conditions and Intramolecular Scope 
While searching for an alternate oxidant to the problematic metal-peroxide system, 
preliminary experiments were run utilizing copper(II) chloride and O2 as the terminal 
oxidant in refluxing THF (Table 4, entry 1). While the isolated yield was low (8%), the 
starting material was fully consumed suggesting the viability of an aerobic oxidation for 
generating the transient nitrosocarbonyl. Fortuitously, by simply lowering the reaction 
temperature and switching to air as the terminal oxidant, the isolated yield could be 
dramatically increased using either copper(I) or copper(II) chloride (Table 4, entries 2 and 3). 
Importantly, these conditions suppressed the rate of ene product decomposition. 
Furthermore, we felt that air was an ideal oxidant because it is readily available, inexpensive 
and the byproducts are environmentally benign.
6c, 6d
 The addition of catalytic pyridine 
resulted in cleaner and more efficient reactions (Table 4, entry 4), however no rate 
enhancement was observed when 2,6-di-tert-butyl-4-methylpyridine (DTBMP) was used, 
which suggests pyridine is not functioning simply as a base (Table 4, entry 5). In addition, no 
reaction was observed under anaerobic conditions (Table 4, entry 6).  
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Table 4 Screening Aerobic Reaction Conditions for the Nitrosocarbonyl Ene 
 
Entry Catalyst Additive Oxidant Time
 
% Yield
b
 
1
c
 CuCl2 – O2 8 h 8 
2 CuCl2 – air 144 h 68 
3 CuCl – air 29 h 87 
4 CuCl pyridine air 6 h 93 
5 CuCl DTBMP air 29 h 94 
6
d 
CuCl pyridine – 48 h 0 
a 
All reactions were performed with reagent grade THF containing 250 ppm BHT 
inhibitor. The following amounts of reagents were used according to Table 1: 5 mol % 
catalyst, 120 mol % peroxide, 1.25 mol % pyridine and 1.25 mol % DTBMP.  
b
 Isolated 
yields. 
c 
Reaction was run at 70˚C. d  Starting material recovered.  
 
With the optimized reaction conditions (5 mol % copper (I) chloride, 1.25 mol % 
pyridine, reagent grade THF, air, rt), we investigated the scope of the intramolecular 
nitrosocarbonyl ene reaction (Tale 5). The allylic and homoallylic nitrosoformate esters both 
cyclize by a Type I mechanism (according to Oppolzer and Snieckus’ classification)9 to 
construct the 2-oxazolidinone and 1,3-oxazine-2-one scaffold (Table 5, 2, 5–7). Olefin 
geometry plays an important role and currently the intramolecular reaction does not 
accommodate substrates bearing a Z-alkene (8 & 9), presumably due to the geometric 
constraints of approaching the alkene with the required skew geometry.  
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Table 5. Substrate Scope Studies for the Intramolecular Nitrosocarbonyl Ene 
 
a
 Product 6 resulted from the reaction of trans-2-hexene-yl 
hydroxycarbamate. The yield is a combined yield of both 
olefin isomers.  
 
2.1.4 Exploring the Intermolecular Scope of the Nitrosocarbonyl Ene Reaction 
Having established a mild, single-pot method for the intramolecular acylnitroso ene 
reaction, we evaluated the bimolecular reaction which provides a convenient method for 
effecting allylic amidation.  Our investigations focused on N-hydroxycarbamates bearing 
protecting groups that were easy to prepare, commonly used in synthesis and could be 
orthogonally deprotected. To our gratification, hydroxylamines protected with Boc, Cbz, 
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Fmoc and Troc groups all participated in the intermolecular ene reaction in greater than 80% 
yield (Table 6). Significantly, with the exception of tert-butyl-N-hydroxycarbamate, 
comparable yields were also obtained with only 1.1 equivalents of -methyl styrene 11. 
Based on reaction trends, vide infra, we currently believe the copper-air catalyst system is 
oxidizing the N-hydroxycarbamate and generating a transient acylnitroso intermediate. 
However, the nature of the copper-oxidant species and the oxidation mechanism require 
further studies. Under the aerobic oxidation conditions tetrahydrofuran can form peroxides, 
however, alternative solvents that do not pose a risk of peroxide formation for, such as 2-
methyltetrahydrofuran (75%), methanol (68%), ethyl acetate (77%), and toluene (77%) can 
be utilized to generate compound 14. 
Table 6. Substrate Scope Studies for the Intermolecular Nitrosocarbonyl Ene 
 
a 
Reactions were performed with reagent grade THF containing 250 ppm BHT 
inhibitor.  
b 
AMS = -methyl styrene. 
 
We chose to investigate the scope of the intermolecular ene reaction with 1.2 equiv of 
the alkene partner and the carbobenzyloxy (Cbz) protected hydroxylamine (16) (Table 7).  
The reaction tolerated a series of alkene reaction partners and furnished allylic N-
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hydroxycarbamate derivates in moderate to excellent yield (Table 7, entries 19–22). The best 
results were obtained from substrates with electron-rich olefins, which is consistent with 
other known ene processes. The reaction can also tolerate alkenes that are deactivated by 
electron withdrawing substituents, as well as an alkene bearing a free hydroxyl group (Table 
7, entries 23 – 25).    
Table 7. Olefin Substrate Scope for the Intermolecular Nitrosocarbonyl Ene 
 
a 
Reactions were performed with reagent grade THF containing 250 ppm BHT 
inhibitor.  
b
 Isolated yields. 
c
 The yield is a combined yield of both olefin isomers. 
 
We next turned our attention to bimolecular reactions involving tiglic-acid derivatives 
because they provide rapid access to ,-disubstituted amino acids. Direct methods to access 
this important structural motif are limited.
10
 Nitroso ene reactions with electron deficient 
tiglic-acid derivatives are often low yielding, especially with nitrosocarbonyl enophiles.
8a
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Therefore, we were thrilled when we discovered that use of 1.2 equiv of methyl tiglate 
resulted in a 73% yield of the desired ene product (Table 7, entry 26). The unprotected acid 
and amide derivates also afforded the desired products in 75% and 78%, respectively (Table 
7, entry 27 & 28). The benzamide analogue underwent clean reaction, however it cyclized in 
situ to form -methylene isoxazolidinone (Table 7, entry 29). 
2.1.5 Regioselectivity of the Nitrosocarbonyl Ene Reaction 
The nitrosocarbonyl ene reaction is heavily influenced by the electronic factors of the 
olefin. For example, using geranyl acetate to probe the reactivity of electronically 
differentiated alkenes (Equation 2, 30), the major product arose from reaction at the distal 
double bond (Equation 2, 31), since the allylic acetate electronically deactivates the proximal 
double bond (Equation 2, 32).
7a, 7c
  
Equation 2. Directing Effects in Geraniol Derivatives in the Nitrosocarbonyl Ene 
 
Similar to nitrosoarene enophiles, nitrosocarbonyl compounds show a strong preference 
for a skew geometry when approaching the olefin.
11
 As a consequence, when the starting 
olefin has a multiple allylic sites of reactivity the nitrosocarbonyl abstracts a hydrogen from 
the twix position during the ene reaction (as defined on compound 35 in Equation 3). For 
example, while three products are obtained when using 1-methyl-1-cyclohexene as the olefin 
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partner, the reaction showed a strong preference for the twix product over the twin or lone 
(Equation 3, 12:2:1 ratio of 36:37:38).
11
 This general pattern of reactivity was conserved 
across all olefin partners screened.
7a, 7c
  
Equation 3. Regioselectivity of Hydrogen Abstraction in the Nitrosocarbonyl Ene 
 
2.1.6 Rendering the Nitrosocarbonyl Ene Reaction Asymmetric 
Inspired by Adam’s work employing a chiral auxiliary on the tiglic acid derivative,12 we 
set out to control the absolute stereochemistry of the nitrosocarbonyl ene reaction. Utilizing 
tiglic acid with Oppolzer’s derived sultam (39), the -methylene isoxazolidinone ((S)-29) 
was produced in situ as predominately a single enantiomer (98.5:1.5 er) and Oppolzer’s 
chiral auxiliary could be quantitatively recovered from the reaction. Single-crystal X-ray 
analysis was used to establish the S-configuration of the newly formed stereocenter in ene 
product (S)-29. This represents the first example of an asymmetric intermolecular 
acylnitroso ene reaction (Equation 4).
13
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Equation 4. Asymmetric Nitrosocarbonyl Ene using Oppolzer’s Sultam 
 
 To explain the observed selectivity we postulate a reactive conformation of 39a based 
on literature precedent.
12, 14
 The favored conformation features an anti-orientation between 
the carbonyl group and the sulfonyl functionality and an s-trans conformation of the 
carbonyl group and the double bond.  A skewed approach of the enophile from the less 
hindered Si-face is favored because the sulfonyl oxygen atoms shield the Re-face. (Figure 
12).  Since both enantiomers of the camphorsultam chiral auxiliary are commercially 
available, both stereoisomers of the ene product are available.  
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Figure 12. Origin of Selectivity for the Asymmetric Nitrosocarbonyl Ene 
 
Preliminary studies demonstrate -methylene isoxazolidinone compounds have similar 
biological activity as -methylidene--lactones and are potent against mouse L-1210 as well 
as human HL-60 and NALM-6 leukemia cell lines.
15
 The precise mechanism of activity is 
currently unknown but these compounds are believed to react as Michael-type acceptors with 
bionucleophiles. Despite their potential as possible novel therapeutics, access to -
methylene isoxazolidinone compounds is virtually unknown, especially in an asymmetric 
sense.
12, 15
 Moreover, isoxazolidinones represent well-established building blocks that can 
serve as synthons for ,-disubstituted amino acids.10 While we envisioned extending this 
methodology to include other enone derivatives, the reaction proved to be limited 
exclusively to the tiglate derivatives. Other enone partners appended to Oppolzer's sultam 
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(e.g. 1-cyclohexene-1-carboxylic acid, 1-cyclopentene-1-carboxylic acid, and α-
methylcinnamic acid) failed to react under the reaction conditions. 
 
2.1.7 Conclusion an Future Outlook 
 The mild aerobic oxidation conditions developed for the ene reaction proved to be 
foundational for our future development of nitrosocarbonyl chemistry. For the first time, 
nitrosocarbonyl compounds could be accessed at room temperature without significant 
decomposition of the resulting products. Moreover, the methodology is operationally simple 
to perform; reactions are performed with reagent grade solvent, are run open to the 
atmosphere and utilizes a readily available and inexpensive catalyst. Additionally, no 
hazardous or toxic oxidants are used, and the only byproduct of oxidation is water.
16
 Based 
on this initial discovery, we sought to expand the scope of the aerobic oxidation of 
hydroxylamines.  
2.2 The Nitroso Hetero Diels–Alder Reaction: Extending the Aerobic Oxidation to 
Other N-Substituted Hydroxylamines 
2.2.1 Background and Motivation for Expanding the Aerobic Oxidation 
During our study of the nitrosocarbonyl ene reaction, which was based on a copper(I)-
catalyzed aerobic oxidation,
16
 Shea, Whiting and co-workers simultaneously and 
independently reported a similar copper(II)-catalyzed aerobic oxidation protocol for the 
nitrosocarbonyl Diels– Alder reaction.17 Under their developed methodology, a range of 
Cbz-protected 1,2-oxazines were accessible, via an intermolecular HDA reaction (Table 8, 
44-50). Additionally, two N-substituted hydroxylamines with appended dienes were also 
trapped as the HDA adducts in an intramolecular fashion (not shown). Importantly, the 
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reaction showed a significant improvement in yield over the previously developed transition 
metal systems, and presumably this method will find future widespread applications. 
Table 8. Shea and Whiting’s Aerobic Oxidation of Cbz-Protected Hydroxylamines 
 
a
 7:1 ratio of Diels–Alder to ene. b 2:1 ratio of regioisomers  
 
When we began studying the Diels–Alder reaction with our newly developed 
methodology, the aerobic oxidation approach was limited to the formation of nitrosoformate 
derivatives (51). Given the importance of nitroso chemistry and the myriad of N-substituted 
nitroso compounds used in synthesis, such as acylnitroso 52, nitrosoformamide 53, 
iminonitroso 54, P-nitroso phosphine oxide 55, P-nitroso phosphate 56, and arylnitroso 57 
derivatives, the development of a general aerobic oxidation of N-substituted hydroxylamines 
is still desired.
7
 Moreover, the substituted hydroxylamine motif is present in a number of 
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pharmaceutically active molecules and natural products (e.g. 58 – 62), making the 
development of new methodologies for hydroxylamine functionalization imperative. This 
section details our development of a general aerobic oxidation for these classes of 
substituted hydroxylamines, which provides a general, catalytic and sustainable alternative to 
stoichiometric oxidation methods to access a range of nitroso compounds (Figure 13). 
Figure 13. Motivation for Expanding the Scope of Aerobic Oxidation 
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2.2.2 Development of Aerobic Oxidation for N-Substituted Hydroxylamines 
Due to the instability and transient nature of nitroso compounds 51-56, we elected to use 
the nitroso HDA reaction as a means to investigate the generality of our catalytic aerobic 
oxidation protocol.  It is well known that nitroso compounds that are directly connected to an 
electron-withdrawing group (51-54) undergo rapid [4+2] cycloaddition reactions with 
conjugated dienes. Furthermore, the HDA reaction is a valuable transformation that plays a 
central role in the synthesis of natural products and biologically active molecules. These 
advantageous properties were key factors in our selection of the nitroso HDA reaction as a 
platform on which to test our new oxidation methodology. 
Our investigations began with our previously developed oxidation conditions (5 mol % 
CuCl, 1.25 mol % pyridine, reagent grade THF and 1 atm air). Under these conditions, 
reactions with acyl-substituted hydroxylamines required long reaction times and proved 
impractical. However, it was found that the aerobic oxidation protocol was more efficient 
and tolerant of a variety of N-substituted hydroxylamines when the catalyst loading was 
increased to 20 mol % and 5 mol % pyridine (Table 9). Generally, compounds containing a 
more electron-withdrawing group on the nitrogen substituent reacted slower. Within the 
acyl-substituted series, N-hydroxyacetamide 66 and N,2-dihydroxybenzamide 69 afforded 
the lowest yields (Table 9, 58% and 73% respectively) and required heating to 50 ºC to help 
facilitate the reaction. Under these conditions decomposition of the acylnitroso species 
became competitive with the HDA reaction, which resulted in the lower yields. 
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Table 9. Nitroso HDA reaction of Nitroso Compounds Bearing Carbonyls 
 
Hydroxylamines bearing formate-based protecting groups, such as Cbz, Boc, Troc, 
Fmoc, and Nppoc, all participated in the acylnitroso HDA reaction in greater than 87% yield 
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(Table 9, 45, 70–73). Other Cbz-derived N-hydroxycarbamates bearing p-substituted 
functional groups proceeded under the reaction conditions with no complications (Table 9, 
74–77). Nitrosoformamide compounds 78–81 reacted analogously and universally afforded 
products in high yield. Importantly, this includes hydroxyurea 78 that previously suffered 
from low isolated yield when stoichiometric periodate oxidation was used.
18
 Hydroxyurea 61 
is used clinically for the treatment of sickle-cell anemia
19
 and evidence suggests that its 
biological activity can be attributed to N–O oxidation by hemoglobin.20 Finally, the mild 
oxidation protocol can be performed successfully in a number of reagent grade solvents, 
such as 2-MeTHF, MeOH, EtOH, i-PrOH, EtOAc, and toluene.  
We next explored the capacity of these conditions to catalyze the aerobic oxidation of 
other known classes of N-substituted hydroxylamines (Table 10). Although less studied, 
HDA reaction with P-nitrosophosphine oxide and nitrosoamidine allows for the direct 
installation of phosphinamide and guanidine functional groups, which are prevalent in 
asymmetric catalysts and biologically active molecules.
21
 In addition, King and co-workers 
have shown that N-phosphinoylnitroso compounds hydrolyze to liberate nitroxyl (HNO), the 
biologically important reduced form of nitric oxide.
22
 Therefore, we were happy to observe 
that N-hydroxyphosphinamide 83 and N-hydroxyphosphoramidate 84 could be oxidized and 
readily trapped with 1,3-cyclohexadiene in moderate to excellent yield. Phosphorous-
migration is a known problem with N-hydroxyphosphoramidates and may contribute to the 
reduced yield of 84.
22c
 The oxidation protocol also worked with N,N’-bis-Boc-N’’-
hydroxylguanidine (Table 10, 85).
21c
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Table 10. Nitroso HDA reaction of Nitroso Compounds Bearing Other Functionalities 
 
a
 Synthesis of 84 commenced from diethyl (trimethylsilyl)oxy-
phosphoramidate, see supporting information. 
b 
The arylhydroxylamines 
were added over 2 h via syringe pump. 
 
Arylnitroso compounds are bench-top stable and consequently much less reactive in the 
hetero Diels–Alder reaction relative to acylnitroso compounds.7b In general, a considerable 
drop in yield is observed for these reactions. In addition, in-situ oxidation of the 
arylhydroxylamine is usually avoided because it is difficult to prevent over-oxidation and 
formation of coupling by-products, such as azoxybenzene.
23
 Initially, subjection of 
phenylhydroxylamine to the optimized reaction conditions resulted in the exclusive 
formation of azoxybenzene. To circumvent this undesired side reaction, we added the 
arylhydroxylamine via syringe pump over the course of 2 h. Utilizing this protocol, the 
azoxybenzene formation could be minimized and the nitroso HDA adducts were isolated in 
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high yield (Table 10, 86 & 87). Notably, this approach provided arylnitroso Diels–Alder 
adducts in high yield and represents a viable solution to the notoriously less efficient 
arylnitroso Diels–Alder cycloaddition. 
Finally, we wanted to investigate a diastereoselective nitroso HDA reaction.  While there 
are a number of elegant methods for performing asymmetric nitroso HDA reactions, the 
most common method for inducing chirality utilizes a chiral auxiliary on the acylnitroso 
dienophile. We chose to investigate the asymmetric HDA reaction using Oppolzer’s 
camphorsultam derivative 88. As shown in Equation 5, exposure of 88 to the optimized 
reaction conditions produced 89 as a single diastereomer in 99% yield. 
Equation 5. Asymmetric Nitroso HDA reaction using Oppolzer’s Sultam 
 
2.2.3 Exploring the Scope of Dienes for the Nitroso HDA Reaction 
HDA trapping of transient nitroso-species is not limited to the use of 1,3-
cyclohexadiene; other more elaborate and less reactive dienes can also be used (Table 11, 
44, 46, & 49). Good functional group compatibility was observed; for example, nitroso 
Diels–Alder adducts of both ergosterol 90 and ergosteryl acetate 91 were isolated in good 
yield and with excellent regioselectivity (16:1 and 35:1 respectively).
24
 Derivatives of these 
and other diene-containing natural products have been studied for their biological activity.
25
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Table 11. Diene Scope for the Nitroso HDA Reaction 
 
a
 Isolated as an inseparable mixture of regioisomers (16:1) 
b 
Isolated as 
an inseparable mixture of regioisomers (35:1) 
 
2.2.4. Determining the Relative Preference for Diels–Alder over Ene 
It is generally believed that the HDA reaction is more rapid if the free nitroso compound 
is present. Therefore, many research groups have hypothesized that the preference for ene 
over Diels–Alder is a reflection of whether or not the nitroso is bound to a metal, and a 
number of studies have invoked this argument when the ene adduct is observed as a major 
product in the presence of a Diels–Alder trapping agent.26 However, these control 
experiments are typically conducted with 2,3-dimethylbutadiene (DMB) as the Diels–Alder 
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trapping agent despite the fact that it is well known that DMB exists as a mixture of s-trans 
and s-cis conformers.
27
 We sought to study this further based on the fact that we did not 
observe formation of the ene adduct with the ergosterol derivatives, despite the presence of 
an olefin on the substrate.  
Shea and Whiting showed that using their mild oxidation protocol they could accurately 
determine the product distribution for dienes that are capable of undergoing both Diels–
Alder cycloaddition and ene reactions.
17
 As expected, we observed similar results with 2,3-
dimethylbuta-1,3-diene (DMB) 47 and 2-methyl-buta-1,3-diene 48 (Figure 14). The 
combined yields were high and the Diels–Alder adducts could be isolated in 71% and 43% 
yield, respectively. Based on these results we hypothesized that the formation of the ene 
product could be a reflection of the diene conformation/reactivity  
Figure 14. Analyzing the Reactivity of Dienes for Diels–Alder versus Ene 
 
In order to further evaluate the rate difference between ene and HDA, a competition 
experiment between an intermolecular HDA cycloaddition and intramolecular ene reaction 
was designed at room temperature using prenyl alcohol-derived N-hydroxycarbamate 1. 
Cyclic dienes locked in the required and reactive s-cis conformation were found to out-
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compete the intramolecular ene reaction and no product derived from the intramolecular ene 
reaction was observed (Figure 15, 95–96). In contrast, in the presence of DMB the 
predominant product resulted from an intramolecular ene reaction (72%). The overall ratio 
of products for this transformation was 14:3:1 (Figure 15, intramolecular ene 2 (72%, 
shown): nitroso HDA cycloaddition (16%, not shown): intermolecular ene (6%, not shown)). 
These results provide clear evidence that the use of unreactive dienes are required if the ene 
reaction is to proceed in preference to the Diels–Alder cycloaddition. While this result does 
not directly rule out the possibility of a metal-bound nitroso complex, special care must be 
taken to ensure that the diene selected is sufficiently reactive so as to not unfairly bias the 
results.  
Figure 15. Examining Intramolecular Ene vs. Intermolecular HDA for Various Dienes 
 
2.2.5 Concluding remarks 
The developed aerobic oxidation proved to be a general solution for accessing nitroso 
compounds from the corresponding N-substituted hydroxylamines.
28
 Additionally, the 
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aerobic oxidation is operationally simple to perform, uses readily available catalyst systems 
and produces only water as an oxidation byproduct. Based on this, we feel that the aerobic 
oxidation will be a widely used methodology for the future of nitroso chemistry. With the 
insight gained from our study into the aerobic oxidation, we felt confident exploring new 
areas of nitrosocarbonyl chemistry. 
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3. Expanding the Scope of Nitrosocarbonyl Transformations: The 
Nitroso Aldol Reaction 
3.1 Historical Background on Nitroso Aldol Reaction 
The efficient and direct -functionalization of carbonyl compounds with heteroatoms 
utilizing an electrophilic reagent is a significant challenge in organic synthesis.
1
 Although a 
number of methods have been developed for the direct α-heterofunctionalization of carbonyl 
compounds, nitrosobenzene and its analogues have been recognized as an attractive 
electrophile for such transformations due to the ease of handling.
2
 
Nitrosoarenes can serve as both an electrophilic source of nitrogen or oxygen and 
determining the factors that influence the ambident reactivity has been the major goal of a 
number of research programs.
3
 Although examples of the regioselective nitroso aldol 
reaction have existed since 1924,
4
 the pioneering work of Yamamoto and co-workers has 
ushered a renaissance in the field, culminating in the report of numerous methodologies 
using arylnitroso compounds to install either an oxygen
5
 or nitrogen heteroatom.
6
 While the 
N-selective nitroso aldol reaction has made considerable progress, the products of the 
oxyamination reaction are synthetically limited because it is prohibitively difficult to cleave 
the N-aryl bond to allow for subsequent nitrogen-bond forming transformations.
6i, 7
  
Comparatively, the aminooxylation reaction (i.e. O-selective aldol) to afford α-oxygenated 
carbonyl compounds has been extensively developed and now represents a versatile method 
to gain access to the α-oxycarbonyl synthon.5 However, the synthetic drawbacks of the N-
aryl bond often render the nitrogen as disposable waste, limiting the O-selective aldol with 
nitrosobenzene primarily to α-hydroxylation reactions (Figure 16).8  
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Figure 16. The Nitroso Aldol Reaction using Nitrosobenzene 
 
The significant limitations of nitrosobenzene has inspired the search for alternative 
nitroso compounds that bear N-substituents that are easier to manipulate but have similar 
versatility.  In principle, nitrosocarbonyl compounds can function in this role.
9
 However, due 
to their high reactivity, nitrosocarbonyls must be generated in situ
10
 and identifying 
conditions compatible with enolate formation has been a significant synthetic challenge. 
Inspired by the dearth of reports utilizing the transient electrophile, we elected to pursue the 
transformation (Figure 17). 
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Figure 17. The Nitrosocarbonyl Aldol Reaction 
 
3.2 Electrophilic α-Amination of Carbonyl Compounds: The N-Selective 
Nitrosocarbonyl Aldol Reaction 
3.2.1 Reaction Development Through Synergistic Catalysis 
Based on our previous success generating nitrosocarbonyl compounds under aerobic 
conditions,
11
 we set out to merge aerobic oxidation with Lewis acid catalysis. The use of 
synergistic catalysis is a powerful approach to reaction design and has emerged as a highly 
attractive strategy for developing new and valuable transformations.
12
 As shown in Figure 
18, we envisioned that the concurrent activation of latent nucleophilic (β-ketoester) and 
electrophilic (nitrosoformate) partners could be achieved.  The union of these catalytic 
processes would result in a direct -amination reaction of β-ketoesters.  
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Figure 18. Proposed Method of Accessing the N-Selective Nitrosocarbonyl Aldol 
 
The central challenge was to identify conditions that would allow for the compatible 
formation of the electrophile and nucleophile in situ, would facilitate subsequent C–N bond 
formation and would avoid decomposition of the highly reactive nitrosoformate ester 
intermediate. In addition to our studies on Cu(I)-catalyzed nitroso formation, Shea and 
Whiting have developed a Cu(II)-catalyzed aerobic oxidation of N-hydroxycarbamates to 
nitrosoformates.
13
 Moreover, copper(II) complexes have proven effective as a means of 
enolate generation in metal-catalyzed functionalization of β-ketoesters.14 In this regard, we 
felt copper complexes held tremendous promise and would be an excellent choice to initiate 
our investigations. 
The reaction of ethyl β-ketoester 1 with carbobenzyloxy (Cbz)-protected hydroxylamine 
2 was chosen as a test reaction. Initial screening of Lewis acids revealed that the proposed α-
amination with nitrosoformates could be accomplished by the addition of copper(II) 
trifluoromethanesulfonate (Cu(OTf)2) to our original optimized conditions for the ene 
reaction (Table 12, entry 1), albeit in a modest 3:1 N/O-selectivity.
 
To our gratification, 
promising levels of N/O-selectivity were obtained by changing the solvent from THF to 
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MeOH (Table 12, entry 2). A further increase in N-selectivity (11:1 to 14:1) resulted when 
pyridine was removed from the reaction (Table 12, entry 3). We found that other polar protic 
solvents, such as ethanol and isopropanol, negatively affected the N-selectivity (Table 12, 
entries 4 and 5). In the absence of either Cu(OTf)2 or CuCl we observe a slight decrease in 
efficiency and N/O-selectivity (Table 12, entries 6 and 7). The conditions that provided the 
optimal balance between efficiency and selectivity was 5 mol % CuCl and 5 mol % 
Cu(OTf)2 (Table 12, entry 8).  It is conceivable that two separate catalysts simultaneously 
activate the nucleophile and electrophile, however other possibilities cannot be ruled out at 
this time.  Importantly, the optimized protocol is practical and operationally simple. It 
involves simultaneous addition and mixing of all reagents, at room temperature, open to air, 
with reagent grade solvent and inexpensive and readily available materials.  
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Table 12. Optimization of N-Selective Nitrosocarbonyl Aldol Reaction 
 
Entry CuCl/Cu(OTf)2 Additive Solvent Time (h) Yield (%)
a 
N/O
b 
1
 
10 / 10 mol % pyr 
c 
THF 56 86 3:1 
2 10 / 10 mol % pyr
 c
 MeOH 9 91 11:1 
3 10 / 10 mol % –– MeOH 12 94 14:1 
4 10 / 10 mol % –– EtOH 24 90 4:1 
5 10 / 10 mol % –– iPrOH 53 80 2:1 
6
 
10 / 0 mol % –– MeOH 48 91 9:1 
7
d 
0 / 10  mol % –– MeOH 192 74 14:1 
8 5 / 5 mol % –– MeOH 24 97 14:1 
a
 Isolated yield of the N- and O-product mixture.  
b
 Determined by 
1
H NMR 
spectroscopy of the crude reaction mixture. 
c 
Reaction conducted with 1.25 mol % 
of pyridine. 
d 
The reaction with 5 mol % catalyst was prohibitively long. 
 
3.2.2 Exploring the Scope of the N-Selective Nitrosocarbonyl Aldol Reaction 
With optimized reaction conditions in hand (5 mol % CuCl and Cu(OTf)2, MeOH, air, 
rt), we investigated the scope of the -amination reaction by initially varying the ester group 
(R
1
) on the β-ketoesters and the N-substituent on the hydroxylamine (R2) (Table 13).  There 
appears to be no substantial steric restrictions of the ester moiety;  methyl, ethyl, allyl and t-
butyl derivatives all proceed in high yield, with comparable reaction rates (Table 13, 3 and 
7–9). X-ray crystal structure analysis of 9 was used to establish that the reaction had taken 
place on nitrogen.  In addition, steric and electronic modifications to the N-substituent on the 
hydroxylamine were also well tolerated. N-Hydroxycarbamates bearing protecting groups 
that could be orthogonally deprotected, Cbz, Boc, Fmoc, Troc, and Nppoc, all participated in 
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greater than 79% yield (Table 13, 10–13). In all cases the O-selective adduct was observed 
in minor amounts and could be separated by column chromatography  
Table 13. Ester and Carbamate Scope Studies for the N-Selective Nitrosocarbonyl Aldol 
 
Encouraged by these results, we further explored the scope of the transformation with a 
series of substituted β-ketoesters (Table 14). β-Ketoesters with alkyl, benzyl, or aryl 
substituents at R
1
 all afforded excellent yields of the desired hydroxyamination product 
(Table 14, 3, 19–22). Notably, a more sterically bulky -branched substrate underwent 
smooth conversion to give 21 in 91% yield.  Next, the electronic nature of aryl substituents 
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at R
1
 was investigated and found to have minimal effect on the reaction outcome.  Both 
electron rich and electron deficient aryl groups were found to be compatible (Table 14, 23–
26). Importantly, initial studies suggest that there is some leeway in the steric bulk of the α-
substituent (R
2
) (Table 14, 27–29). For example, -substitution (R2) with methyl, ethyl and 
benzyl groups all proceeded in excellent yield.  The methodology can also be used for cyclic 
-ketoesters (Table 14, 30 and 31) but the O-regioisomer became more competitive in such 
cases, affording O-selective products in 30% and 58%, respectively. In general the rate of the 
reaction slowed and higher ratios of the O-selective adduct were observed as the steric bulk 
of the -substitution increased and with cyclic substrates. Unsubstituted carbonyl 
compounds can be activated toward electrophilic substitution as well. Interestingly, in this 
case we observed N−O bond heterolysis and presumably the formation of an α-imino β-
ketoester that is trapped by methanol to afford compound 32.
4, 15
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Table 14. Scope of Substitution on β-Ketoester for N-Selective Nitrosocarbonyl Aldol 
 
 
To demonstrate the synthetic utility of this method, the reaction was performed on gram-
scale (Equation 6).  The catalyst loading could be lowered to 1 mol % with no significant 
loss in overall yield, although the reaction required ten days for completion.   
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Equation 6. Gram Scale N-Selective Nitrosocarbonyl Aldol Reaction 
 
3.2.3 Synthetic Manipulations on the N-Selective Nitrosocarbonyl Aldol Products 
While we envisioned a number of synthetic transformations for the -amination 
products, we focused on a series of functional group manipulations that highlight the utility 
of using a nitrosoformate intermediate as the electrophilic source of nitrogen. For example, 
hydrogenation of the Cbz-group with 5 mol % Pd/C or an acid catalyzed deprotection of 
Boc-group leads to -hydroxylamine product (Figure 19, 35).  It is worth noting that the 
expected N–O bond cleavage under the reducing conditions was not observed.  In addition, 
this compound was surprisingly stable to column chromatography; presumably these effects 
are due to steric hindrance. Alternatively, the N–O bond can be cleaved using Zn and 2N 
HCl to afford 36 in excellent yield.  Most notably, the free amine can be obtained by a 
hydrogenation of 36.
16
  Given the difficulty in isolating 37 and its tendency to undergo self-
condensation, we were unable to go directly from the -amination product (Table 13, 3 or 
12) to the free amine because more forcing conditions were required to break the N–O bond.  
Lastly, N-oxazolidinone 38 can be obtained directly by a reduction of the β-keto 
functionality with sodium borohydride. The reduction was highly diastereoselective and the 
relative stereochemistry was established by X-ray crystal structure analysis of a 
corresponding O-acylated derivative. As illustrated in Figure 19, the hydroxylamine (35), the 
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carbamate (36), the free amine (37) and the N-oxazolidinone (38) were all obtained in a 
straightforward manner using conditions that should be amenable to a more complex setting 
and would be difficult to access using current methodology.  
Figure 19. Facile Derivitization of N-Selective Nitrosocarbonyl Aldol Products 
 
a 
Pd/C (5 mol %), MeOH, H2 (73%). 
b 
TFA, CH2Cl2 (95%),
 c
 Zn, 2N HCl, reflux, 
(79% yield) 
d 
 1. Zn, 2N HCl, reflux (79%), 2. Pd/C (5 mol %), H2 (90%)  
e
  i. NaBH4, MeOH, ii. SiO2 (71%). 
 
3.2.4 Conclusion and Future Outlook 
The first example of the N-selective nitrosocarbonyl aldol facilitated the expansion of 
nitrosocarbonyl chemistry beyond the ene and Diels – Alder reactions.17 Since our report, a 
number of research groups have reported variations on the N-selective aldol through both 
Lewis acid activation,
18
 and organocatalysis.
19
 While these examples show the significant 
progress has been made on rendering the transformation asymmetric through activation of 
pro-chiral nucleophiles, utilizing the electrophile as the asymmetry inducing element is still 
unprecedented. We anticipate that accomplishing this goal will dramatically impact the 
future of nitrosocarbonyl chemistry. 
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3.3 Electrophilic α-Oxygenation of Carbonyl Compounds: the O-Selective 
Nitrosocarbonyl Aldol Reaction  
3.3.1 Background and Optimization Studies for the O-Selective Aldol Reaction 
Although conditions are known to reverse the regioselectivity (O- vs N-selectivity) for 
the nitroso aldol reaction using stable arylnitroso compounds,
5-6
 the ability to tune the 
reaction conditions to regioselectively control whether nucleophiles react on nitrogen or 
oxygen with highly reactive and transient nitrosocarbonyls remained unexplored prior to our 
work.
20
 Despite this, we envisaged that if our N-nitrosocarbonyl aldol reaction conditions 
could be tuned without disturbing the aerobic oxidation process,
11, 17
 the regioselectivity of 
the nitroso aldol reaction could be reversed (Figure 20). 
Figure 20. Proposed Development of an O-Selective Nitrosocarbonyl Aldol 
 
Inspired by some initial results from the N-selective transformation, we found that, of the 
N-protected hydroxylamines screened, N-Boc-hydroxylamine (42) with -ketoester 1 
provided the aldol product with an increased amount of the O-regioisomer; However, the 
reaction was still predominantly N-selective (Table 15, entry 1-4). By switching from MeOH 
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as the solvent to a more sterically encumbered alcohol, such as EtOH and i-PrOH, the 
process could be rendered more O-selective (Table 15, entries 5 & 6).  Switching from 
copper(II) trifluoromethanesulfonate (Cu(OTf)2) to copper(II) chloride to copper(II) acetate 
monohydrate (Cu(OAc)2·H2O) further increased O-selectivity while maintaining a high yield 
(Table 15, entries 7 & 8).  To our gratification, the O-selectivity and the rate could be 
increased significantly by the addition of 5 mol % of 2-ethyl-2-oxazoline (EtOx),
13
 with 
Cu(OAc)2·H2O being the optimal Cu(II) source (Table 15, entries 9–11).  Pyridine, among 
other ligands, was also screened but led to reduced O-selectivity (Table 15, entry 12). 
Removal of the Cu(I) source led to a dramatic decrease in rate (Table 15,entry 13), while 
removal of the Cu(II) source adversely affected both the selectivity and yield of the reaction 
(Table15, entry 14). As with the N-selective system, the formation of a single discrete 
catalyst from the mixed metal system cannot be ruled out, but we believe the observed trends 
in reactivity (Table 15) are suggestive of a dual catalytic process. 
  57 
Table 15. Optimization of the O-Selective Nitrosocarbonyl Reaction 
 
Entry Cu
II
 Source CO2R Ligand
a 
Solvent Time (h) Yield (%)
b 
O/N ratio
c 
1 Cu(OTf)2 Boc – MeOH 24 96 1:4 
2 Cu(OTf)2 Troc – MeOH 24 99 1:9 
3 Cu(OTf)2 Fmoc – MeOH 24 95 1:10 
4 Cu(OTf)2 Cbz – MeOH 24 97 1:13 
5 Cu(OTf)2 Boc – EtOH 24 82 1:1 
6 Cu(OTf)2 Boc – i-PrOH 48 83 2:1 
7 CuCl2 Boc – i-PrOH 120 90 3:1 
8 Cu(OAc)2
d 
Boc – i-PrOH 196 97 3:1 
9 Cu(OTf)2 Boc EtOx i-PrOH 24 93 3:2 
10 CuCl2 Boc EtOx i-PrOH 20 75 6:1 
11 Cu(OAc)2
 d
 Boc EtOx i-PrOH 18 94 10:1 
12 Cu(OAc)2
 d
 Boc Pyr i-PrOH 24 97 7:1 
13
e 
Cu(OAc)2
 d
 Boc EtOx i-PrOH 52 90 20:1 
14 – Boc EtOx i-PrOH 8 53 5:1 
a 
EtOx=2-ethyl-2-oxazoline. 
b
 Isolated yield of the O- and N-product mixture. 
c 
Determined by 1H NMR spectroscopy of the mixture of crude material. 
d
 The hydrate of 
Cu(OAc)2 was used. 
e
 No CuCl was added to the reaction. 
 
3.3.2 Exploring the Scope of the O-Selective Nitrosocarbonyl Aldol Reaction 
With optimized reaction conditions in hand (5 mol % CuCl, 5 mol % Cu(OAc)2•H2O, 5 
mol % 2-ethyl-2-oxazoline, i-PrOH, air, rt), we investigated the scope of our aminooxylation 
reaction by varying the -ketoester component (Table 16). In contrast to our previously 
developed N-nitrosocarbonyl aldol reaction,
17
 the regioselectivity was noticeably influenced 
by the substitution of the β-ketoester. As a general trend, with more steric bulk at the 4-
position (R
1
) of the β-ketoester, the regioselectivity of the transformation was reduced; 
methyl (Table 16, 44, 10:1 O:N) proved to be much more regioselective than benzyl (able 
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16, 45, 7:1 O:N), ethyl (Table 16, 46, 3:1 O:N), and isopropyl (Table 16, 47, 2:1 O:N). 
Varying the steric component at the ester position (R
2
) also had an effect on regiochemistry. 
The methyl ester (Table 16, 48, 11:1 O:N) proved to be more O-selective than the ethyl ester 
(Table 16, 49, 10:1 O:N), whereas the allyl (Table 16, 50, 7:1 O:N) and the t-Bu (Table 16, 
51, 5:1 O:N) esters showed a reduction in regioselectivity.  
Table 16. Scope of 4-Position and Ester for the O-Selective Nitrosocarbonyl Aldol 
 
 With regards to substitution at the 2-position of the β-ketoester, the converse was 
true: increasing the steric bulk rendered the transformation completely O-selective (Table 
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17, entries 54–56). However, to obtain excellent yields of 54 and 55, 3 equivalents of the 
corresponding -ketoester was required in order to outcompete the condensation between the 
in situ formed nitrosocarbonyl species and the N-Boc-hydroxylamine. The scope of the -
ketoester could also be extended to include non-alkyl substituents, such as fluorine, with no 
reduction in efficiency or regioselectivity (Table 17, entry 57). Additionally the scope of the 
transformation could be extended to include cyclic β-ketoesters; the reaction was tolerant of 
both 5- and 6-membered rings (Table 17, entries 58 & 59) as well as substitution on the 
cyclic backbone (Table 17, entry 60), with all cases being completely O-selective. 
Table 17. Scope of 2-Position and Cyclic Substrates for the O-Selective Aldol 
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 In addition to N-Boc hydroxylamine, a wide variety of carbamate-derived protecting 
groups can be used: Cbz, Fmoc, Troc, Nppoc and Moz all gave the O-aldol product in good 
yield (Table 18, entries 65, 68–71). In contrast to the acyclic substrates, changes to the ester 
component (Table 18, entries 64–66) were well tolerated as methyl, ethyl, and tert-butyl all 
proceeded in good yield and with perfect regiocontrol. The notable exception was the 
reaction derived from the ester bearing a 2,6-dimethyl phenol (Table 18, 67). In this case, we 
observed a 3% yield of the N-regioisomer. Further investigations are underway to help 
elucidate the difference in reactivity between the acyclic and cyclic substrates. 
Table 18. Scope of Ester and Carbamate for Cyclic Compounds 
 
 In all cases, the combined yield of both regioisomers was high (>90%) and the O-
selective product could easily be isolated in moderate to excellent yield after column 
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chromatography. It is particularly noteworthy that simultaneous mixing of all reagents at 
room temperature can be used, even in the most challenging cases. Presumably, the slow rate 
of oxidation relative to enolization is the key to avoiding deleterious side reactions; the 
transient nitrosocarbonyl is immediately trapped by the nucleophilic -ketoester upon 
formation. Moreover, the reaction could be conducted at gram scale, with only slight 
reduction in reaction efficiency (Equation 7) 
Equation 7. Gram Scale Reaction for the O-Selective Nitrosocarbonyl Aldol Reaction 
 
3.3.3 Asymmetric Studies for the O-Selective Nitrosocarbonyl Aldol Reaction 
Due to the Lewis Acid-ligand combination used, the reaction can be rendered 
asymmetric by simply substituting the 2-ethyl-2-oxazoline ligand with 6 mol % (R,R)-PhBox 
ligand (Table 19).
20
 Interestingly, the steric bulk of the -ketoester played a role in achieving 
higher levels of enantioinduction. Initially, we were pleased to observe that the reaction with 
commercially available -ketoester 1 afforded good levels of enantioselectivity in the 
formation of product 76 (Table 19, 92:8 er). Replacement of the ethyl ester moiety with the 
more sterically demanding tert-butyl ester significantly improved the enantioselectivity from 
92:8 er to 99:1 er, respectively (Table 19, 78).  The product derived from an ester bearing a 
2,6-dimethyl phenol (Table 19, 77) also resulted in excellent enantioselectivity (99:1 er) and 
was slightly more efficient (85% yield). To our delight the same asymmetric reaction 
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conditions could be extended to the cyclic substrates (Table 19, entries 79–82). Once again, 
the tert-butyl ester moiety provided the highest levels of enantioselectivity (82, 99:1 er).  
While not a perfect correlation, the general trend of the transformation suggests that the 
greater the steric demand of the ester group, the higher the level of enantioinduction. Single 
crystal X-ray analysis of a derivative of 82 was used to determine the absolute 
stereochemistry. 
Table 19.  Ester Dependence of Enantioselective O-Selective Nitrosocarbonyl Aldol 
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3.3.4 Elucidating Factors Influencing the Regiochemistry of the Aldol Reaction 
While models have been developed to rationalize the ambident reactivity of arylnitroso 
compounds for the aldol reaction,
3
 similar guiding principles for nitrosocarbonyl species are 
non-existent. Therefore, we sought to better understand the source of the regiochemical 
switch by studying the steric and electronic environment about the Lewis acid.  From our 
optimization studies (Table 15, entries 9 and 11) a dramatic difference was observed in 
regiochemistry when the Lewis acid was switched from Cu(OTf)2 to Cu(OAc)2•H2O when 
EtOx ligand was present. Based on that observation, we screened a number of Cu(II) Lewis 
acids using our optimized reaction conditions to determine what role the counterion played 
in selectivity. Weakly coordinating counterions, such as -OTf and -BF4 favor an unselective 
aldol reaction, whereas strongly associating carboxylate counterions favor reaction on 
oxygen (1.5:1 vs 10:1 O:N, see Figure 21A). Additionally, with two electronically similar 
carboxylate counterions, the increased steric bulk of the 2-ethylhexanoate counterion further 
enhances the O-selectivity from 10:1 to 14:1.  
In order to better understand the influence of the acetate–metal complex on the 
regiochemistry, a varying amount of NaOAc was added to an unselective reaction (20 mol % 
CuCl, 20 mol % Cu(OTf)2, 20 mol % EtOx, i-PrOH, air, rt.). At low concentrations of 
NaOAc (0–15 mol%), the reaction showed no increase in O-selectivity (2:1, O:N; see Figure 
21B). However, above 15 mol% the regiochemistry linearly increased up to 40 mol % (7:1, 
O:N), which equaled the molar concentration of the copper catalysts. Employing greater than 
40 mol% of NaOAc showed no additional influence on the regiochemistry (Figure 21B). 
Without the addition of NaOAc the reaction gave a 9 : 1 selectivity (O : N) and with 40 mol 
% NaOAc the reaction was completely O-selective (not depicted). 
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Figure 21. Effect of Reaction Conditions on O-Selectivity 
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A) Role of counterion derived from the Cu(II) Lewis acid on the O- and N-selectivity. B) 
Addition of NaOAc to an unselective reaction (20 mol % CuCl, 20 mol % Cu(OTf)2, 20 
mol % EtOx, i-PrOH, air, rt.) leads to an increase in O-selectivity. C) Addition of EtOx 
ligand results in an increase in O-selectivity. 
a 
Regioselectivity was determined by 
1
H 
NMR analysis of the crude reaction mixture. 
b
 the hydrate of the Cu(II) source was used.  
c 
2-EtHex = 2-ethylhexanoate.  
 
Based on the experiments with NaOAc, we decided to re-examine the effects of EtOx 
ligand on the regiochemistry (Figure 21C). Previously we only evaluated the reaction 
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without EtOx and with 5 mol % EtOx (Table 15).  The same trend was also observed when 
the amount of EtOx ligand was varied from 0 to 40 mol %. However, to our gratification, the 
reaction was completely O-selective in the presence of 40 mol % EtOx (Figure 21C, 
depicted by dotted arrow) and the same effect was observed when using (R,R)-PhBOX as the 
ligand instead of EtOx (not shown). Combined, these studies elucidate that weakly Lewis 
acidic metal complexes bearing strongly coordinating counterions and ligands are important 
for the O-selective process.
21
  
On the basis of the absolute configuration of the products and the combined results 
obtained during our investigations, we tentatively propose a reaction mechanism that 
involves the approach of the nitrosocarbonyl to the catalyst-coordinated -ketoester, as 
shown in Figure 22. We speculate that the decreased Lewis acidity and the increased steric 
environment associated with the catalyst--ketoester complex during the bond-forming 
event largely govern the reversal in selectivity.  Assuming the reaction proceeds through a 
square-pyramidal or octahedral geometry (not depicted),
21a-d
 it is conceivable that the 
counterion occupies the axial position, which would prevent coordination of the nitroso 
species to the Lewis acid and force the nitroso electrophile to approach over the β-ketoester.  
Using large and more associating counterions, excess ethyl oxazoline or sterically bulky 
PhBox ligand further enhances this effect. Presumably, the reaction predominately occurs on 
oxygen because this helps avoid unfavorable steric interactions between the protecting-group 
of the nitroso species and the -ketoester-metal complex.  This hypothesis is consistent with 
the observation that the use of N-Boc-protected hydroxylamine gave the best results for the 
O-selective process (Table 15, entries 1-4) and helps rationalize why the sterics of the 
-ketoester can have a significant effect on the regiochemical outcome, specifically at the R1 
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and R
3
 position of the -ketoester (see Table 16). Further investigations are underway to 
help elucidate the complexities of the regiochemical outcome of the nitrosocarbonyl aldol 
reaction and explore other possible models.  
Figure 22. Proposed Stereochemical Model for the O-Selective Nitrosocarbonyl Aldol 
 
3.3.5 Synthetic Manipulations on the O-Selective Nitrosocarbonyl Aldol Products 
Finally, we wanted to display the synthetic utility offered by using nitrosocarbonyl 
compounds. Typically, the utility of the O-selective nitroso aldol reaction has been 
highlighted by the transformation of the -aminooxy-carbonyl to the corresponding -
hydroxy-carbonyl.
5b, 5c, 5f, 5j, 6e, 20
 This approach provides efficient access to a highly valued 
synthetic target, -hydroxy-carbonyl.8 However, it also treats the substituted nitrogen group 
as a waste byproduct, which diminishes the atom economy and can restrict the synthetic 
utility of the overall transformation. This phenomenon is most likely a consequence of using 
nitrosobenzene as the electrophile and the difficulties associated with cleaving the N-aryl 
bond for subsequent transformations. Thus, we chose to take advantage of the appended 
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nitrogen group by utilizing it in a series of annulation reactions (Figure 23).
22
 Treatment of 
the O-aldol product with DBU and vinyltriphenylphosphonium bromide efficiently affords 
the highly substituted 1,2-oxazine 84 via cascade Michael and Wittig reactions. This 
transformation provides an attractive and synthetically useful approach to access to 1,2-
oxazine bearing a quaternary center and a nitrogen substituent that can be easily 
deprotected.
17
 This structural motif can be challenging to construct using the nitrosocarbonyl 
hetero-Diels–Alder reaction because moderate regioselectivity is often observed in these 
cases.
9b
 Alternatively, the O-aldol product can be treated with vinyldiphenylsulfonium 
triflate to access the highly substituted epoxyoxazine 85 as a single diastereomer, determined 
by X-ray. We were thrilled to discover that both annulation reactions could be carried out 
conveniently in a one-pot process by simply adding the reagents for the annulation reaction 
directly to the reaction mixture after the O-nitrosocarbonyl aldol reaction was complete. 
These one-pot annulation reactions are feasible because the aerobic oxidation conditions are 
mild and the oxidation byproducts produced do not interfere with the subsequent reaction. 
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Figure 23. Combining O-Selective Nitrosocarbonyl Aldol with Annulation Chemistry 
 
3.3.6 Conclusion and Future Outlook 
The O-selective methodology complements our previously disclosed N-selective nitroso 
aldol reaction and the two, as a set, showcase the ambident reactivity of nitrosocarbonyl 
compounds. While the O-selective variant has garnered much less attention than the N-
selective counterpart,
18-19
 we envision that the next frontier of O-selective aldol chemistry is 
the expansion of the scope to include unactivated carbonyls (e.g. ketones and aldehydes). 
Moreover, a better mechanistic understanding of the factors contributing to the 
regiochemical outcome would be foundational in the development in new nitrosocarbonyl 
chemistry. 
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4. Accessing Nitrosocarbonyl Compounds with Temporal and Spatial 
Control via the Photoredox Oxidation of N-substituted Hydroxylamines 
4.1 Background and Significance 
Nitrosocarbonyl compounds are exceptionally reactive intermediates that have found 
widespread use in a number of classic C-N or C-O bond–forming reactions, such as the ene,1 
Diels–Alder,2 and aldol reactions.3 In recent years, a number of research groups have 
explored new methodologies to generate nitrosocarbonyl intermediates, such as oxidation 
under aerobic conditions,
1-3
 utilizing transition metals with stoichiometric peroxide,
4
 
manganese dioxide oxidations, 
5
 and oxidations employing TEMPO and BPO,
6
 among 
others.
7
  While many of these new oxidation methodologies have facilitated the expansion of 
nitrosocarbonyl chemistry, none have explored the potential of generating nitrosocarbonyl 
intermediates with temporal and spatial control. This unique property, often neglected in the 
context of small molecule organic synthesis, is an important facet to consider when 
expanding nitrosocarbonyl chemistry into biological and materials science applications. 
Photoredox catalysis is an emerging tool for the synthesis of complex molecules that has 
been shown to be effective in contexts requiring temporal and spatial control. While the 
genesis of photoredox catalysis can be traced back to Kellog in the 1970’s, the field has 
undergone a renaissance in recent years, based on the pioneering work of a number of 
research groups.
8
 In particular, the recent work by the groups of Yoon,
9
 and Stephenson,
10
 
highlight the advantageous usage of photoredox catalysis in the oxidative generation of 
reactive intermediates. Recently, Hawker and co-workers have translated photoredox 
catalysis into material science,
11
 which provides excellent spatial arrangement of functional 
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groups at surfaces.
12
 The key to this methodology was visible-light mediated Ir-catalyzed 
ATRA chemistry developed by Stephenson and co-workers.
13
 Because nitrosocarbonyl 
compounds participate in a variety of organic reactions, the in-situ formation of this highly 
reactive functional group using photoredox conditions would furnish a general procedure for 
patterning surfaces bearing a range of properties. Moreover, because nitrosocarbonyl 
compounds serve as HNO donors,
14
 it could also provide a means to generate HNO in using 
visible-light to control its release. To evaluate this potential, we began by investigating the 
in-situ generation of nitrosocarbonyl compounds using photoredox conditions.  A recent 
report by Tan inspired us to disclose our results in this area (Figure 24).
15
 
Figure 24. Exploring Photoredox Conditions for the Generation of Nitrosocarbonyls 
 
4.2 Development of Photoredox Methodology to Generate Nitrosocarbonyls.  
4.2.1 Optimization of the Photoredox Reaction 
Due to the transient nature of nitroso compounds and their associated inherent 
instability,
16
 we selected the nitroso HDA reaction to test the feasibility of a photoredox 
catalyst system. Nitroso compounds directly attached to an electron withdrawing group 
undergo rapid [4+2] cycloaddition reactions with conjugated dienes, a reaction platform that 
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has been explored extensively by our research group
2a
 and others.
17
 Cbz-protected 
hydroxylamine 1 and 1,3-dicyclohexadiene 2 were elected as candidates for standardizing 
reaction conditions (Table 20) and investigations began with commercially available and 
widely employed Ru(bpy)3Cl2•6H2O. At 1 mol % loading and in DCE at room temperature, 
we were pleased to see a 35% yield of the desired oxazine product (Table 20, entry 1). 
Analysis of the reaction mixture revealed a large amount of an undesired HDA product 
resulting from reaction of the diene with diatomic oxygen in a [4+2] cycloaddition and 
subsequent ring-opening reaction,
18
 suggesting the potential interference of singlet oxygen 
on our desired reaction pathway.
19
 Pleasingly, the addition of pyridine (2.0 equiv) 
completely inhibited this unproductive pathway (Table 20, entry 2) and allowed us to 
achieve an improved yield of 80%. Screening other Ru photocatalysts, (Table 20 entries 3–6) 
showed no improvement in yield or reaction duration over Ru(bpy)3Cl2•6H2O. In 
considering which photoredox catalysts to employ, Ru(bpy)3
2+*
 is both a good oxidant and 
reductant.
8
 Switching to a photocatalyst like Ir(ppy)3, which is more reducing in its excited 
state, had a negative impact on the yield (Table 20, entries 7 & 8). Using Eu-based catalyst 
(Table 20, entry 9) satisfactorily augmented the yield but has the added disadvantage of 
requiring UV light for activation. Based on this, we elected to further optimize the reaction 
with Ru(bpy)3Cl2•6H2O. 
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Table 20. Optimization of Photoredox Conditions for Generation Nitrosocarbonyls 
 
Entry Catalyst (1 mol %) Solvent Additive (equiv) Yield (%)
a 
1 Ru(bpy)3Cl2•6H2O DCE - 35 
2 Ru(bpy)3Cl2•6H2O DCE pyridine  (2.0) 80 
3 Ru(bpz)3Cl2 - - 49 
4 Ru(bpz)3Cl2 DCE pyridine  (2.0) 73 
5 Ru(bpm)3BArF2 DCE pyridine  (2.0) 30 
6 Ru(phen)3Cl2 DCE pyridine  (2.0) 24 
7 Ir-fac(ppy)3 DCE pyridine  (2.0) 34 
8 Ir(BTP)3 DCE pyridine  (2.0) 63 
9 Eu(dbm)3(phen)
b 
DCE pyridine  (2.0) 95 
10 Ru(bpy)3Cl2•6H2O DCE 2,6-lutidine (2.0) 87 
11 Ru(bpy)3Cl2•6H2O DCE 2,6-lutidine (0.5) 74 
12 Ru(bpy)3Cl2•6H2O DCE 2,6-lutidine (0.05) 60 
13 Ru(bpy)3Cl2•6H2O MeNO2 2,6-lutidine (2.0) 63 
14 Ru(bpy)3Cl2•6H2O MeCN 2,6-lutidine (2.0) 55 
15 Ru(bpy)3Cl2•6H2O DCE 2,6-lutidine (2.0) <5%
c 
16 - DCE 2,6-lutidine (2.0) <5%
c 
a
 Isolated yields.
 b
 280 nm light was used. 
c
 Starting material was recovered  
 
Next we looked at the dependence of the reaction on the chosen additive; screening 
various bases (NEt3, iPr2NEt, etc.) led us to determine that 2,6-lutidine was the additive of 
choice for our reaction set up. Variations in the additive loading (Table 20, entries 10 – 12) 
indicated 2.0 equiv of 2,6-lutidine was optimal, and a brief solvent screen (Table 20, entries 
13 & 14) indicated DCE to indeed be our preferred solvent. Finally, the reaction does not 
proceed in the dark under the same conditions and duration (Table 20 entry 15), nor is any 
conversion observed in the absence of catalyst (Table 20, entry 16). Based on these results 
we elected to explore the reaction with 1 mol % Ru(bpy)3Cl2•6H2O and 2 equiv 2,6-lutidine 
in DCE (Table 20, entry 10).  
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4.2.2 Exploration of the Scope with Nitrosocarbonyl Diels–Alder and Ene Reactions 
With optimized reaction conditions in hand, we elected to briefly explore the scope of 
the Diels–Alder reaction to ensure generality of reaction conditions. Fortunately both the 5–  
and 6– membered ring dienes readily underwent the Diels–Alder reaction with no competing 
production of the endoperoxide or hydroxyenone (Table 21, 7 & 3). Additionally, 1,4-
diphenylbutadiene also underwent clean conversion to the desired oxazine product (Table 
21, 8). The reaction was not limited to Cbz-protected hydroxylamines, as Boc-protected 
hydroxylamines were readily converted to the corresponding oxazine products (Table 21, 
entries 9 & 10).  
Table 21. Scope of the Nitrosocarbonyl HDA under Photoredox Conditions. 
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While the Diels–Alder reaction with nitrosoformate intermediates is known to be a 
highly efficient reaction,
17
 the corresponding ene reaction of nitrosoformate intermediates 
often suffers from poor yields due to the over-oxidation of the allylic hydroxylamine 
products.
20
 Recent efforts have been undertaken by a number of research groups to 
circumvent this known decomposition reaction,
21
 and thus the ene reaction has proven to be 
an effective tool for evaluating the mildness of oxidation reaction conditions.
7
 In this 
context, we elected to test our newly developed oxidation conditions with a subset of olefin 
partners. We were delighted to find that the ene adducts were readily formed under our 
optimized conditions with no observable product decomposition. As with other studies, the 
efficiency of the ene reaction is directly correlated to the substitution of the olefin; fully 
substituted olefins, such as 2,3-dimethylbutene, form the corresponding allylic 
hydroxylamine in quantitative yield (Table 22, 13). In contrast, mono-substituted olefins 
such as 1-octene react with nitrosocarbonyl compounds with reduced yields (Table 22, 17). 
In each case, the photoredox conditions compared favorably with previous oxidative 
nitrosocarbonyl ene methodologies (Table 22, 13–17).1 Based on these results, we envision 
that these conditions can be utilized for a wide variety of reaction platforms and will 
facilitate the expansion of nitrosocarbonyl chemistry into previously unexplored areas of 
organic synthesis.  
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Table 22. Scope of Nitrosocarbonyl Ene Reaction Under Photoredox Conditions 
 
4.3. Mechanistic Investigation of the Photoredox Generation of Nitrosocarbonyls 
4.3.1 Probing the Temporal and Spatial Control of the Photoredox Oxidation  
Encouraged by the mildness of our reaction conditions, we next elected to explore the 
efficiency of temporal control for our optimized conditions. While on-off studies are not 
normally performed for photoredox reactions in small molecule chemistry, this type of 
experiment is regularly conducted with photoredox polymerizations,
11, 22
 and is a 
prerequisite for transitioning a methodology into a number of materials science applications 
such as the patterning of functionalized surfaces.
12
 Therefore, we were delighted to find that 
the reaction could be effectively turned on and off based on the presence or absence of light. 
The reaction showed no reduction in efficiency even after iteratively turning the light on and 
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off. Moreover, the reaction could even be shut off for extended periods of time (e.g. 18 
hours) and started again once the light was reintroduced, highlighting a unique element of 
control never exploited for the generation of nitrosocarbonyl intermediates (Figure 25). 
Figure 25. On-Off Studies for the Newly Developed Photoredox Oxidation 
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a
 Reactions conducted using dimethyl terephthalate as the internal standard. 
b 
Aliquots 
were removed at the indicated times and conversion was determined by 
1
HNMR analysis 
 
We next explored the distance dependence of our newly developed reaction conditions. 
For the design of this experiment, the lights were placed at a variable distance away from the 
sidewall of the reaction flask and the reaction was monitored periodically for conversion. As 
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expected, when the lights were touching the sidewall of the flask, the reaction proceeded the 
fastest, with a rate paralleling our on-off study. As the lights were moved further from the 
flask, the reaction rate dropped precipitously. Based on these results, there is a clear spatial 
dependence of the reaction rate: the intensity of the light has a direct effect on the reaction 
(Figure 26). Based on the distance dependence and the on-off studies, we believe that this 
reaction has the potential to find widespread use in applications where temporal and spatial 
control are desired, and our studies in this area will be reported in due time. 
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Figure 26. Distance Dependence of Newly Developed Photoredox Oxidation 
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a
 Reactions conducted using dimethyl terephthalate as the internal standard. 
b 
Aliquots 
were removed at the indicated times and conversion was determined by 
1
HNMR 
analysis. 
c
 The 26W lights were placed at the indicated distances relative to the sidewall 
of the reaction vessel.  
 
4.3.2 Exploring Possible Mechanistic Pathways 
Based on the trends we observed during the reaction development, we were interested in 
further exploring the mechanism. In particular, we wanted to distinguish between a 
photoredox mechanism and a mechanism involving singlet oxygen. In order to probe this, 
we turned to Stern-Volmer studies to confirm the direct interaction between the catalyst and 
  81 
the Cbz-protected hydroxylamine.
23
 As expected, the magnitude of fluorescence of the 
catalyst had a linear dependence on the concentration of the Cbz-protected hydroxylamine,
24
 
indicating an interaction between the excited state of the catalyst and the Cbz-protected 
hydroxylamine (Figure 27). In contrast, no fluorescence quenching was observed in the 
presence of varying concentrations of the diene (See SI for more information). Based on 
these results, we propose that the excited state of the catalyst (Ru(bpy)3Cl2
*
) is directly 
oxidizing the Cbz-protected hydroxylamine to the corresponding radical cation, consistent 
with the known redox potentials of the catalyst excited state (E1/2 =  1.08V vs Ag/AgNO3)
8
 
and the Cbz-protected hydroxylamine (Ep/2 = 0.95V vs Ag/AgNO3, see supporting 
information). The subsequent reduction of molecular oxygen forms the corresponding 
superoxide radical, which facilitates the conversion of the Cbz-hydroxylamine radical cation 
to the nitrosocarbonyl species (Figure 28, mechanism A). 
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Figure 27. Fluorescence Quenching Experiments with Cbz-Protected Hydroxylamine 
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a
 Fluorescence quenching studies were performed in a sealed cuvette under an 
atmosphere of argon using 1 mg/mL of Ru(bpy)3Cl2•6H2O in 1,2-dichloroethane.  
 
To explore the mechanism further, we tested the reaction efficiency in the presence of a 
known singlet oxygen sensitizer, tetraphenylporphyrin (TPP).
25
 To our surprise, upon 
irradiation of the reaction, a small amount of hetero–Diels–Alder adduct was observed, 
although additional aliquots of cyclohexadiene were added periodically (3 equivalents every 
2 hours), due to competing consumption of the diene by singlet oxygen.
19
 Under these 
conditions, a significant amount of both the endoperoxide and ring–opened 4-hydroxy-2-
cyclohexenone were isolated,
18
 along with the desired nitrosocarbonyl HDA adduct 
(Equation 8). Under the optimized reaction conditions, direct energy transfer from 
Ru(bpy)3Cl2
*
 to molecular oxygen will produce singlet oxygen, which can potentially 
oxidize the Cbz-protected hydroxylamine directly and form the corresponding 
nitrosocarbonyl compound (Figure 28, mechanism B).  
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Equation 8. Singlet Oxygen Mediated Oxidation using 5,10,15,20-Tetraphenylporphyrin 
 
 
Despite the results using TPP, we believe that the reaction proceeds predominantly 
through a photoredox mechanism (Figure 28, mechanism A), based on the compatibility of 
redox potentials between the hydroxylamine and Ru(bpy)3Cl2
*
, the Stern-Volmer studies, 
and on the lack of formation of products derived from singlet oxygen under the optimized 
conditions. However, at this time a singlet oxygen–mediated mechanism cannot be ruled out 
(Figure 28, mechanism B).  
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Figure 28. Proposed Mechanisms for the Photoredox Generation of Nitrosocarbonyls 
 
4.4 Concluding Remarks 
In conclusion, the developed photoredox conditions provide a unique pathway to 
generate transient nitrosocarbonyl intermediates with both temporal and spatial control, 
demonstrated by the capacity to turn the reaction on and off and the distance dependence. 
Additionally, the reaction conditions are sufficiently mild so as to not decompose the ene 
products, suggesting the oxidation methodology can be used to explore new frontiers of 
nitrosocarbonyl chemistry. The reaction is operationally simple to perform, using lights 
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purchased from a local hardware store, reagent grade solvents, air as the terminal oxidant 
and a readily available photoredox catalyst. We envision, based on the results, that this 
newly developed methodology has significant potential utility both in the context of small 
molecule chemistry and in the applied context of biology or materials science.  
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5. Iodine(III)–Mediated Oxidative Aromatic Substitution (SOAr) of 
Phenols and Aniline Derivatives 
5.1 The Synthetic Strategy of Oxidative Aromatic Substitution  
The direct functionalization of substituted aromatic compound with regiochemical 
control is a great challenge in organic synthesis. Prior to the advent of transition metal 
catalyzed aromatic functionalization reactions, the predominant strategy for aromatic 
functionalization was electrophilic or nucleophilic aromatic substitution (SEAr and SNAr, 
respectively). These strategies rely on matching of intrinsic electronic environments between 
the two coupling partners in order to achieve efficient reactivity. As a consequence, the 
incorporation of specific functionalities to modulate electronics prior to substitution is 
required. Moreover, the electronic matching of coupling partners leads to specific 
regiochemical outcomes, which significantly limits substitution at electronically mismatched 
positions.  
Figure 29. Direct Aromatic Substitution Strategies 
 
Recently, an alternative to the classic SEAr and SNAr strategies has emerged that allows 
direct aromatic substitutions without the requisite matching of electronic environments. 
Termed “oxidative aromatic substitution,” or SOAr, nucleophilic functionalization of all four 
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sites of an aromatic ring can be accomplished through the oxidation of electron rich phenols 
and aniline derivatives. While aromatic oxidations are commonly used as a dearomatizing 
strategy, rearomatization under a variety of reaction conditions after nucleophilic addition is 
also possible, providing a complementary aromatic substitution pathway to SEAr and SNAr.   
Figure 30. Synthetic Strategy of Oxidative Aromatic Substitution (SOAr) 
 
Although other oxidants can be utilized in the dearomatization step,
1
 the recent 
widespread use iodine(III) reagents has facilitated the expansion of the SOAr synthetic 
strategy.
2
 In light of recent developments in the field, this review will focus specifically on 
the iodine(III)–mediated oxidative aromatic substitution synthetic strategy as applied to the 
functionalization of phenols and aniline derivatives.  
5.2 ipso–Selective Oxidative Aromatic Substitution (iSOAr) 
 The ipso–selective variant of the SOAr synthetic strategy is, by far, the most 
underutilized of the set. While examples of 
i
SOAr date back to the work of Taylor and co-
workers in the 1970’s who utilized toxic thallium(III) nitrate (TTN) as the oxidizing agent,3 
to date only a small subset of potential synthetic transformations have been explored, all of 
which exploit the hetero-functionalization of the corresponding quinine intermediate. To 
  89 
date, three specific mechanisms have been exploited in 
i
SOAr reactions. In all examples, the 
i
SOAr reaction necessarily proceeds through the quinone intermediate (step 1: 
dearomatization) with concomitant condensation of a nucleophile onto the ketone (step 2: 
condensation). The major differentiating factor of the developed approaches is the 
mechanism of rearomatization (step 3). The first (Type 1 
i
SOAr) invokes the 1,6 elimination 
of ROH through the deprotonation of an adjacent carbon. Often this step is followed by 
hydrolysis of the rearomatized product to generate the primary heteroatom. In contrast, if a 
nucleophile with an adjacent heteroatom is utilized (e.g. hydroxylamines and hydrazines), 
the lone pair participated in the rearomatization process by helping facilitate the elimination 
of MeOH (Type 2 
i
SOAr). If a nucleophile with no adjacent acidic protons or heteroatoms is 
utilized, the rearomatization can be accomplished by the chemical reduction of the quinone 
intermediate (Type 3 
i
SOAr, Figure 31). Examples of each of these mechanisms will be 
discussed in the following sections.  
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Figure 31. Divergent Pathways for the 
i
SOAr Reaction 
 
5.2.2 Examples of Type 1 
i
SOAr 
To date, only one example of Type 1 
i
SOAr has been reported that specifically utilizes an 
iodine(III) reagent. This example, reported by our research group, allows the direct 
conversion of phenol derivatives into the corresponding aniline. We found that p-cresol 1 
could be directly converted to aniline derivative 2 using ethyl glycine, an inexpensive source 
of nitrogen, as the nucleophile (Equation 10). After rearomatization via the Type 1 pathway, 
hydrolysis of the imine intermediate afforded the aniline.  
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Equation 9. Direct Conversion of p-Cresol to p-Toluidine via Type 1 
i
SOAr 
 
5.2.3 Examples of Type 2 
i
SOAr 
To date, two examples of Type 2 
i
SOAr have been reported, both of which converted 
phenols into nitrogenous aromatic compounds. The first reported example by Zheng and 
coworkers utilized substituted hydrazines to gain access to aromatic azo compounds 5, aryl 
hydrazones 6, and indoles 7 from the corresponding phenols, depending on the substitution 
pattern of the starting material (Figure 32). When hydrazines lacking adjacent acidic protons 
are employed, the reaction proceeds directly to the azo compound 5, which could be isolated 
in moderate yield. In contrast, when hydrazines with tautomeric protons are utilized, 
hydrazone intermediate 4 will funnel directly to the indole, through a Fischer indolization 
pathway in good yield (Figure 32).
4
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Figure 32. Divergent Reaction Pathways When Utilizing Hydrazines in Type 2 
i
SOAr 
 
Inspired by the work of Zheng and co-workers, we elected to explore the Type 2 
i
SOAr 
synthetic strategy for accessing substituted nitrosoarene compounds. Based on our 
longstanding interest in utilizing nitroso compounds in synthesis, we were delighted to 
discover that p-methoxynitroso benzene could be accessed in high yield from p-methoxy 
phenol in one pot. Whereas Zheng and co-workers observed bis-1,4 addition to form the 
[1,2,2] bridged structure when substituted hydroxylamines were utilized, under the 
optimized reaction conditions, we observed exclusive 1,2 addition of the unsubstituted 
hydroxylamine with the concomitant elimination of methanol to form the nitrosoarene 
directly. When p-alkoxy phenols were utilized, the nitrone intermediate was not observed 
during the course of the reaction. In contrast, with p-cresol, the nitrone was the only 
observable product, and aqueous hydroxylamine and an additional Lewis acid (10 mol % 
Dy(OTf)3) had to be utilized in order to fully convert the nitrone to the nitrosoarene (Table 
23). 
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Table 23. Accessing Nitrosoarenes from Phenols via a Type 2 
i
SOAr Pathway 
 
a
 Isolated as an inseparable 5:1 mixture of p-Oi-Pr:p-OMe 
nitrosobenzene.
 b
 2 equiv H2NOH(aq) and 5 mol % Dy(OTf)3 
were used instead 
 
Additionally, the reaction was not limited solely to p-substituted phenol starting 
materials. A double oxidation procedure can also be used to gain access to p-methoxynitroso 
benzene directly from phenol. Under the reaction conditions, the p-methoxy group is 
incorporated from the first oxidation of the aromatic ring, and constitutes a tandem 
p
SOAr 
and 
i
SOAr reaction (Equation 11).  
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Equation 10. Tandem SOAr reactions to Access Nitrosoarenes Directly from Phenol 
 
5.2.4 Examples of Type 3 
i
SOAr 
When the condensing nucleophile used does not have adjacent functionalities that can 
participate in the rearomatization process, an additional reducing agent is required to 
complete the 
i
SOAr pathway. To date, Fan and co-workers are the only research group to 
utilize this particular strategy, gaining access to a wide variety of diarylamines from N-tosyl 
aniline derivatives. While a number of Lewis acids were screened for the condensation step 
of the reaction, Bi(OTf)3 was the most optimal, efficiently converting the N-tosyl 
iminoquinone to the corresponding, N-aryl iminoquinone. Elemental zinc and trifluoroacetic 
acid was determined to be the most efficient conditions for the rearomatization process, and 
fortuitously, all three reaction steps could be carried out consecutively in a single pot. Under 
the optimized reaction conditions, a wide variety of differentially functionalized 
diarylamines were accessible (Table 24).
5
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Table 24. Scope of Diaraylamine Formation from Type 3 
i
SOAr 
 
5.3. Ortho–Selective Oxidative Aromatic Substitution (oSOAr) 
The ortho-selective variant of oxidative aromatic substitution is a widely explored 
transformation that proceeds through a variety of mechanistic pathways. Nucleophilic 
addition to the ortho position of the phenol or aniline can proceed directly from the 
iodonium intermediate with concomitant elimination of iodobenzene and 2 equivalents of 
the acetate derivative (Type 1 
o
SOAr). This pathway typically occurs in non–alcoholic  
solvents when soft nucleophiles are used. Alternatively, addition can occur to the ipso 
position of the starting phenol or aniline derivative after oxidation to the quinone 
intermediate. After addition, a pinacol–type rearrangement can occur to induce 
rearomatization (Type 2 
o
SOAr). This reaction pathway often occurs when hard nucleophiles 
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are used under strongly basic conditions, although rearomatization can be accomplished 
under strongly basic or acidic conditions. Finally, another mechanism can be invoked under 
strongly acidic conditions after oxidation to the quinone. In this mechanism, elimination of 
methanol from the quinone intermediate affords the stabilized cation which, after addition 
and rearomatization, affords the ortho functionalized phenol or aniline derivative (Type 3 
o
SOAr). Specific examples of each reaction type are provided in the following section.  
 
5.3.1 Examples of Type 1 
o
SOAr 
The most widely used nucleophile in Type 1 
o
SOAr are substituted olefins. In particular, 
a number of research groups have utilized phenols to form a variety benzofuran derivatives 
  97 
through the addition of an electron rich olefin to the oxidized phenol intermediate. Olefin 
addition to 34 affords cationic ketone intermediate 35, which cyclizes to form the 
corresponding oxonium 36. Upon deprotonation, the desired dihydrobenzofuran derivative 
37 is formed. To date a number of nucleophilic olefins have been employed, including 
styrenes,
6
 furans,
7
 vinyl ethers,
8
 allyl silanes
9
 and naphthalene derivatives.
10
  
Figure 33. Olefin Addition to Oxidized Phenols to Form Benzofuran Derivatives 
 
This reaction pathway has also been utilized in natural product synthesis. Taking 
inspiration from the work of Swenton and co-workers who explored the addition of styrene 
derivatives to oxidized phenol intermediates,
6
 Kuo and co-workers exploited the 
dimerization of isoeugenol to form the desired benzofuran, which was used to form the 
natural product salvinal in three additional steps (Equation 13).
11
 
  98 
Equation 11. Synthesis of Salvinal Through a Type 1 
o
SOAr Synthetic Strategy 
 
Substituted anilines have also been utilized as coupling partners in Type 1 
o
SOAr  
reactions. Like the phenol derivatives, it is not necessary to fully oxidize the aniline to the 
iminoquinone intermediate, since the addition of iodine(III) reagents effectively activate the 
aniline for nucleophilic addition. For example, Canesi and co-workers observed the direct 
addition of thiophene derivatives to the ortho position of sulfonate protected anilines after 
oxidation with PIDA.
12
  Mechanistically, cyclization onto the thiophenium intermediate after 
addition was not observed, unlike reactions with the furan derivatives. The reaction was 
tolerant of a variety of substitution patterns on both the aniline and the thiophene 
component. Additionally, while a number of N-tosyl anilines were utilized, the reaction also 
tolerated a variety of substitution patterns on the sulfone, such as the ethyl, vinyl, and 4-
NO2Ph sulfonamides (Table 25).
12
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Table 25. Addition of Thiophene Derivatives to Aryl Sulfonamides via Type 1 
o
SOAr 
 
Nucleophilic addition to the ortho position of aniline derivatives can also be 
accomplished in an intramolecular fashion. For example, electron rich benzyl and benzoate 
substituted anilines readily cyclize to form the phenanthridine and phenanthridinone species 
(Equation 13). Notably, electron rich benzyl and benzoate substitution leads directly to the 
desired compound (Equation 13, 66 and 67), whereas use of less nucleophilic substituents on 
nitrogen lead to exclusive dimer formation (not shown).
13
 Mechanistically, this particular 
transformation may proceed through the radical cation, a mechanism commonly seen in the 
work of Kita and co-workers utilizing phenyl ethers.
14
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Equation 12. Intramolecular Cyclization to Phenanthridine And Phenanthridinones 
 
An alternative reaction is observed when PIDA is used instead of PIFA. Rather than 
addition through the aromatic ring of the benzoate, Yu and co-workers observed the addition 
of the oxygen component of the benzamide to form the benzoxazole in high yield when 
PIDA and TMSOTf were used. Unlike Dominguez and co-workers, no dimerization was 
observed. Notably, both the p–anisidine and p–phenylenediamine both participated in the 
reaction with no reduction in yield (Table 26).
15
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Table 26. Formation of Benzoxazoles Through an Intramolecular Type 1 
o
SOAr 
 
It is worth noting that Kita and co-workers have extensively explored this pathway for 
the functionalization of phenyl ethers.
14
 While it is beyond the scope of this review, many 
research groups exploring Type 1 
o
SOAr with phenols and anilines have been directly 
influenced by Kita’s work.  
5.3.2 Examples of Type 2 
o
SOAr 
As an alternative to direct addition to oxidized phenol intermediates, the 
o
SOAr synthetic 
strategy can proceed through the quinone intermediate instead. Using hard nucleophiles such 
is alkyl and alkynyl lithium species or Grignard reagents, 1,2 addition is the predominant 
pathway. However, under the strongly basic conditions, intermediate 92 will undergo a 
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pinacol–type rearrangement with elimination of the corresponding alkoxide to form the 
ortho-functionalized phenol (Figure 34). Renaud and co-workers explored this pathway 
extensively with the quinone monoacetal species.
16
 Alternatively, allylindium bromides can 
react in the same manner, although acidic conditions are required to induce the desired 
pinacol–type rearomatization pathway.17 
Figure 34. Ortho Functionalization of Phenols via a Type 2 
o
SOAr Pathway 
 
The Type 2 
o
SOAr synthetic strategy was utilized in the synthesis of biaryl natural 
product derivative 4’-OMe honokiol by Denton and co-workers. Denton, who extensively 
explored SOAr reactions under electrochemical oxidation conditions, used the addition or 
aryl Grignard reagent 100 to dienone 99 to form the desired compound in moderate yield. 
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Notably, as observed in the work of Renaud, elimination of the acetate anion occurred in situ 
to form the rearomatized product (Equation 14).
18
  
Equation 13. Synthesis of 4’-OMe Honokiol via a Type 2 oSOAr Synthetic Strategy 
 
5.3.2 Examples of Type 3 
o
SOAr 
As an alternative to the strongly basic conditions of Type 2 
o
SOAr, acidic conditions can 
also be utilized to accomplish the ortho functionalization of phenols and aniline derivatives. 
After iodine(III) oxidation to the quinone intermediate, activation by a Brønsted acid will 
afford quinonium intermediate 104, which allows the selective formation of the ortho–
substituted phenol or aniline derivative. This pathway has been most extensively explored by 
Kita and co-workers for the addition of electron rich arenes using montmorillonite (MT) clay 
as the Brønsted acid (106, Figure 35),
19
 and for the addition of silyl enol ethers using a 
polystyrene–anchored perfluorobenzoic acid (107, Figure 35).20 Notably, Kita also explored 
the synthesis of oxygenated terphyl compounds through the sequential addition of multiple 
electron rich arenes (not shown).
21
 The reaction is not limited C-C bond forming reactions, 
as MT clay could be used to induce TMS-thiophenol addition (108, Figure 35).
20
 
Additionally, serendipitous halogen addition to the ortho position of phenol and aniline 
derivatives was observed by Zeng and co-workers when the quinone derivatives were treated 
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with hydrazine hydrochloride (109, Figure 35).
22
 Finally, Novak and co-workers explored 
the kinetics of type 3 
o
SOAr reaction using azides and other nucleophiles (not shown).
23
  
Figure 35. Type 3 
o
SOAr Reactions using Brønsted Acids. 
 
Similarly, nucleophilic addition can occur at the ortho position of ortho-quinone 
monoacetals. Peddinti and co-workers found that treatment of ortho-methoxyphenols led to 
exclusive ortho-quinone acetal formation, however Lewis acid (BF3•Et2O) activation of the 
quinone intermediate still lead to a Type 3 
o
SOAr pathway. Under the optimized conditions a 
breadth of biaryl compounds were accessible (Table 27).
24
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Table 27. Synthesis of Biaryl Compounds Through the Ortho-Quinone 
 
Substituted olefins can also react with quinone intermediates to form similar 
dihydrobenzofuran products from the Type 1 
o
SOAr. Unlike their Type 1 
o
SOAr counterparts, 
the quinone intermediate was first generated in each case, and the Lewis or Brønsted acids 
activate the quinone for nucleophilic addition through the loss of MeOH. Wang and co-
workers utilized SnCl4 as a Lewis acid to activate quinone monoacetals for ortho addition.
25
 
After elimination of methyl sulfide, the benzofuran could be isolated in good yield. Kita also 
made significant contributions to this reaction pathway. Using pentafluorobenzoic acid 
(PFBA), or the polystyrene–immobilized PFBA as a Brønsted acid, Kita and co-workers 
explored the addition of styrene derivatives, vinyl thioethers and simple olefins all in good 
yield.
26
 In each case, rearomatization occurred after cyclization, as the benzofuran 
derivatives were isolated exclusively (Figure 36).  
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Figure 36. Addition of Olefins to Acid Activated Quinone Monoacetals 
 
5.4 meta–Selective Oxidative Aromatic Substitution  
As an aromatic functionalization methodology, the meta-selective variant of oxidative 
aromatic substitution complements SEAr nicely. Whereas phenols and anilines typically react 
at the ortho or para positions of the aromatic ring in SEAr reactions, functionalization of the 
same starting materials at the meta position can be accomplished with SOAr. As with 
addition to other positions of the ring, 
m
SOAr can occur through a variety of mechanism, but 
the formation of the quinone intermediate is a necessity. Type 1 
m
SOAr occurs through direct 
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1,4–addition of a nucleophile with concomitant elimination of the alcohol to facilitate 
rearomatization. Type 2 
m
SOAr reactions invoke the cationic activation of quinone 
intermediate through either a Lewis or Brønsted acid, or through cyclization onto a tethered 
functional group. Elimination of the alcohol again facilitates rearomatization, Finally, Type 
3 
m
SOAr can occur through the quinone intermediate when acetate derivatives are used 
during the dearomatization. Under the reaction conditions, the acetate can migrate from the 
para to the meta position, activating the ring for rearomatization. Examples of each are 
given in the following section (Figure 37). 
Figure 37. Mechanistic pathways for meta–Selective Oxidative Aromatic Substitution 
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5.4.1 Examples of Type 1 
m
SOAr 
The direct addition of alcohols to the meta position of an aromatic ring can be 
accomplished provided that the starting phenol can form the quinone intermediate. 
Therefore, hydroquinones are the required starting material, and additional electron 
withdrawing groups are necessary to further activate the quinone intermediate. By subjecting 
hydroquinone 117 to PIDA in a variety of protic solvents, Prakash and co-workers found that 
the desired phenyl ethers can be isolated in moderate yield (Equation 15).
27
 
Equation 14. Addition of Alcohols to Hydroquinones via Type 1 
m
SOAr 
 
Utilizing Prakash’s methodology, Chong and coworkers synthesized a wide variety of 
dihydroxychromone derivatives that were evaluated for bioactivity, highlighting the unique 
potential of 
m
SOAr reactions in the synthesis of natural product derivatives and 
pharmaceutically active compounds (Equation 16).
28
  
Equation 15. Synthesis of Dihydroxychromone  
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As with other SOAr reactions, it is not necessary to proceed through the para-quinone 
intermediate; the ortho-quinone acetal can also be employed. In particular, Liao and co-
workers found that the nucleophilic addition of indoles to the meta-position of ortho-
quinones provided the 3-arylindoles in good yield (Table 28). Notably, no Diels–Alder was 
observed between the indole and the ortho-quinone if the reactions were run in refluxing 
methanol.
29
 
Table 28.  Direct Addition of Indoles to ortho-Quinone Intermediates 
 
Enolates and enolate derivatives are commonly used nucleophiles in Type 1 
m
SOAr 
reactions. Aube and co-workers were the first to make significant contributions to this 
reaction type, using phenols bearing ortho electron withdrawing groups and a variety of 
enolate derived nucleophiles. Although Michael addition without rearomatization, and 
double Michael addition products were observed, the Type 1 
m
SOAr products could also be 
isolated in good yield from the quinone intermediate (Table 29, 143 – 146).30 Fan and co-
workers also found that enolate derivatives could be added to iminoquinones to form the 
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rearomatized meta-functionalized aromatic compound (Table 29, 148 – 150). Additionally, 
this transformation could be carried out in one pot directly from the tosyl–protected aniline 
in high yield (Table 29, 147).
31
 
Table 29. Addition of Enolate Derivatives to Quinones via Type 1 
m
SOAr 
 
In addition to the single Michael addition products, Both Aube and Fan observed double 
Michael addition adducts resulting from the addition of the heteroatom of the nucleophile, 
forming the [3,3,1] bridged species.
30-31
 While 152 was the primary product isolated in a 
number of transformations, Fan and co-workers observed that the addition of quinine 
induced the retro-Michael elimination and formation of the 
m
SOAr product in high yield.
31
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Equation 16. Double Michael Addition and Elimination to Form the 
m
SOAr Product 
 
The 
m
SOAr synthetic strategy has also found use in the total synthesis of sorbiterrin A by 
Porco and co-workers. After formation of ortho-quinone 155 through the treatment of 154 
with PIFA, the addition of enol 156 and silica gel induced the Type 1 
m
SOAr reaction and 
subsequent cyclization onto the appended dienone. This product was then carried onto 
sorbiterrin A 158 in three additional steps (Equation 18).
32
  
Equation 17. Synthesis of Sorbiterrin A via a Type 1 
m
SOAr Synthetic Strategy 
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5.4.2 Examples of Type 2 
m
SOAr 
Cationic activation of the quinone intermediate is a common pathway for promoting 
meta substitution. As with Type 1 
m
SOAr, electron rich aromatics are common nucleophiles 
used. In particular, Fan and co-workers found that treatment phenol with PIDA followed by 
the addition of p-toluenesulfonic acid and the desired indole led directly to the 
m
SOAr 
product 162 in good yield. Notably, under the acidic conditions, the phenol was converted to 
the methylphenyl ether.
33
 Similarly, Chittimalla found that indoles could be added to phenols 
after ortho oxidation, providing the desired products in moderate to high yield. In both 
reactions, the addition of a Brønsted acid activates the quinone intermediates for 1,4 
addition, and helps facilitate rearomatization (Figure 38).
34
 
Figure 38. Addition of Indoles to Phenols via a Type 2 
m
SOAr Reaction  
 
Alternatively, electron rich furans can undergo Michael addition to iminoquinone 
intermediate. Treatment of iminoquinone 166 with a Lewis acid promotes addition of furan 
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to the meta position. When the 2-OTMS furan is used, lactone product 168 is isolated, 
whereas the use of unsubstituted furan gives triaryl compound 169 (Equation 19).
35
  
Equation 18. Addition of Furan to Iminoquinone Acetals via Type 2 
m
SOAr 
 
The Type 2 
m
SOAr synthetic strategy is not limited to the addition of electron rich 
aromatics; Maruoka and co-workers found that enamines were also viable nucleophiles for 
meta addition. Using a binaphthyl-derived Brønsted acid (R)-173, Maruoka found that the 
absolute stereochemistry of the homobenzylic aminal products could be set with high 
enantio– and diastereoselectivities. In particular, the reaction was tolerant of amine 
substitution on both the starting iminoquinone acetal and enamine, as well as meta 
substitution on the iminoquinone acetal (Table 30).
36
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Table 30. Addition of Enamines to Iminoquinone Acetals via Type 2 
m
SOAr   
 
Electron rich olefin can also participate in type 2 
m
SOAr reactions directly from the 
substituted aniline by proceeding through iminoquinone 194. Addition of PIFA to aniline 
derivatives bearing a para proton, halogen of alkoxide facilitates the formation of the 
iminoquinone in situ. After oxidation, the addition of a Lewis or Brønsted acid along with an 
olefin produces dihydrobenzofuran 196 in low to excellent yield (Equation 20).
37
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Equation 19. Formation of Dihydrobenzofurans from Anilines via Type 2 
m
SOAr 
 
As an alternative to cationic activation by the addition of a Lewis or Brønsted acid, Fan 
has extensively explored the use of ortho-alkynyl phenols and anilines which readily cyclize 
to form cationic benzofuran or indole intermediates. Mechanistically, the anilines and 
phenols proceed through different pathways; After oxidation, anilines first undergo Michael 
addition followed by cyclization onto the alkyne, whereas phenols are activated for Michael 
addition by the cyclization onto the alkyne. In both cases, cyclization forms an 
organometallic intermediate which readily traps electrophiles. To date, this cascade approach 
to functionalized indoles and benzofurans has been utilized to form azepinoindoles from 
isocyanides and α,β-unsaturated acids (Figure 39, 199)38 and from substituted anilines and 
aldehydes (Figure 39, 200),
39
 to form the dihydrocyclopentadiene indole from reactions with 
substituted olefins (Figure 39, 201),
40
 and to form the difunctionalized benzofurans from 
anilines and α,β-unsaturated acids (Figure 39, 202).41 Notably, all the transformations can be 
conducted in one reaction vessel from the aniline or phenol, and without purification at 
intermediate steps through the sequential addition of reagents.  
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Figure 39. Cationic Activation of Phenols and Anilines Through Cyclization 
 
Fan and co-workers also observed that it is not necessary to use an exogenous 
electrophile to functionalize the C-3 position of the benzofuran or indole; proto-
demetallation of the organometallic intetrmediate afford the C-3 unsubstituted product. For 
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example, after oxidation with PhIO in TFE, the addition of Pd(II) induces cyclization of the 
phenol onto the alkyne, and the cationic intermediate could be trapped with substituted 
anilines to afford the furoquinoline derivatives directly in good yield (Table 31).
42
  
Table 31. Formation of Furoquinoline Derivatives Through a Type 2 
m
SOAr Reaction 
 
Fan also explored a double cyclization reaction to form the N-heteroarylated indole and 
benzofuran products. By treatment of the combination of ortho-alkynyl quinones and ortho-
alkynyl anilines with Cu(OTf)2, the meta addition-double cyclization product could be 
isolated in good yield. This methodology was used to access a wide variety of indole and 
benzofuran products and showcases the unique potential of SOAr methodologies for use in 
cascade reactions (Table 32).
43
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Table 32.  Use of Type 3 
m
SOAr  in a Meta Addition-Double Cyclization Cascade 
 
5.4.1 Examples of Type 3 
m
SOAr 
Type 3 
m
SOAr reactions are the least explored of the reaction types for meta 
functionalization. The migratory approach to meta addition was first explored by Barlin and 
Riggs in 1954. While the addition of PIDA in MeOH to p-substituted acetanilide yielded the 
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quinone product, conducting the reaction in AcOH yielded the m-acetoxy acetanilide.
44
 This 
dichotomy in reactivity was studied further by Nair and co-workers, who determined that the 
acetate’s ability to bridge to the meta-position (intermediate 255) facilitated the isolation of 
the m-acetoxy acetanilide primarily.
45
 While other functionalities could presumably 
participate in this reactivity platform, to date, the acetate and propionate are the only 
nucleophiles that have been utilized. This approach has also been utilized in the synthesis of 
rolipram from paracetamol by Schmidt and co-workers (not shown).
46
 
Equation 20. Meta-Acetoxylation of p-Substituted Acetanilides by Type 3 
m
SOAr 
 
Migration can also occur from ortho-quinone acetals by the same mechanism. Treatment 
of phenols bearing ortho-methoxy groups with PIDA in acetic or propionic acid yielded the 
ortho-quinone acetal, which could be converted to the m-substituted phenol by exposure to a 
Lewis or Brønsted acid. This particular synthetic strategy was used by Stevens and co-
workers to derivatize tyrphostatin protein kinase inhibitors (Equation 22).
47
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Equation 21. Synthesis of Tyrphostatin Protein Kinase Inhibitors by Type 3 
p
SOAr 
 
5.5 para–Selective Oxidative Aromatic Substitution  
The addition of nucleophiles to the para position in oxidative aromatic substitution is the 
most commonly observed reaction type for p-unsubstituted anilines and phenols. As with all 
other oxidative aromatic substitution reactions, 
p
SOAr reactions proceed through a variety of 
mechanisms. Type 1 
p
SOAr is mechanistically similar to Type 1 
o
SOAr in the nucleophilic 
addition occurs after activation by iodine(III). Although ortho addition (Type 1 
o
SOAr ) is a 
competing pathway, para-addition is the favored reaction in most cases. Care must be taken 
to ensure that over-oxidation to the quinone acetal does not occur. Type 2 
p
SOAr proceeds 
specifically through the quinone acetal and requires the addition of a reducing agent after 
oxidation. Finally, Type 3 
p
SOAr is an underexplored methodology that, to date, has only 
been utilized to form 4-fluorophenols through the elimination of a tert-butyl group. 
Examples of each reaction type are given in the following section. 
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Figure 40. Mechanistic Pathways for para–Selective Oxidative Aromatic Substitution 
 
5.4.1 Examples of Type 1 
p
SOAr 
Alcohols and other oxygen-based nucleophiles are the most widely used reagents for 
Type 1 
p
SOAr, although often a second oxidation occurs to form the quinone acetal. Despite 
this, a number of research groups have explored controlled additions to the para position 
using N-protected anilines. For example, Gu and co-workers investigated the addition of 
various alcohols, acetate and tosylate mediated by the addition of BF3•OEt2 (Figure 41, 263–
265).
48
 Alternatively, Liegault developed the para-triflation of substituted anilines using 
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AgTf as the triflate-source,
49
 and Kikugawa used the in situ hydrolysis of p-trifluoroacetate-
substituted anilines to access the p-aminophenol products (Figure 41, 266–267).50  
Figure 41. Para-Addition of Oxygen Nucleophiles via Type 1 
p
SOAr 
 
To date, only one example off a C-C bond forming reaction by a type 1 
p
SOAr 
mechanism has been explored. Specifically, Kita and co-workers extended their type 1 
o
SOAr 
method for the addition of electron rich aromatics. Specifically Kita found that electron rich 
benzenes (271), napthyls (272) and heteroaromatics (273) all formed the biaryl compounds 
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in moderate to high yield (Table 32). Additionally this approach can be combined in a 
sequential process with the previously developed Type 1 
o
SOAr to afford the poly-arylated 
product (not shown).
51
 
Table 33. Addition of Electron Rich Aromatics via a Type 1 
p
SOAr 
 
5.4.1 Examples of Type 2 
p
SOAr 
In contrast to Type 1 
p
SOAr, the Type 2 synthetic strategy is vastly underexplored. To 
date, the only reported example is in the context of (–) puraquinoic acid by Clive and co-
workers. Oxidation of phenol 274 using PIDA in MeOH afforded quinone acetal 
intermediate 275, and reduction with Zn in acetic acid yielded the desired hydroquinone 276 
in 58% over the two steps. This product was further elaborated into (–) puraquinoic acid 
277, highlighting the potential utility of Type 2 
p
SOAr in the synthesis of complex 
molecules.
52
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Equation 22. Synthesis of (–) Puraquinoic Acid via Type 2 pSOAr 
 
5.4.1 Examples of Type 3 
p
SOAr 
In its current state of development, Type 3 
p
SOAr is the most limited of the approaches to 
para-functionalizations. To date, fluorine is the only nucleophile that has been employed in 
Type 3 
p
SOAr reactions and the scope is currently limited to p-tert-butyl phenols (Equation 
24).
53
 However, despite the limited scope, this methodology has been used to incorporate 
18
F 
into phenols for potential use in positron emission tomography (not shown).
54
 If the scope of 
nucleophiles can be expanded, this synthetic strategy has the potential for more widespread 
use.   
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Equation 23. Addition of Fluoride to Phenols via Type 3 
p
SOAr 
 
5.6 Conclusions and Future Outlook 
Iodine(III) –mediated oxidative aromatic substitution is a highly efficient synthetic 
strategy to functionalize phenol and aniline derivatives. By carefully tuning the reaction 
conditions, each position of the ring can selectively functionalized under mild reaction 
conditions. Despite sizeable contributions from a number of research groups, there is still 
substantial room to make significant advancements in this underdeveloped field.  
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6. Supporting Information 
6.1 Chapter 2 Supporting Information 
6.1.1 Supporting Information for the Nitrosocarbonyl Ene Reaction 
Materials and Methods. Unless stated otherwise, reactions were conducted in flame-dried 
glassware under an atmosphere of air using reagent grade solvents. All commercially 
obtained reagents were used as received. Reaction temperatures were controlled using a 
Heidolph temperature modulator, and unless stated otherwise, reactions were performed at 
room temperature (rt, approximately 23 ˚C). Thin-layer chromatography (TLC) was 
conducted with E. Merck silica gel 60 F254 pre-coated plates, (0.25 mm) and visualized by 
exposure to UV light (254 nm) or stained with potassium permanganate. Flash column 
chromatography was performed using normal phase silica gel (60 Å, 230-240 mesh, 
Geduran®). 
1
H NMR spectra were recorded on Varian Spectrometers (at 400, 500 and 600 
MHz) and are reported relative to deuterated solvent signals. Data for 
1
H NMR spectra are 
reported as follows: chemical shift (δ ppm), multiplicity, coupling constant (Hz) and 
integration. 
13
C NMR spectra were recorded on Varian Spectrometers (125 and 150 MHz). 
Data for 
13
C NMR spectra are reported in terms of chemical shift. IR spectra were recorded 
on a Jasco FT/IR 4100 and are reported in terms of frequency of absorption (cm
-1
). High 
resolution mass spectra and X-Ray analyses were obtained from the UC Santa Barbara Mass 
Spectrometry and X-Ray Facilities. Enantiomers were separated using a Shimadzu HPLC 
fitted with a Chiralpak IB column (4.6mm x 250mm). All HPLC analyses used to determine 
enantiopurity were calibrated with samples of the racemate. Optical rotation was recorded on 
a Rudolph Research Analytical Autopol III. 
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Hydroxycarbamates 1, S-1, S-2, S-3, and S-4, were prepared according to literature 
precedent.
1
 Hydroxycarbamate 16, S-5, S-6, S-7 and all olefins were used as received. Imide 
S-17 and sultam 39 were prepared according literature precedent.
2
 The crystal structure data 
for isoxazolidinone (S)-29 can be obtained free of charge from the Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. CCDC 824260 
Starting Materials 
(1) 3-Methylbut-2-en-1-yl hydroxycarbamate 
 
Spectral data matched literature precedent. 
1
H NMR (600 MHz, CDCl3) δ 7.65 (bs, 2H), 
5.33 – 5.26 (m, 1H), 4.59 (d, J = 7.3 Hz, 2H), 1.71 (s, 3H), 1.66 (s, 3H) ppm; 13C NMR (150 
MHz, CDCl3) δ 159.8, 140.2, 118.3, 63.2, 25.9, 18.2 ppm. 
(S-1) (E)-But-2-en-1-yl hydroxycarbamate 
 
1
H NMR (600 MHz, CDCl3) δ 7.19 (bs, 1H), 6.47 (bs, 1H), 5.87 – 5.78 (m, 1H), 5.60 (dt, J 
= 13.6, 6.6 Hz, 1H), 4.59 (d, J = 6.6 Hz, 2H), 1.73 (d, J = 6.5, 3H) ppm; 
13
C NMR (150 
MHz, CDCl3) δ 159.3, 132.6, 124.9, 67.2, 18.0 ppm; IR (thin film) 3399, 1715, 1455, 1271, 
1115 cm
-1
, HRMS (ESI) m/z 154.0511 (154.0475 calcd for C5H9NNaO3
+
 [MNa]
+
). 
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(S-2) E)-Hex-2-en-1-yl hydroxycarbamate 
 
Spectral data matched literature precedent. 
1
H NMR (600 MHz, CDCl3) δ 7.56 (bs, 1H), 
7.53 (s, 1H), 5.77 (dt, J = 14.7, 6.7 Hz, 1H), 5.54 (dt, J = 14.1, 6.6 Hz, 1H), 4.56 (d, J = 6.5 
Hz, 2H), 2.01 (q, J = 7.2 Hz, 2H), 1.43 – 1.34 (m, 2H), 0.88 (t, J = 7.4 Hz, 3H) ppm; 13C 
NMR (150 MHz, CDCl3) δ 159.6, 137.3, 123.7, 67.2, 34.4, 22.2, 13.8 ppm. 
(S-3) 4-Methylpent-3-en-1-yl hydroxycarbamate 
 
 
1
H NMR (600 MHz, CDCl3) δ 7.60 (bs, 1H), 7.49 (s, 1H), 5.07 (t, J = 7.1 Hz, 1H), 4.09 (t, J 
= 7.1 Hz, 2H), 2.32 (q, J = 7.1 Hz, 2H), 1.69 (s, 3H), 1.60 (s, 3H) ppm; 
13
C NMR (150 MHz, 
CDCl3) δ 159.9, 135.2, 119.0, 66.1, 28.0, 25.9, 17.9 ppm. IR (thin film) 3272, 2963, 1697, 
1434, 1251, 1102 cm
-1
; MS (ESI) m/z 182.08 (182.08 calcd for C7H13NNaO3
+
 [MNa]
+
). 
(S-4) (Z)-Hex-2-en-1-yl hydroxycarbamate 
 
Spectral data matched literature precedent. 
1
H NMR (600 MHz, CDCl3) δ 7.44 (bs, 2H), 
5.69 – 5.61 (m, 1H), 5.56 – 5.49 (m, 1H), 4.69 (d, J = 6.9 Hz, 2H), 2.07 (q, J = 7.3 Hz, 2H), 
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1.43 – 1.34 (m, 2H), 0.89 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (150 MHz, CDCl3) δ 159.7, 
136.0, 123.2, 62.2, 29.7, 22.7, 13.8 ppm. 
(S-17) (E)-N-(2-Methylbut-2-enoyl)benzamide 
 
Spectral data matched literature precedent.
3
 
1
H NMR (600 MHz, CDCl3) δ 8.71 (bs, 1H), 
7.79 (d, J = 7.6 Hz, 2H), 7.56 (t, J = 7.4 Hz, 1H), 7.46 (t, J = 7.7 Hz, 2H), 6.57 (q, J = 6.5 
Hz, 1H), 1.91 (s, 3H), 1.84 (d, J = 6.9 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 168.4, 
166.7, 134.9, 133.8, 133.0, 132.9, 128.9, 128.0, 14.4, 12.6 ppm. 
(39) (E)-1-((6S,7aS)-8,8-Dimethyl-2,2-dioxidohexahydro-1H-3a,6 
methanobenzo[c]isothiazol-1- yl)-2-methylbut-2-en-1-one 
 
Spectral data matched literature precedent. [α]D
25
 7.50° (c 1.00, CHCl3) 
1
H NMR (600 MHz, 
CDCl3) δ 6.37 (dddd, J = 6.9, 6.9, 6.9, 1.3 Hz, 1H), 4.04 (dd, J = 7.7, 4.6 Hz, 1H), 3.48 (d, J 
= 13.6 Hz, 1H), 3.38 (d, J = 13.6 Hz, 1H), 2.02 (dd, J = 13.6, 7.8 Hz, 1H), 1.98 – 1.84 (m, 
7H), 1.82 (d, J = 6.9, 3H), 1.45 – 1.33 (m, 2H), 1.23 (s, 3H), 0.99 (s, 3H) ppm; 13C NMR 
(150 MHz, CDCl3) δ 172.5, 137.7, 131.7, 65.6, 53.8, 48.1, 47.9, 45.5, 38.5, 33.5, 26.8, 21.5, 
20.1, 14.3, 12.9 ppm. 
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Substrate Scope for Nitrosocarbonyl Ene Reaction 
General Procedure for the Ene Reaction: To a stirred solution of benzyl 
hydroxycarbamate 16 and olefin 17 in THF was added 5 mol % CuCl and 1.25 mol % 
pyridine. The reaction was stirred at 23 ˚C open to the air until complete by TLC. Upon 
completion, the reaction was quenched with EDTA (0.5 M, pH 7.0), diluted with ethyl 
acetate and stirred until color no longer persisted in organic layer (approx. 30 min). The 
reaction was extracted with ethyl acetate three times and the combined organic layers were 
dried over MgSO4. The product was filtered and then concentrated in vacuo. The residue 
was purified by column chromatography to afford hydroxycarbamate 18. 
(2) 3-Hydroxy-4-(prop-1-en-2-yl)oxazolidin-2-one 
 
According to the general procedure, CuCl (3.4 mg, 0.034 mmol, 0.05 equiv) and pyridine 
(0.67 μL, 0.0086 mmol, 0.0125 equiv) were added to 3-methylbut-2-en-1-yl 
hydroxycarbamate 1 (100 mg, 0.69 mmol, 1.0 equiv) in 20 mL THF. The resulting mixture 
was stirred for 6 h at 23 ˚C. The reaction was quenched with 20 mL EDTA (0.5 M, pH 7.0) 
and extracted with ethyl acetate (3 x 20 mL). The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo. The residue was purified by column 
chromatography to afford oxazolidinone 2 (92 mg, 93%) as a colorless solid. 
1
H NMR (600 
MHz, CDCl3) δ 8.52 (bs, 1H), 5.12 (s, 1H), 5.08 (s, 1H), 4.46 – 4.37 (m, 2H), 4.06 – 3.97 
(m, 1H), 1.77 (s, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 161.2, 139.2, 117.2, 65.9, 64.9, 
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17.0 ppm; IR (thin film) 3270, 2976, 1762, 1475, 1213, 1092 cm
-1
; MS (ESI) m/z 166.06 
(166.05 calcd for C6H9NNaO3
+
 [MNa]
+
). 
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(5) 3-Hydroxy-4-vinyloxazolidin-2-one 
 
According to the general procedure, CuCl (3.8 mg, 0.038 mmol, 0.05 equiv) and pyridine 
(0.74 μL, 0.0095 mmol, 0.0125 equiv) were added to (E)-but-2-en-1-yl hydroxycarbamate S-
1 (100mg, 0.763 mmol, 1.0 equiv) in 22 mL THF. The resulting mixture was stirred for 14 h 
at 23 ˚C. The reaction was quenched with 22 mL EDTA (0.5 M, pH 7.0) and extracted with 
ethyl acetate (3 x 22 mL). The combined organic layers were dried over MgSO4, filtered and 
then concentrated in vacuo. The residue was purified by column chromatography to afford 
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oxazolidinone 5 (70 mg, 71%) as a colorless solid. 
1
H NMR (600 MHz, CDCl3) δ 8.44 (bs, 
1H), 5.75 (ddd, J = 17.6, 10.1, 7.8 Hz, 1H), 5.41 (d, J = 17.1 Hz, 1H), 5.34 (d, J = 10.2 Hz, 
1H), 4.37 (t, J = 8.3 Hz, 1H), 4.30 (dd, J = 16.5, 8.2 Hz, 1H), 3.92 (t, J = 8.7 Hz, 1H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 160.8, 132.5, 122.2, 66.6, 62.8 ppm; IR (thin film) 3270, 
2913, 1764, 1428, 1216, 1092 cm
-1
; HRMS (ESI) m/z 152.0316 (152.0318 calcd for 
C5H7NNaO3
+
 [MNa]
+
). 
(6) -Hydroxy-4-(but-1-en-1-yl)oxazolidin-2-one 
 
According to the general procedure, CuCl (1.5 mg, 0.016 mmol, 0.05 equiv) and pyridine 
(0.31 μL, 0.0039 mmol, 0.0125 equiv) were added to (E)-hex-2-en-1-yl hydroxycarbamate 
S-2 (50 mg, 0.31 mmol, 1.0 equiv) in 10 mL THF. The resulting mixture was stirred for 8 h 
at 23 ˚C. The reaction was quenched with 10 mL EDTA (0.5 M, pH 7.0) and extracted with 
ethyl acetate (3 x 10 mL). The combined organic layers were dried over MgSO4, filtered and 
then concentrated in vacuo. The residue was purified by column chromatography to afford 
oxazolidinone 6 (48 mg, 96%) as an inseparable 3:1 E:Z mixture as a colorless solid. 
1
H 
NMR (600 MHz, CDCl3): δ 8.01 (bs, 1H), 5.93 (dt, J = 15.3, 6.3 Hz, 1H), δ 5.83 (dt, J = 
10.7, 7.6 Hz, 1H), 5.42 – 5.32 (m, 1H), 4.72 (q, J = 8.6 Hz, 1H), 4.38 (t, J = 8.3 Hz, 4H), 
4.30 (q, J = 8.4 Hz, 3H), 3.95 (t, J = 8.9 Hz, 1H), 3.92 (t, J = 9.2 Hz, 1H), 2.23 – 2.03 (m, 
2H), 1.01 (t, J = 7.5 Hz, 3H), 1.00 (t, J = 7.5 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 
160.9, 160.8, 141.1, 140.7, 123.3, 123.2, 67.0, 66.8, 62.7, 57.1, 25.5, 21.3, 14.4, 13.2 ppm; 
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IR (thin film) 3290, 2965, 1767, 1462, 1211, 1086 cm
-1
; MS (ESI) m/z 180.07 (180.06 calcd 
for C7H11NNaO3
+
 [MNa]
+
). 
(7) 3-Hydroxy-4-(prop-1-en-2-yl)-1,3-oxazinan-2-one 
 
 According to the general procedure, CuCl (1.5 mg, 0.016 mmol, 0.05 equiv) and pyridine 
(0.31 μL, 0.0039 mmol, 0.0125 equiv) were added to 4-methylpent-3-en-1-yl 
hydroxycarbamate S-3 (50 mg, 0.314 mmol, 1.0 equiv) in 10 mL THF. The resulting mixture 
was stirred for 13 h at 23 °C. The reaction was quenched with 10 mL EDTA (0.5 M, pH 7.0) 
and extracted with ethyl acetate (3 x 10 mL). The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo. The residue was purified by column 
chromatography to afford oxazinone 7 (43 mg, 88%) as a colorless solid. 
1
H NMR (600 
MHz, CDCl3) δ 8.95 (bs, 1H), 5.07 (s, 1H), 5.06 (s, 1H), 4.27 – 4.13 (m, 3H), 2.21 (dddd, J 
= 14.2, 9.2, 6.7, 3.9 Hz, 1H), 2.02 – 1.96 (m, 1H), 1.75 (s, 3H) ppm; 13C NMR (150 MHz, 
CDCl3) δ 155.6, 141.3, 114.2, 63.9, 63.8, 27.1, 18.5 ppm; IR (thin film) 3422, 2918, 1690, 
1435, 1284, 1125 cm
-1
; HRMS (ESI) m/z 180.0586 (180.0631 calcd for C7H11NNaO3
+
 
[MNa]
+
). 
(13) tert-butyl hydroxy(2-phenylallyl)carbamate 
 
  137 
According to the general procedure CuCl (1.9 mg, 0.019 mmol, 0.05 equiv) and pyridine 
(0.38 μL, 0.0048 mmol, 0.0125 equiv) were added to tert-butyl hydroxycarbamate S-5 (50 
mg, 0.38 mmol, 1.0 equiv) and α-methylstyrene 11 (49 mg, 0.42 mmol, 1.1 equiv) in 5 mL 
THF. The resulting reaction mixture was stirred for 14 h at 23 ˚C. The reaction was 
quenched with 10 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 × 10 mL). 
The combined organic layers were dried over MgSO4, filtered and then concentrated in 
vacuo. The residue was purified by column chromatography to afford hydroxycarbamate 13 
(55 mg, 57%) as a colorless solid. Spectral data matched literature precedent. 
1
H NMR (600 
MHz, CDCl
3
) δ 7.46 – 7.41 (m, 2H), 7.36 – 7.31 (m, 2H), 7.31 – 7.27 (m, 1H), 7.14 (bs, 
1H), 5.47 (s, 1H), 5.30 (s, 1H), 4.52 (s, 2H), 1.44 (s, 9H) ppm; 
13
C NMR (150 MHz, CDCl3) 
δ 156.8, 143.1, 139.2, 128.5, 128.0, 126.6, 115.0, 82.2, 54.3, 28.4 ppm. 
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(14) Benzyl hydroxy(2-phenylallyl)carbamate 
 
According to the general procedure, CuCl (4.4 mg, 0.045 mmol, 0.05 equiv) and pyridine 
(0.91 μL, 0.011 mmol, 0.0125 equiv) were added to benzyl hydroxycarbamate 16 (150 mg, 
0.90 mmol, 1.0 equiv) and α-methylstyrene 11 (127 mg, 1.1 mmol, 1.1 equiv) in 9 mL THF. 
The resulting reaction mixture was stirred for 16 h at 23 ˚C. The reaction was quenched with 
18 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 × 18 mL). The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue 
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was purified by column chromatography to afford hydroxycarbamate 14 (204 mg, 80%) as a 
colorless solid. 
1
H NMR (600 MHz, CDCl3) δ 7.34 – 7.15 (m, 10H), 6.98 (bs, 1H), 5.39 (s, 
1H), 5.18 (s, 1H), 5.02 (s, 2H), 4.48 (s, 2H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 157.4, 
142.5, 138.8, 136.0, 128.7, 128.6, 128.5, 128.3, 128.1, 126.5, 115.4, 68.3, 54.5 ppm; IR (thin 
film) 3271, 2930, 1700, 1454, 1234, 1099 cm
-1
; HRMS (ESI) m/z 306.1392 (306.1108 calcd 
for C17H17NNaO3
+
 [MNa]
+
). 
(15) (9H-Fluoren-9-yl)methyl hydroxy(2-phenylallyl)carbamate 
 
According to the general procedure, CuCl (1.0 mg, 0.011 mmol, 0.05 equiv) and pyridine 
(0.21 μL, 0.0028 mmol, 0.0125 equiv) were added to (9H-fluoren-9-yl)methyl 
hydroxycarbamate S-6 (55 mg, 0.21 mmol, 1.0 equiv) and α-methylstyrene 11 (28 mg, 0.23 
mmol, 1.1 equiv) in 2 mL THF. The resulting reaction mixture was stirred for 7 h at 23 °C. 
The reaction was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl 
acetate (3 × 4 mL). The combined organic layers were dried over MgSO4, filtered and then 
concentrated in vacuo. The residue was purified by column chromatography to afford 
hydroxycarbamate 15 (62 mg, 78%) as a yellow solid. 1H NMR (600 MHz, CDCl3) δ 7.76 
(d, J = 7.5 Hz, 2H), 7.56 (d, J = 7.5 Hz, 2H), 7.42 – 7.36 (m, 4H), 7.33 – 7.26 (m, 5H), 5.48 
(s, 1H), 5.26 (s, 1H), 4.53 (s, 2H), 4.43 (d, J = 6.9 Hz, 2H), 4.21 (t, J = 6.8Hz, 1H) ppm; 13C 
NMR (150 MHz, CDCl3) δ 157.5, 143.7, 142.4, 141.5, 138.7, 128.6, 128.1, 127.9, 127.3, 
126.4, 125.2, 120.2, 115.1, 68.4, 54.5, 47.2 ppm; IR (thin film) 3270, 3060, 2953, 1701, 
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1449, 1248, 1117 cm-1; HRMS (ESI) m/z 394.1417 (394.1421 calcd for C24H21NNaO3+ 
[MNa]+). 
(16A) 2,2,2-Trichloroethyl hydroxy(2-phenylallyl)carbamate 
 
According to the general procedure, CuCl (1.2 mg, 0.012 mmol, 0.05 equiv) and pyridine 
(0.24 μL, 0.0030 mmol, 0.0125 equiv) were added to 2,2,2-trichloroethyl hydroxycarbamate 
S-7 (50 mg, 0.24 mmol, 1.0 equiv) and α-methylstyrene 11 (31 mg, 0.26 mmol, 1.1 equiv) in 
2 mL THF. The resulting reaction mixture was stirred for 11 h at 23 ˚C. The reaction was 
quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 × 4 mL). The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo. 
The residue was purified by column chromatography to afford hydroxycarbamate 16A (63 
mg, 81%) as a colorless solid. 
1
H NMR (600 MHz, CDCl3) δ 7.46 – 7.44 (m, 2H), 7.35 – 
7.29 (m, 3H), 5.53 (s, 1H), 5.33 (s, 1H), 4.70 (s, 2H), 4.65 (s, 2H) ppm; 
13
C NMR (150 
MHz, CDCl3) δ 155.3, 142.1, 138.4, 128.7, 128.3, 126.6, 116.2, 95.2, 75.6, 54.7 ppm; IR 
(thin film) 3255, 2954, 1720, 1444, 1230, 1125 cm
-1
; HRMS (ESI) m/z 346.0074 (345.9783 
calcd for C12H12Cl3NNaO3
+
 [MNa]
+
). 
(19) Benzyl hydroxy(oct-2-en-1-yl)carbamate 
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According to the general procedure, CuCl (4.5 mg, 0.045 mmol, 0.05 equiv) and pyridine 
(0.91 μL, 0.011 mmol, 0.0125 equiv) were added to benzyl hydroxycarbamate 16 (151 mg, 
0.90 mmol, 1.0 equiv) and 1-octene S-8 (121 mg, 1.1 mmol, 1.2 equiv) in 9 mL THF. The 
resulting reaction mixture was stirred for 32 h at 23 ˚C. The reaction was quenched with 18 
mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 × 18 mL). The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue 
was purified by column chromatography to afford hydroxycarbamate 19 (106 mg, 42%) as 
an inseparable 3:1 E:Z mixture as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.37 – 7.31 
(m, 5H), 6.98 (bs, 1H), 5.67 (dt, J = 15.0, 6.7 Hz, 1H), 5.64 – 5.58 (m, 1H), 5.51 – 5.45 (m, 
1H), 5.18 (s, 2H), 4.20 (d, J = 5.0 Hz, 1H), 4.18 (d, J = 6.9 Hz, 2H), 4.07 (d, J = 6.3 Hz, 
2H), 2.06 (q, J = 7.1 Hz, 2H), 2.02 (q, J = 7.0 Hz, 2H), 1.38 – 1.22 (m, 6H), 0.88 (t, J = 7.1 
Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 157.7, 157.6, 136.1, 136.0, 128.7, 128.7, 
128.5, 128.5, 128.3, 128.3, 123.2, 123.0, 68.3, 68.2, 52.9, 47.7, 32.4, 31.6, 31.6, 29.3, 28.9, 
27.5, 22.7, 14.2 ppm; IR (thin film) 3270, 2926, 1702, 1455, 1354, 1237, 1097 cm
-1
; HRMS 
(ESI) m/z 300.1522 (300.1578 calcd for C16H23NNaO3
+
 [MNa]
+
). 
(20) Benzyl cyclohex-2-en-1-yl(hydroxy)carbamate 
 
According to the general procedure, CuCl (4.5 mg, 0.045 mmol, 0.05 equiv) and pyridine 
(0.91 μL, 0.011 mmol, 0.0125 equiv) were added to benzyl hydroxycarbamate 16 (150 mg, 
0.9 mmol, 1.0 equiv) and cyclohexene S-8 (89 mg, 1.1 mmol, 1.2 equiv) in 9 mL THF. The 
resulting reaction mixture was stirred for 34 h at 23 ˚C. The reaction was quenched with 18 
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mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 × 18 mL). The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue 
was purified by column chromatography to afford hydroxycarbamate 20 (156 mg, 71%) as a 
colorless solid. 
1
H NMR (600 MHz, CDCl3) δ 7.37 – 7.31 (m, 5H), 6.48 (bs, 1H), 5.96 – 
5.90 (m, 1H), 5.56 (dd, J = 10.2, 1.4 Hz, 1H), 5.20 (s, 2H), 4.70 – 4.64 (m, 1H), 2.09 – 2.02 
(m, 1H), 2.00 – 1.80 (m, 4H), 1.66 – 1.56 (m, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 
157.5, 136.2, 132.2, 128.8, 128.5, 128.3, 126.6, 68.2, 55.8, 25.9, 24.6, 21.3 ppm; IR (thin 
film) 3177, 2929, 1685, 1414, 1294, 1102 cm
-1
; MS (ESI) m/z 270.14 (270.11 calcd for 
C14H17NNaO3
+
 [MNa]
+
). 
(21) (E)-Benzyl hydroxy(oct-5-en-4-yl)carbamate 
 
According to the general procedure, CuCl (4.5 mg, 0.045 mmol, 0.05 equiv) and pyridine 
(0.91 μL, 0.011 mmol, 0.0125 equiv) were added to benzyl hydroxycarbamate 16 (150 mg, 
0.90 mmol, 1.0 equiv) and (E)-4-octene S-9 (121 mg, 1.1 mmol, 1.2 equiv) in 9 mL THF. 
The resulting reaction mixture was stirred for 45 h at 23 ˚C. The reaction was quenched with 
18 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 × 18 mL). The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue 
was purified by column chromatography to afford hydroxycarbamate 21 (181 mg, 73%) as 
an inseparable 3:1 E:Z mixture as an oil. 
1
H NMR (600 MHz, CDCl3) δ 7.37 – 7.31 (m, 5H), 
7.15 (bs, 1H), 5.65 (dt, J = 15.5 Hz, 1H), 5.54 – 5.45 (m, 1H), 5.20 (d, J = 12.3 Hz, 1H), 
5.16 (d, J = 12.4 Hz, 1H), 4.79 (apt. q, J = 8.4 Hz, 1H), 4.45 (apt. q, J = 7.2 Hz, 1H), 2.06 – 
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1.99 (m, 2H), 1.80 – 1.75 (m, 1H), 1.54 – 1.48 (m, 1H), 1.47 – 1.43 (m, 1H), 1.31 – 1.18 (m, 
3H), 0.90 (t, J = 7.5 Hz, 3H), 0.83 (t, J = 7.4 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 
157.9, 157.5, 136.3, 136.2, 135.1, 134.4, 128.7, 128.4, 128.4, 128.2, 128.2, 126.6, 126.5, 
68.0, 68.0, 61.0, 55.9, 34.5, 33.9, 25.5, 21.3, 19.5, 19.4, 14.3, 14.0, 14.0, 13.6 ppm; IR (thin 
film) 3255, 2961, 1698, 1456, 1320, 1094 cm
-1
; HRMS (ESI) m/z 300.1592 (300.1578 calcd 
for C16H23NNaO3
+
 [MNa]
+
). 
(22) Benzyl (2,3-dimethylbut-3-en-2-yl)(hydroxy)carbamate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and pyridine 
(0.30 μL, 0.0038 mmol, 0.0125 equiv) were added to benzyl hydroxycarbamate 16 (49 mg, 
0.30 mmol, 1.0 equiv) and 2,3- dimethylbut-2-ene S-10 (30 mg, 0.36 mmol, 1.2 equiv) in 3 
mL THF. The resulting reaction mixture was stirred for 8 h at 23 ˚C. The reaction was 
quenched with 6 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 × 6 mL). The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo. 
The residue was purified by column chromatography to afford hydroxycarbamate 22 (72 mg, 
98%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.37 – 7.29 (m, 5H), 6.77 (bs, 1H), 
5.16 (s, 2H), 4.84 (s, 1H), 4.76 (s, 1H), 1.74 (s, 3H), 1.48 (s, 6H) ppm; 
13
C NMR (150 MHz, 
CDCl3) δ 158.3, 149.8, 136.0, 128.6, 128.4, 128.3, 109.5, 68.1, 66.1, 25.7, 19.3 ppm; IR 
(thin film) 3324, 2987, 1685, 1454, 1329, 1104 cm
-1
; MS (ESI) m/z 272.16 (272.13 calcd for 
C14H19NNaO3
+
 [MNa]
+
). 
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(23) Benzyl hydroxy(1-hydroxy-3-methylbut-3-en-2-yl)carbamate 
 
According to the general procedure, CuCl (4.4 mg, 0.044 mmol, 0.05 equiv) and pyridine 
(0.91 μL, 0.011 mmol, 0.0125 equiv) were added to benzyl hydroxycarbamate 16 (150 mg, 
0.9 mmol, 1.0 equiv) and 3- methylbut-2-en-1-ol S-11 (93 mg, 1.1 mmol, 1.2 equiv) in 9 mL 
THF. The resulting reaction mixture was stirred for 17 h at 23 ˚C. The reaction was 
quenched with 18 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 × 18 mL). 
The combined organic layers were dried over MgSO4, filtered and then concentrated in 
vacuo. The residue was purified by column chromatography to afford hydroxycarbamate S 
23 (193 mg, 85%) as a colorless solid. 
1
H NMR (600 MHz, CD3OD) δ 7.41 – 7.37 (m, 2H), 
7.34 (t, J = 7.3 Hz, 2H), 7.32 – 7.28 (m, 1H), 5.17 (apt. q, J = 12.4 Hz, 2H), 4.94 (s, 1H), 
4.89 (s, 1H), 4.59 (dd, J = 8.8, 5.1 Hz, 1H), 3.90 (dd, J = 11.1, 9.4 Hz, 1H), 3.75 (dd, J = 
11.3, 5.0 Hz, 1H), 1.75 (s, 3H) ppm; 
13
C NMR (150 MHz, CD3OD) δ 159.6, 142.7, 137.9, 
129.5, 129.1, 128.9, 113.9, 68.6, 66.0, 60.7, 21.3 ppm; IR (thin film) 3232, 2942, 1697, 
1402, 1315, 1248, 1103 cm
-1
; HRMS (ESI) m/z 274.0956 (274.1058 calcd for 
C13H17NNaO4
+
 [MNa]
+
). 
(24) 2-(((Benzyloxy)carbonyl)(hydroxy)amino)-3-methylbut-3-en-1-yl acetate 
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According to the general procedure, CuCl (4.5 mg, 0.045 mmol, 0.05 equiv) and pyridine 
(0.91 μL, 0.011 mmol, 0.0125 equiv) were added to benzyl hydroxycarbamate 16 (151 mg, 
0.9 mmol, 1.0 equiv) and 3-methylbut-2-en-1-yl acetate S-12 (139 mg, 1.1 mmol, 1.2 equiv) 
in 9 mL THF. The resulting reaction mixture was stirred for 32 h at 23 ˚C. The reaction was 
then quenched with 18 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 × 18 
mL). The combined organic layers were dried over MgSO4, filtered and then concentrated in 
vacuo. The residue was purified by column chromatography to afford hydroxycarbamate 24 
(203 mg, 77%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.41 – 7.29 (m, 5H), 6.65 – 
6.55 (m, 1H), 5.20 (apt. q, J = 12.3 Hz, 1H), 4.99 (s, 1H), 4.92 (s, 1H), 4.81 – 4.75 (m,1H), 
4.71 (t, J = 10.9 Hz, 1H), 4.20 (dt, J = 11.3, 3.5 Hz, 1H), 1.89 (s, 3H), 1.77 (s, 3H) ppm; 
13
C 
NMR (150 MHz, CDCl3) δ 172.1, 157.6, 139.9, 136.1, 128.6, 128.4, 128.2, 114.3, 68.0, 
61.5, 61.4, 21.2, 20.8 ppm; IR (thin film) 3306, 2959, 1702, 1454, 1240, 1113 cm
-1
; HRMS 
(ESI) m/z 316.1123 (316.1163 calcd for C15H19NNaO5
+
 [MNa]
+
). 
(25) Benzyl (1-((tert-butyldimethylsilyl)oxy)-3-methylbut-3-en-2-
yl)(hydroxy)carbamate 
 
According to the general procedure CuCl (4.5 mg, 0.045 mmol, 0.05 equiv) and pyridine 
(0.91 μL, 0.011 mmol, 0.0125 equiv) were added to benzyl hydroxycarbamate 16 (151 mg, 
0.9 mmol, 1.0 equiv) and tert-butyldimethyl((3-methylbut-2-en-1-yl)oxy)silane S-13 (218 
mg, 1.1 mmol, 1.2 equiv) in 9 mL THF. The resulting reaction mixture was stirred for 23 h 
at 23 ˚C. The reaction was quenched with 18 mL EDTA (0.5 M, pH 7.0) and extracted with 
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ethyl acetate (3 × 18 mL). The combined organic layers were dried over MgSO4, filtered and 
then concentrated in vacuo. The residue was purified by column chromatography to afford 
hydroxycarbamate 25 (290 mg, 88%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.44 
– 7.28 (m, 5H), 6.37 (s, 1H), 5.19 (apt. q, J = 12.3 Hz, 2H), 4.96 (s, 1H), 4.93 (s, 1H), 4.63 
(dd, J = 8.6, 5.0 Hz, 1H), 4.02 (t, J = 9.7 Hz, 1H), 3.82 (dd, J = 10.3, 5.0 Hz, 1H), 1.78 (s, 
3H), 0.87 (s, 9H), 0.06 (s, 6H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 158.1, 141.0, 136.2, 
128.7, 128.4, 128.2, 113.6, 68.1, 64.6, 61.2, 26.0, 25.8, 21.3, 18.3, -3.4, -5.3, -5.3 ppm; IR 
(thin film) 3244, 2953, 2855, 1699, 1406, 1322, 1253, 1109 cm
-1
; HRMS (ESI) m/z 
388.1902 (388.1922 calcd for C19H31NNaO4Si
+
 [MNa]
+
). 
(26) Methyl 3-(((benzyloxy)carbonyl)(hydroxy)amino)-2-methylenebutanoate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and pyridine 
(0.30 μL, 0.0037 mmol, 0.0125 equiv) were added to benzyl hydroxycarbamate 16 (50 mg, 
0.30 mmol, 1.0 equiv) and (E)-methyl 2-methylbut-2-enoate S-14 (48 mg, 0.36 mmol, 1.2 
equiv) in 10 mL THF. The resulting mixture was stirred for 24 h at 23 ˚C. The reaction was 
quenched with 6 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 6 mL). The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo. 
The residue was purified by column chromatography to afford hydroxycarbamate 26 (61 mg, 
73%) as a colorless solid. 
1
H NMR (600 MHz, CDCl3) δ 7.39 – 7.27 (m, 5H), 6.29 (s, 1H), 
5.88 (s, 1H), 5.17 (s, 2H), 5.14 (q, J = 7.0 Hz, 1H), 3.71 (s, 3H), 1.41 (d, J = 7.0 Hz, 3H) 
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ppm; 
13
C NMR (150 MHz, CDCl3) δ 167.3, 156.8, 139.7, 136.2, 128.7, 128.3, 128.2, 127.3, 
68.0, 54.9, 52.3, 16.3 ppm; IR (thin film) 3312, 2951, 1717, 1439, 1299, 1080 cm-1; MS 
(ESI) m/z 302.0917 (302.0999 calcd for C14H17NNaO5
+
 [MNa]
+
). 
(27) 3-(((Benzyloxy)carbonyl)(hydroxy)amino)-2-methylenebutanoic acid 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and pyridine 
(0.30 μL, 0.0037 mmol, 0.0125 equiv) were added to benzyl hydroxycarbamate 16 (50 mg, 
0.30 mmol, 1.0 equiv) and (E)-2-methylbut-2-enoic acid S-15 (35 mg, 0.36 mmol, 1.2 equiv) 
in 10 mL THF. The resulting mixture was stirred for 36 h at 23 ˚C. The reaction was 
quenched with 6 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 6 mL). The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo. 
The residue was purified by column chromatography to afford hydroxycarbamate 26 (60 mg, 
75%) as a colorless solid. 
1
H NMR (600 MHz, CD3OD) δ 7.40 – 7.27 (m, 5H), 6.28 (s, 1H), 
5.87 (s, 1H), 5.20 (q, J = 7.0 Hz, 1H), 5.16 (s, 2H), 1.37 (d, J = 6.9 Hz, 3H) ppm; 
13
C NMR 
(150 MHz, CD3OD) δ 169.4, 158.7, 142.4, 137.9, 129.5, 129.1, 128.9, 126.2, 68.6, 55.1, 
16.5 ppm; IR (thin film) 3397, 2950, 1646, 1456, 1273, 1019 cm
-1
; HRMS (ESI) m/z 
288.0763 (288.0842 calcd for C13H15NNaO5
+
 [MNa]
+
). 
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(28) Benzyl (3-carbamoylbut-3-en-2-yl)(hydroxy)carbamate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and pyridine 
(0.30 μL, 0.0037 mmol, 0.0125 equiv) were added to benzyl hydroxycarbamate 16 (50 mg, 
0.30 mmol, 1.0 equiv) and (E)-2- methylbut-2-enamide S-16 (35 mg, 0.36 mmol, 1.2 equiv) 
in 10 mL THF. The resulting mixture was stirred for 12 h at 23 ˚C. The reaction was 
quenched with 6 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 6 mL). The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo. 
The residue was purified by column chromatography to afford hydroxycarbamate 27 (58 mg, 
72%) as a colorless solid. 
1
H NMR (600 MHz, CD3OD) δ 7.40 – 7.26 (m, 5H), 5.83 (s, 1H), 
5.60 (d, J = 1.4 Hz, 1H), 5.20 (q, J = 7.2 Hz, 1H), 5.16 (apt. d, J = 1.6, 2H), 1.37 (d, J = 6.9 
Hz, 3H) ppm; 
13
C NMR (150 MHz, CD3OD) δ 172.9, 158.7, 145.4, 137.8, 133.1, 129.5, 
129.1, 128.9, 120.4, 68.6, 55.6, 16.0, 14.0, 12.4 ppm; IR (thin film) 3408, 3231, 2943, 1635, 
1429, 1310, 1118 cm
-1
; HRMS (ESI) m/z 287.1060 (287.1002 calcd for C13H16N2NaO4
+
 
[MNa]
+
). 
(29) Benzyl 3-methyl-4-methylene-5-oxoisoxazolidine-2-carboxylate 
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According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and pyridine 
(0.30 μL, 0.0037 mg, 0.0125 equiv) were added to benzyl hydroxycarbamate 16 (50 mg, 
0.30 mmol, 1.0 equiv) and (E)-N-(2-methylbut-2-enoyl)benzamide S-17 (73 mg, 0.36 mmol, 
1.2 equiv) in 10 mL THF. The resulting mixture was stirred for 44 h at 23 ˚C. The reaction 
was quenched with 6 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 6 mL). 
The combined organic layers were dried over MgSO4, filtered and then concentrated in 
vacuo. The residue was purified by column chromatography to afford 5-oxoisoxazolidine 29 
(58 mg, 78%) as a colorless solid. The enantiomers were separated by chiral HPLC 
(Chiralpak IB column, 4.6mm x 250mm, 95:5 hexanes/i-PrOH, 1 mL/min, (R) Rt = 13.9 
min, (S) Rt = 18.8 min). 
1
H NMR (600 MHz, CDCl3) δ 7.42 – 7.32 (m, 5H), 6.38 (d, J = 2.8 
Hz, 1H), 5.77 (d, J = 2.4 Hz, 1H), 5.28 (d, J = 12.2 Hz, 1H), 5.25 (d, J = 12.2 Hz, 1H), 5.03 
– 4.98 (m, 1H), 1.57 (d, J = 6.5 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 165.5, 156.4, 
136.4, 135.1, 128.9, 128.9, 128.6, 124.1, 69.0, 59.6, 22.0; IR (thin film) 2922, 1783, 1455, 
1246, 1130 cm
-1
; HRMS (ESI) m/z 270.0790 (270.0737 calcd for C13H13NNaO4
+
 [MNa]
+
). 
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((S)-29) (S) Benzyl 3-methyl-4-methylene-5-oxoisoxazolidine-2-carboxylate 
 
According to the general procedure, CuCl (1.0 mg, 0.0090 mmol, 0.05 equiv) and pyridine 
(0.18 μL, 0.0023 mmol, 0.0125 equiv) were added to benzyl hydroxycarbamate 16 (30 mg, 
0.18 mmol, 1.0 equiv) and (E)-1-((6S,7aS)-8,8-dimethyl-2,2-dioxidohexahydro-1H-3a,6-
methanobenzo[c]isothiazol-1- yl)-2-methylbut-2-en-1-one 39 (64 mg, 0.22 mmol, 1.2 equiv) 
in 5 mL THF. The resulting mixture was stirred for 48 h at 23 ˚C. The reaction was 
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quenched with 5 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 5 mL). The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo. 
The residue was purified by column chromatography to afford 5-oxoisoxazolidine (S)-29 (34 
mg, 76%) as a solid. The enantiomeric excess was determined by chiral HPLC (Chiralpak IB 
column, 4.6mm x 250mm, 95:5 hexanes/i- PrOH, 1 mL/min, (R) Rt = 13.9, (S) Rt = 18.7 
min). [α]D
25
 +131.3° (c 1.00, CHCl3); Spectral data consistent with 29. 
(31) (E)-6-(((Benzyloxy)carbonyl)(hydroxy)amino)-3,7-dimethylocta-2,7-dien-1-yl 
acetate 
 
According to the general procedure, CuCl (4.5 mg, 0.045 mmol, 0.05 equiv) and pyridine 
(0.91 μL, 0.011 mmol, 0.0125 equiv) were added to benzyl hydroxycarbamate 16 (151 mg, 
0.90 mmol, 1.0 equiv) and geranyl acetate 30 (213 mg, 1.1 mmol, 1.2 equiv) in 9 mL THF. 
The resulting reaction mixture was stirred for 26 h at 23 ˚C. The reaction was quenched with 
18 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 × 18 mL). The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue 
was purified by column chromatography to afford hydroxycarbamate 31 and 32 (284 mg, 
87%) in a 9:1 mixture as a colorless oil. A pure fraction of 31 was obtained for 
characterization by column chromatography (31): 
1
H NMR (600 MHz, CDCl3) δ 7.37 – 7.29 
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(m, 5H), 6.62 (bs, 1H), 5.33 (t, J = 7.0 Hz, 1H), 5.18 (s, 2H), 4.93 (s, 2H), 4.61 – 4.49 (m, 
2H), 4.44 – 4.40 (m, 1H), 2.13 – 2.03 (m, 2H), 2.02 (s, 3H), 1.83 – 1.76 (m, 1H), 1.74 (s, 
3H), 1.68 (s, 3H); 
13
C NMR (150 MHz, CDCl3) δ 171.4, 157.4, 143.2, 141.8, 136.2, 128.8, 
128.5, 128.3, 119.0, 113.5, 68.2, 62.9, 61.5, 36.3, 27.3, 21.2, 20.9, 16.7 ppm. The mixture of 
isomers is enriched in 32 because a fraction of 31 was removed by column chromatography, 
see above. Mixture of isomers (31 and 32): 
1
H NMR (400 MHz, CDCl3) δ 7.41 – 7.28 (m, 
5H), 6.10 (s, 1H), 5.70 (d, J = 15.7 Hz, 1H), 5.46 (dt, J = 15.6, 7.0 Hz, 1H), 5.33 (dt, J = 7.1, 
1.2 Hz, 1H), 5.20 (s, 2H), 5.17 (s, 2H), 5.03 (d, J = 12.1 Hz, 1H), 4.94 (d, J = 4.2 Hz, 1H), 
4.57 (d, J = 7.1 Hz, 2H), 4.46 – 4.39 (m, 1H), 2.69 (d, J = 6.9 Hz, 2H), 2.04 (s, 3H), 2.03 (s, 
2H), 1.74 (s, 3H), 1.68 (s, 3H), 1.47 (s, 6H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 171.4, 
158.7, 157.6, 143.3, 143.3, 141.8, 136.1, 128.7, 128.7, 128.5, 128.5, 128.3, 128.2, 128.2, 
119.2, 118.9, 113.4, 113.3, 68.1, 63.4, 62.9, 61.6, 61.5, 42.4, 36.3, 27.9, 27.3, 26.3, 23.6, 
21.2, 20.8, 16.7, 16.6 ppm; IR (thin film) 3305, 2941, 1698, 1454, 1234, 1097 cm
-1
; HRMS 
(ESI) m/z 384.1755 (384.1789 calcd for C20H27NNaO5
+
 [MNa]
+
). 
(36) Benzyl hydroxy(2-methylcyclohex-2-en-1-yl)carbamate 
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According to the general procedure CuCl (4.5 mg, 0.045 mmol, 0.05 equiv) and pyridine 
(0.91 μL, 0.011 mmol, 0.0125 equiv) were added to benzyl hydroxycarbamate 16 (151 mg, 
0.9 mmol, 1.0 equiv) and 1- methylcyclohex-1-ene 35 (104 mg, 1.1 mmol, 1.2 equiv) in 9 
mL THF. The resulting reaction mixture was stirred for 46 h at 23 ˚C. The reaction was 
quenched with 9 mL EDTA (0.5 M, pH 7) and extracted with ethyl acetate (3 × 10 mL). The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo. 
The residue was purified by column chromatography to afford hydroxycarbamate 36 and 37 
(155 mg, 66%) as a 6:1 mixture. Hydroxycarbamate 38 was also isolated (12.7 mg, 5%) as a 
colorless solid. A pure fraction of 36 was obtained for characterization by column 
chromatography. (36): 
1
H NMR (400 MHz, CDCl3) δ 7.38 – 7.34 (m, 5H), 5.68 (s, 1H), 5.22 
– 5.21 (m, 2H), 4.56 (bs, 1H), 2.10 – 1.98 (m, 1H), 1.98 – 1.87 (m, 2H), 1.86 – 1.75 (m, 2H), 
1.62 (s, 3H), 1.60 – 1.50 (m, 2H) ppm; 13C NMR (150 MHz, CDCl3) δ 157.6, 157.6, 136.2, 
131.9, 128.8, 128.5, 128.3, 127.9, 68.2, 58.3, 27.0, 25.2, 21.3, 20.3 ppm. IR (thin film) 3269, 
2939, 1696, 1454, 1297, 1102 cm
-1
; HRMS (ESI) m/z 284.1222 (284.1265 calcd for 
C15H19NNaO3
+
 [MNa]
+
). The mixture of isomers is enriched in 37 because a fraction of 36 
was removed by column chromatography, see above. Mixture of isomers (36 and 37): 
1
H 
NMR (400 MHz, CDCl3) δ 7.37 – 7.33 (m, 5H), 5.70 – 5.63 (m, 1H), 5.26 – 5.16 (m, 4H), 
4.80 (s, 1H), 4.71 (s, 1H), 4.57 – 4.45 (m, 2H), 2.12 – 1.76 (m, 6H), 1.62 (s, 3H) ppm. A 
pure fraction of 38 was obtained for characterization by column chromatography. (38): 
1
H 
NMR (500 MHz, CDCl3) δ 7.46 – 7.30 (m, 5H), 5.87 (s, 1H), 5.83 – 5.77 (m, 1H), 5.77 – 
5.65 (m, 1H), 5.26 – 5.16 (m, 2H), 2.10 – 1.89 (m, 2H), 1.73 – 1.52 (m, 4H), 1.40 (s, 3H) 
ppm. Mixture of isomers (36, 37, and 38): 
13
C NMR (150 MHz, CDCl3) δ 157.8, 156.7, 
155.5, 145.6, 136.3, 136.2, 135.1, 134.2, 132.0, 129.1, 128.8, 128.7, 128.7, 128.7, 128.6, 
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128.6, 128.4, 128.3, 128.2, 128.0, 127.7, 127.6, 127.1, 106.5, 71.7, 68.5, 68.1, 68.0, 61.8, 
58.3, 35.2, 30.5, 27.2, 27.0, 25.6, 25.1, 21.3, 20.2 ppm. 
 
6.1.2 Supporting Information for the Nitroso Diels–Alder Reaction 
Materials and Methods. Unless stated otherwise, reactions were conducted in flame-dried 
glassware under an atmosphere of air using reagent grade solvents. All commercially 
obtained reagents were used as received. Reaction temperatures were controlled using a 
Heidolph temperature modulator, and unless stated otherwise, reactions were performed at 
room temperature (rt, approximately 23 ºC). Thin-layer chromatography (TLC) was 
conducted with E. Merck silica gel 60 F254 pre-coated plates, (0.25 mm) and visualized by 
exposure to UV light (254 nm) or stained with potassium permanganate. Flash column 
chromatography was performed using normal phase silica gel (60 Å, 230-240 mesh, 
Geduran®). 1H NMR spectra were recorded on Varian Spectrometers (at 400, 500 and 600 
MHz) and are reported relative to deuterated solvent signals. Data for 1H NMR spectra are 
reported as follows: chemical shift (δ ppm), multiplicity, coupling constant (Hz) and 
integration. 
13
C NMR spectra were recorded on Varian Spectrometers (125 and 150 MHz). 
Data for 
13
C NMR spectra are reported in terms of chemical shift. 
31
P NMR spectra were 
recorded on a Varian Spectrometer (162 MHz) and are reported in terms of chemical shift. 
Data for 
31
P NMR spectra are reported relative to H3PO4. IR spectra were recorded on a 
Perkin Elmer Spectrum Two FT/IR and are reported in terms of frequency of absorption (cm
-
1
). Low resolution mass spectra were obtained from the UC Santa Barbara Mass 
Spectrometry Facility. 
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Starting Materials 
Hydroxamic acids S-18, S-19, S-20, and S-21 were purchased from commercial 
sources and used as received. N-hydroxycarbamates 16, S-5, and S-6 were purchased from 
commercial sources and used as received. N-hydroxycarbamates S-7, S-22, S-23, S-24, S-25, 
S-26 and 1 were prepared from the corresponding alcohol according to literature precedent.
4
 
Starting N-hydroxyureas S-28, S-29, and S-30 were prepared according to the same 
procedure from the corresponding amine. Hydroxyurea (S-27) was purchased from a 
commercial source and used as received. Hydroxylamine S-17 was prepared according to 
literature precedent.
5
 Hydroxylamine S-18 was prepared according to literature precedent.
6
 
Hydroxylamine S-19 and S-20 were prepared according to literature precedent.
7
 
Hydroxylamine S-21 was prepared according to literature precedent.
8
 
Substrate scope for Nitroso Hetero–Diels–Alder Reaction 
General Procedure for the Diels–Alder Reaction: To a stirred solution of hydroxamic 
acid 63 and cyclohexa-1,3-diene 64 in THF was added 20 mol % CuCl and 5 mol % 
pyridine. The reaction was stirred at room temperature open to the air until complete by 
TLC. Upon completion, the reaction was quenched with EDTA (0.5 M, pH 7.0), diluted with 
ethyl acetate and stirred until color no longer persisted in organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford oxazine 65. 
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(44) Benzyl 2-oxa-3-azabicyclo[2.2.1]hept-5-ene-3-carboxylate 
 
According to the general procedure, CuCl (11 mg, 0.11 mmol, 0.20 equiv) and pyridine (2.2 
μL, 0.027 mmol, 0.05 equiv) were added to benzyl hydroxycarbamate 16 (90 mg, 0.54 
mmol, 1.0 equiv) and cyclopentadiene S-36 (50 μL, 0.59 mmol, 1.1 equiv) in 5 mL THF. 
The resulting mixture was stirred for 2 h at rt. The reaction was quenched with 10 mL EDTA 
(0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 10 mL). The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo. The residue was purified by 
column chromatography to afford oxazine 44 (117 mg, 94%) as a colorless solid. 
1
H NMR 
(600 MHz, CDCl3) δ 7.46 – 7.28 (m, 5H), 6.37 (s, 2H), 5.23 (s, 1H), 5.19 (dd, J = 12.3, 1.7 
Hz, 1H), 5.12 (dd, J = 12.3, 1.8 Hz, 1H), 5.04 (s, 1H), 2.00 (dd, J = 8.7, 1.7 Hz, 1H), 1.74 (d, 
J = 8.7 Hz, 1H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 159.4, 135.8, 134.6, 133.1, 128.6, 
128.4, 128.3, 84.0, 67.9, 65.2, 48.3 ppm; IR (thin film) 3032, 2961, 1741, 1386, 1177, 1090 
cm
-1
; MS (ESI) m/z 254.04 (254.08 calcd for C13H13NNaO3
+
 [MNa]
+
). 
(45) Benzyl 2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxylate 
.  
According to the general procedure, CuCl (6.0 mg, 0.060 mmol, 0.20 equiv) and pyridine 
(1.2 μL, 0.015 mmol, 0.05 equiv) were added to benzyl hydroxycarbamate 16 (50 mg, 0.30 
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mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (34 μL, 0.36 mmol, 1.2 equiv) in 3 mL THF. 
The resulting mixture was stirred for 4 h at rt. The reaction was quenched with 6 mL EDTA 
(0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 6 mL). The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo. The residue was purified by 
column chromatography to afford oxazine 45 (70 mg, 96%) as a colorless solid. 
1
H NMR 
(600 MHz, CDCl3) δ 7.40 – 7.27 (m, 5H), 6.53 (ddd, J = 13.7, 7.1, 7.1 Hz, 2H), 5.19 (d, J = 
12.3 Hz, 1H), 5.12 (d, J = 12.3 Hz, 1H), 4.81 (s, 1H), 4.75 (s, 1H), 2.20 (dddd, J = 13.0, 8.2, 
3.6, 3.6 Hz, 1H), 2.11 (dddd, J = 12.7, 9.3, 3.3, 3.3 Hz, 1H), 1.48 (dddd, J = 12.3, 12.3, 2.9, 
2.9 Hz 1H), 1.37 (ddd, J = 12.5, 12.5, 3.2 Hz, 1H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 
158.3, 136.1, 132.1, 131.8, 128.6, 128.3, 128.2, 71.2, 67.8, 50.3, 23.6, 20.7 ppm; IR (thin 
film) 3061, 2939, 1701, 1455, 1264, 1074 cm
-1
; MS (ESI) m/z 268.11 (268.09 calcd for 
C14H15NNaO3
+
 [MNa]
+
). 
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(46) Benzyl 9,10-dimethyl-9,10-dihydro-9,10-(epoxyimino)anthracene-11 
carboxylate 
 
According to the general procedure, CuCl (5.8 mg, 0.058 mmol, 0.20 equiv) and pyridine 
(1.2 μL, 0.015 mmol, 0.05 equiv) were added to benzyl hydroxycarbamate 16 (49 mg, 0.29 
mmol, 1.0 equiv) and 9,10-dimethylanthracene S-38 (72 mg, 0.35 mmol, 1.2 equiv) in 3 mL 
THF. The resulting mixture was stirred for 5 h at rt. The reaction was quenched with 6 mL 
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EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 6 mL). The combined organic 
layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue was 
purified by column chromatography to afford oxazine 46 (104 mg, 96%) as a yellow solid. 
1
H NMR (600 MHz, CDCl3) δ 7.50 – 7.43 (m, 2H), 7.43 – 7.36 (m, 2H), 7.31 – 7.19 (m, 
7H), 6.98 (m, 2H), 5.00 (s, 2H), 2.63 (s, 3H), 2.26 (s, 3H) ppm; 
13
C NMR (150 MHz, 
CDCl3) δ 159.8, 141.9, 140.6, 136.3, 128.4, 127.8, 127.4, 127.4, 127.1, 121.7, 120.8, 79.3, 
67.3, 64.2, 16.7, 15.2 ppm; IR (thin film) 3033, 2984, 1713, 1460, 1276, 1070 cm
-1
; MS 
(ESI) m/z 394.17 (394.14 calcd for C24H21NNaO3
+
 [MNa]
+
). 
(47) Benzyl 4,5-dimethyl-3,6-dihydro-2H-1,2-oxazine-2-carboxylate 
 
According to the general procedure, CuCl (12 mg, 0.12 mmol, 0.20 equiv) and pyridine (2.4 
μL, 0.030 mmol, 0.05 equiv) were added to benzyl hydroxycarbamate 16 (100 mg, 0.60 
mmol, 1.0 equiv) and 2,3- dimethylbuta-1,3-diene S-41 (83 μL, 0.72 mmol, 1.2 equiv) in 6 
mL THF. The resulting mixture was stirred for 8 h at rt. The reaction was quenched with 12 
mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 12 mL). The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue 
was purified by column chromatography to afford oxazine 47 (88 mg, 71%) as a colorless 
solid and carbamate 93 (21 mg, 17%) as a colorless oil. (47): 
1
H NMR (600 MHz, CDCl3) δ 
7.41 – 7.29 (m, 5H), 5.21 (s, 2H), 4.22 (s, 2H), 3.97 (s, 2H), 1.66 (s, 3H), 1.58 (s, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 155.7, 136.2, 128.7, 128.4, 128.3, 123.3, 121.9, 71.8, 67.8, 
48.6, 15.4, 14.0 ppm; IR (thin film) 2916, 2847, 1710, 1411, 1219, 1089 cm
-1
; MS (ESI) m/z 
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270.13 (270.11 calcd for C14H17NNaO3
+
 [MNa]
+
). Benzyl hydroxy(3-methyl-2-
methylenebut-3-en-1-yl)carbamate (93): 
1
H NMR (600 MHz, CDCl3) δ 7.39 – 7.31 (m, 
5H), 6.39 (bs, 1H), 5.29 (s, 1H), 5.20 (s, 2H), 5.17 (s, 1H), 5.09 (s, 1H), 5.00 (s, 1H), 4.40 (s, 
2H), 1.93 (s, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 157.2, 141.5, 141.1, 136.0, 128.8, 
128.6, 128.4, 115.1, 113.7, 68.3, 53.2, 21.4 ppm; IR (thin film) 3292, 2950, 1793, 1456, 
1246, 1102 cm
-1
; MS (ESI) m/z 270.14 (270.11 calcd for C14H17NNaO3
+
 [MNa]
+
). 
 
(48) Benzyl 4-methyl-3,6-dihydro-2H-1,2-oxazine-2-carboxylate 
 
According to the general procedure, CuCl (5.9 mg, 0.060 mmol, 0.20 equiv) and pyridine 
(1.2 μL, 0.015 mmol, 0.05 equiv) were added to benzyl hydroxycarbamate 16 (50 mg, 0.30 
mmol, 1.0 equiv) and 2- methylbuta-1,3-diene S-42 (36 μL, 0.36 mmol, 1.2 equiv) in 3 mL 
THF. The resulting mixture was stirred for 3 h at rt. The reaction was quenched with 6 mL 
EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 6 mL). The combined organic 
layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue was 
purified by column chromatography to afford oxazine 48 and S-43 (25 mg, 43%. 2:1 
mixture, inseparable) as a colorless solid and carbamate 94 (21 mg, 36%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) (48): δ 7.47 – 7.29 (m, 5H), 5.53 (s, 1H), 5.22 (s, 2H), 4.39 (s, 
2H), 4.02 (s, 2H), 1.73 (s, 3H) ppm (S-43): δ 7.47 – 7.29 (m, 5H), 5.52 (s, 1H), 5.21 (s, 2H), 
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4.28 (s, 2H), 4.11 (s, 2H), 1.66 (s, 3H) ppm; (Mixture): 
13
C NMR (150 MHz, CDCl3) δ 
155.8, 155.7, 136.2, 136.2, 131.8, 130.3, 128.8, 128.5, 128.4, 128.4, 118.2, 116.5, 71.9, 
68.8, 67.9, 67.9, 48.7, 45.0, 19.9, 18.5 ppm; IR (thin film) 3034, 2914, 1708, 1410, 1217, 
1099 cm
-1
; MS (ESI) m/z 256.10 (256.09 calcd for C13H15NNaO3
+
 [MNa]
+
). Benzyl 
hydroxy(2-methylenebut-3-en-1-yl)carbamate (94): 
1
H NMR (600 MHz, CDCl
3) δ 7.40 – 
7.30 (m, 5H), 6.39 (dd, J = 17.8, 11.1 Hz, 1H), 6.39 (bs, 1H), 5.29 (d, J = 17.8 Hz, 1H), 5.21 
(d, J = 10.5 Hz, 3H), 5.20 (d, J = 10.0 Hz, 1H), 5.10 (d, J = 11.1 Hz, 1H), 4.35 (s, 2H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 157.2, 140.1, 136.7, 136.0, 128.8, 128.6, 128.4, 118.3, 
114.9, 68.4, 51.8 ppm; IR (thin film) 3293, 2933, 1702, 1455, 1250, 1104 cm
-1
; MS (ESI) 
m/z 256.10 (256.09 calcd for C13H15NNaO3
+
 [MNa]
+
). 
(49) Benzyl 3,6-diphenyl-3,6-dihydro-2H-1,2-oxazine-2-carboxylate 
 
According to the general procedure, CuCl (5.9 mg, 0.060 mmol, 0.20 equiv) and pyridine 
(1.2 μL, 0.015 mmol, 0.05 equiv) were added to benzyl hydroxycarbamate 16 (50 mg, 0.30 
mmol, 1.0 equiv) and (1E,3E)-1,4-diphenylbuta-1,3-diene S-37 (74 mg, 0.36 mmol, 1.2 
equiv) in 3 mL THF. The resulting mixture was stirred for 12 h at rt. The reaction was 
quenched with 6 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 6 mL). The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo. 
The residue was purified by column chromatography to afford oxazine 49 (89 mg, 80%) as a 
colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.54 (d, J = 7.4 Hz, 2H), 7.49 – 7.30 (m, 12H), 
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6.17 (ddd, J = 10.1, 4.3, 2.0 Hz, 1H), 6.09 (d, J = 10.2 Hz, 1H), 5.68 (s, 1H), 5.63 (s, 1H), 
5.33 (d, J = 12.3 Hz, 1H), 5.20 (d, J = 12.4 Hz, 1H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 
155.0, 138.9, 137.1, 136.3, 129.2, 128.9, 128.8, 128.7, 128.3, 128.3, 128.2, 128.1, 128.1, 
127.9, 126.2, 79.9, 67.8, 29.6 ppm; IR (thin film) 3032, 2956, 1701, 1412, 1273, 1092 cm
-1
; 
MS (ESI) m/z 394.16 (394.14 calcd for C24H21NNaO3
+
 [MNa]
+
). 
(66) 1-(2-oxa-3-azabicyclo[2.2.2]oct-5-en-3- yl)ethanone 
 
As modified from the general procedure, CuCl (13 mg, 0.14 mmol, 0.20 equiv) and 
pyridine (2.6 μL, 0.033 mmol, 0.05 equiv) were added to N-hydroxyacetamide S-18 (50 mg, 
0.37 mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (76 μL, 0.80 mmol, 1.2 equiv) in 6 mL 
THF. The resulting mixture was stirred for 27 h at 50 ºC. The reaction was quenched with 12 
mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 12 mL). The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue 
was purified by column chromatography to afford oxazine 66 (59 mg, 58%) as a colorless 
solid. 
1
H NMR (600 MHz, CDCl3) δ 6.62 (dd, J = 6.9, 6.9 Hz, 1H), 6.50 (dd, J = 6.6, 6.6 
Hz, 1H), 5.32 – 5.20 (m, 1H), 4.80 – 4.68 (m, 1H), 2.24 – 2.15 (m, 1H), 2.08 (ddd, J = 9.2, 
9.2, 3.3 Hz, 1H), 1.95 (s, 3H), 1.52 – 1.44 (m, 2H) ppm; 13C NMR (150 MHz, CDCl3) δ 
170.5, 133.2, 131.5, 72.0, 46.4, 23.7, 21.3, 21.1 ppm; IR (thin film) 2939, 2865, 1655, 1366, 
1268, 1049 cm
-1
; MS (ESI) m/z 176.06 (176.07 calcd for C8H11NNaO2
+
 [MNa]
+
). 
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(67) 2-oxa-3-azabicyclo[2.2.2]oct-5-en-3-yl(phenyl)methanone 
 
According to the general procedure, CuCl (7.3 mg, 0.074 mmol, 0.20 equiv) and pyridine 
(1.5 μL, 0.018 mmol, 0.05 equiv) were added to N-hydroxybenzamide S-19 (50 mg, 0.37 
mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (42 μL, 0.44 mmol, 1.2 equiv) in 4 mL THF. 
The resulting mixture was stirred for 96 h at rt. The reaction was quenched with 8 mL EDTA 
(0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 8 mL). The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo. The residue was purified 
by column chromatography to afford oxazine 67 (63 mg, 80%) as a colorless solid. By low 
temperature NMR, two conformational isomers were observed in a 2:1 ratio. Major: 
1
H 
NMR (500 MHz, CD3OD, -68 ºC) δ 7.67 – 7.37 (m, 5H), 6.67 (ddd, J = 7.7, 5.7, 1.2 Hz, 
1H), 6.52 (ddd, J = 7.9, 6.3, 1.4 Hz, 1H), 5.07 – 5.02 (m, 1H), 4.81 – 4.77 (m, 1H), 2.37 – 
2.23 (m, 2H), 1.69 – 1.47 (m, 2H) ppm; Minor: 1H NMR (500 MHz, CD3OD, -68 ºC) δ 7.67 
– 7.37 (m, 5H), 6.79 (ddd, J = 7.8, 6.2, 1.4 Hz, 1H), 6.61 (ddd, J = 8.0, 5.6, 1.5 Hz, 1H), 
5.45 – 5.40 (m, 1H), 4.85 – 4.81 (m, 1H), 2.37 – 2.23 (m, 1H), 2.21 – 2.15 (m, 1H), 1.69 – 
1.47 (m, 2H) ppm; Mixed: 
13
C NMR (125 MHz, CD3OD, -68 ºC) δ 169.4, 167.7, 134.8, 
134.6, 134.1, 133.3, 132.5, 132.3, 131.8, 130.2, 130.0, 128.9, 128.8, 73.8, 73.6, 53.8, 53.7, 
48.1, 48.1, 24.2, 24.1, 22.4, 21.6 ppm; IR (thin film) 3060, 2938, 1642, 1449, 1270, 1084 
cm
-1
; MS (ESI) m/z 238.11 (238.08 calcd for C13H13NNaO2
+
 [MNa]
+
). 
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(68) 1-(2-oxa-3-azabicyclo[2.2.2]oct-5-en-3-yl)-2-phenylethanone 
 
According to the general procedure, CuCl (6.7 mg, 0.067 mmol, 0.20 equiv) and pyridine 
(1.4 μL, 0.017 mmol, 0.05 equiv) were added to N-hydroxy-2-phenylacetamide S-20 (51 mg, 
0.34 mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (39 μL, 0.40 mmol, 1.2 equiv) in 3 mL 
THF. The resulting mixture was stirred for 12 h at rt. The reaction was quenched with 6 mL 
EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 6 mL). The combined organic 
layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue was 
purified by column chromatography to afford oxazine 68 (72 mg, 93%) as a light brown 
solid. 
1
H NMR (600 MHz, CDCl3) δ 7.40 – 7.27 (m, 5H), 6.58 – 6.50 (m, 2H), 5.19 (d, J = 
12.3 Hz, 1H), 5.13 (d, J = 12.3 Hz, 1H), 4.85 – 4.80 (m, 1H), 4.77 – 4.73 (m, 1H), 2.20 
(dddd, J = 12.8, 9.0, 3.5, 3.5 Hz, 1H), 2.11 (dddd, J = 12.7, 9.2, 3.2, 3.2 Hz, 1H), 1.48 (dddd, 
J = 12.2, 12.2, 2.8, 2.8, 1H), 1.37 (ddd, J = 12.7, 12.7, 3.2 Hz, 1H) ppm; 
13
C NMR (150 
MHz, CDCl3) δ 158.3, 136.1, 132.1, 131.8, 128.6, 128.3, 128.2, 71.2, 67.8, 50.3, 23.6, 20.7 
ppm; IR (thin film) 3062, 2939, 1700, 1455, 1265, 1074 cm
-1
; MS (ESI) m/z 268.09 (268.07 
calcd for C14H15KNO2
+
 [MK]
+
). 
(69) 2-oxa-3-azabicyclo[2.2.2]oct-5-en-3-yl(2-hydroxyphenyl)methanone 
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As modified from the general procedure, CuCl (6.5 mg, 0.065 mmol, 0.20 equiv) and 
pyridine (1.3 μL, 0.016 mmol, 0.05 equiv) were added to N,2-dihydroxybenzamide S-21 (50 
mg, 0.33 mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (37 μL, 0.39 mmol, 1.2 equiv) in 3 
mL THF. The resulting mixture was stirred for 120 h at 50 ºC. The reaction was quenched 
with 6 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 6 mL). The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo. 
The residue was purified by column chromatography to afford oxazine 69 (55 mg, 73%) as a 
colorless solid. 
1
H NMR (600 MHz, CDCl3) δ 11.33 (s, 1H), 7.87 (d, J = 7.5 Hz, 1H), 7.34 
(dd, J = 7.7, 7.7 Hz, 1H), 6.94 (d, J = 8.2 Hz, 1H), 6.81 (dd, J = 7.6, 7.6 Hz, 1H), 6.70 (dd, J 
= 6.9, 6.9 Hz, 1H), 6.58 (dd, J = 6.3, 6.3 Hz, 1H), 5.48 – 5.41 (m, 1H), 4.92 – 4.88 (m, 1H), 
2.37 – 2.29 (m, 1H), 2.28 – 2.19 (m, 1H), 1.62 – 1.52 (m, 2H) ppm; 13C NMR (150 MHz, 
CDCl3) δ 169.2, 161.1, 133.8, 132.8, 132.2, 130.6, 120.7, 118.3, 117.8, 115.1, 72.8, 23.6, 
21.1 ppm; IR (thin film) 2939, 1627, 1486, 1253, 1087 cm
-1
; MS (ESI) m/z 254.11 (254.08 
calcd for C13H13NNaO3
+
 [MNa]
+
). 
(70) tert-butyl 2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxylate 
 
According to the general procedure, CuCl (7.5 mg, 0.076 mmol, 0.20 equiv) and pyridine 
(1.5 μL, 0.019 mmol, 0.05 equiv) were added to tert-butyl hydroxycarbamate S-5 (51 mg, 
0.38 mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (44 μL, 0.46 mmol, 1.2 equiv) in 4 mL 
THF. The resulting mixture was stirred for 3 h at rt. The reaction was quenched with 8 mL 
EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 8 mL). The combined organic 
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layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue was 
purified by column chromatography to afford oxazine 70 (77 mg, 96%) as a yellow oil. 
1
H 
NMR (600 MHz, CDCl3) δ 6.56 – 6.45 (m, 2H), 4.75 – 4.64 (m, 2H), 2.15 (dddd, J = 12.9, 
9.3, 3.7, 3.7 Hz, 1H), 2.06 (dddd, J = 12.9, 9.4, 3.5, 3.5 Hz, 1H), 1.48 – 1.40 (m, 10H), 1.35 
– 1.29 (m, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 157.8, 131.9, 131.7, 81.7, 70.8, 50.3, 
28.3, 23.7, 20.7 ppm; IR (thin film) 2976, 2865, 1698, 1367, 1162, 1074 cm
-1
; MS (ESI) m/z 
234.13 (234.11 calcd for C11H17NNaO3
+
 [MNa]
+
). 
(71) 2,2,2-Trichloroethyl 2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxylate 
 
According to the general procedure, CuCl (4.8 mg, 0.048 mmol, 0.20 equiv) and pyridine 
(1.0 μL, 0.012 mmol, 0.05 equiv) were added to 2,2,2-trichloroethyl hydroxycarbamate S-7 
(50 mg, 0.24 mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (28 μL, 0.29 mmol, 1.2 equiv) in 
2.5 mL THF. The resulting mixture was stirred for 3 h at rt. The reaction was quenched with 
5 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 5 mL). The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue 
was purified by column chromatography to afford oxazine 71 (60 mg, 87%) as a white solid. 
1
H NMR (600 MHz, CDCl3) δ 6.61 (ddd, J = 7.7, 5.7, 1.1, 1H), 6.55 (ddd, J = 7.7, 5.7, 1.7, 
1H), 4.89 – 4.79 (m, 3H), 4.68 (d, J = 12.0 Hz, 1H), 2.25 (dddd, J = 13.0, 9.4, 3.7, 3.7 Hz, 
1H), 2.17 (dddd, J = 12.8, 9.3, 3.4, 3.4 Hz, 1H), 1.53 (dddd, J = 12.8, 12.8, 3.2, 3.2 Hz, 1H), 
1.44 – 1.39 (m, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 155.9, 131.9, 95.3, 75.1, 71.6, 
50.6, 28.4, 23.5, 20.8 ppm; IR (thin film) 2940, 2864, 1708, 1392, 1261, 1051 cm
-1
; MS 
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(ESI) m/z 307.98 (98%), 309.98 (100%), 311.98 (35%) (307.96, 309.96, 311.96 calcd for 
C9H10Cl3NNaO3
+
 [MNa]
+
). 
(72) 9H-fluoren-9-yl)methyl 2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxylate 
 
According to the general procedure, CuCl (4 mg, 0.040 mmol, 0.20 equiv) and pyridine (0.8 
μL, 0.010 mmol, 0.05 equiv) were added to (9H-fluoren-9-yl)methyl hydroxycarbamate S-6 
(51 mg, 0.20 mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (23 μL, 0.24 mmol, 1.2 equiv) in 
2 mL THF. The resulting mixture was stirred for 6 h at rt. The reaction was quenched with 4 
mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 4 mL). The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue 
was purified by column chromatography to afford oxazine 72 (66 mg, 99%) as a yellow 
solid. 
1
H NMR (600 MHz, CDCl3) δ 7.76 (d, J = 7.5 Hz, 2H), 7.60 (dd, J = 6.2, 6.2 Hz, 2H), 
7.39 (dd, J = 7.0, 7.0 Hz, 2H), 7.31 (ddd, J = 7.3, 7.3, 7.3 Hz, 2H), 6.55 – 6.36 (m, 2H), 4.82 
– 4.68 (m, 2H), 4.48 – 4.68 (m, 2H), 4.25 (dd, J = 7.0, 7.0 Hz, 1H), 2.28 – 2.18 (m, 1H), 
2.17 – 2.18 (m, 1H), 1.49 (dd, J = 12.2, 12.2 Hz, 1H), 1.39 (dd, J = 11.9, 11.9 Hz, 1H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 158.4, 143.9, 143.8, 141.5, 132.2, 131.7, 127.9, 127.3, 
127.3, 125.3, 125.3, 120.1, 120.1, 71.2, 67.9, 50.4, 47.2, 23.7, 20.7 ppm; IR (thin film) 3063, 
2940, 1704, 1451, 1265, 1078 cm
-1
; MS (ESI) m/z 356.13 (356.13 calcd for C21H19NNaO3
+
 
[MNa]
+
). 
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(73) 2-(2-Nitrophenyl)propyl 2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxylate 
 
According to the general procedure, CuCl (4.2 mg, 0.043 mmol, 0.20 equiv) and pyridine 
(0.87 μL, 0.011 mmol, 0.05 equiv) were added to 2-(2-nitrophenyl)propyl hydroxycarbamate 
S-22 (51 mg, 0.21 mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (25 μL, 0.26 mmol, 1.2 
equiv) in 2 mL THF. The resulting mixture was stirred for 6 h at rt. The reaction was 
quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 4 mL). The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo. 
The residue was purified by column chromatography to afford oxazine 73 (66 mg, 96%, 1:1 
dr, inseparable) as a brown oil. 
1
H NMR (600 MHz, CDCl3) δ 7.72 (d, J = 8.1 Hz, 1H), 7.53 
(t, J = 7.6 Hz, 1H), 7.47 – 7.41 (m, 1H), 7.34 (t, J = 7.7 Hz, 1H), 6.47 – 6.33 (m, 2H), 4.72 – 
4.64 (m, 1H), 4.63 – 4.55 (m, 1H), 4.33 – 4.17 (m, 2H), 3.71 – 3.61 (m, 1H), 2.15 – 2.09 (m, 
1H), 2.06 – 1.94 (m, 1H), 1.41 (dddd, J = 12.9, 12.9, 3.1, 3.1 Hz, 1H), 1.36 – 1.25 (m, 4H) 
ppm; 
13
C NMR (150 MHz, CDCl3) δ 158.1, 150.5, 137.4, 137.4, 132.8, 132.0, 131.7, 131.6, 
128.5, 127.6, 127.6, 124.2, 124.2, 71.1, 71.1, 69.8, 69.7, 50.4, 33.6, 23.6, 20.6, 20.6, 18.1, 
18.1 ppm; IR (thin film) 2973, 2939, 1738, 1512, 1263, 1077 cm
-1
; MS (ESI) m/z 341.12 
(341.11 calcd for C16H18N2NaO5
+
 [MNa]
+
). 
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(74) 4-methoxybenzyl 2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxylate 
 
According to the general procedure, CuCl (5.0 mg, 0.051 mmol, 0.20 equiv) and pyridine 
(1.0 μL, 0.013 mmol, 0.05 equiv) were added to 4-methoxybenzyl hydroxycarbamate S-23 
(50 mg, 0.25 mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (29 μL, 0.30 mmol, 1.2 equiv) in 
2.5 mL THF. The resulting mixture was stirred for 3 h at rt. The reaction was quenched with 
5 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 5 mL). The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue 
was purified by column chromatography to afford oxazine 74 (68 mg, 97%) as a colorless 
oil. 
1
H NMR (600 MHz, CDCl3) δ 7.29 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 6.56 – 
6.46 (m, 2H), 5.13 (d, J = 12.0 Hz, 1H), 5.05 (d, J = 12.0 Hz, 1H), 4.79 (s, 1H), 4.74 (s, 1H), 
3.79 (s, 3H), 2.19 (dddd, J = 13.1, 9.3, 3.7, 3.7 Hz, 1H), 2.09 (dddd, J = 12.8, 9.2, 3.3, 3.3 
Hz, 1H), 1.47 (dddd, J = 12.3, 12.3, 3.0, 3.0 Hz, 1H), 1.40 – 1.33 (m, 1H) ppm; 13C NMR 
(150 MHz, CDCl3) δ 159.8, 158.4, 132.1, 131.8, 130.2, 128.3, 114.0, 71.2, 67.8, 55.4, 50.3, 
23.6, 20.7 ppm; IR (thin film) 3060, 2939, 1737, 1516, 1249, 1075 cm
-1
; MS (ESI) m/z 
298.13 (298.11 calcd for C15H17NNaO4
+
 [MNa]
+
). 
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(75) 4-((tert-butyldimethylsilyl)oxy)benzyl 2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-
carboxylate 
 
According to the general procedure, CuCl (4.9 mg, 0.050 mmol, 0.20 equiv) and pyridine 
(1.0 μL, 0.012 mmol, 0.05 equiv) were added to 4-((tert-butyldimethylsilyl)oxy)benzyl 
hydroxycarbamate S-24 (73 mg, 0.24 mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (26 μL, 
0.27 mmol, 1.2 equiv) in 2.5 mL THF. The resulting mixture was stirred for 2 h at rt. The 
reaction was quenched with 5 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 
x 5 mL). The combined organic layers were dried over MgSO4, filtered and then 
concentrated in vacuo. The residue was purified by column chromatography to afford 
oxazine 75 (78 mg, 85%) as a colorless solid. 
1
H NMR (600 MHz, CDCl3) δ 7.22 (d, J = 8.3 
Hz, 2H), 6.79 (d, J = 8.3 Hz, 2H), 6.56 – 6.49 (m, 2H), 5.13 (d, J = 12.0 Hz, 1H), 5.04 (d, J 
= 12.0 Hz, 1H), 4.80 (s, 1H), 4.75 (s, 1H), 2.20 (dddd, J = 13.0, 9.1, 3.7, 3.7 Hz, 1H), 2.11 
(dddd, J = 12.7, 9.2, 3.3, 3.3 Hz, 1H), 1.48 (dddd, J = 12.2, 12.2, 3.0, 3.0 1H), 1.37 (ddd, J = 
11.8, 11.8, 3.3 Hz, 1H), 0.97 (s, 9H), 0.18 (s, 6H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 
158.5, 156.0, 132.2, 131.8, 130.1, 128.9, 120.2, 71.2, 67.8, 50.4, 25.9, 23.7, 20.8, 18.4, -4.2 
ppm; IR (thin film) 2955, 2858, 1701, 1512, 1260, 1075 cm
-1
; MS (ESI) m/z 398.20 (398.18 
calcd for C20H29NNaO4Si
+
 [MNa]
+
). 
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(76) 4-(trifluoromethyl)benzyl 2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxylate 
 
According to the general procedure, CuCl (4.2 mg, 0.043 mmol, 0.20 equiv) and pyridine 
(0.85 μL, 0.011 mmol, 0.05 equiv) were added to 4-(trifluoromethyl)benzyl 
hydroxycarbamate S-25 (50 mg, 0.21 mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (24 μL, 
0.26 mmol, 1.2 equiv) in 2 mL THF. The resulting mixture was stirred for 4 h at rt. The 
reaction was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 
x 4 mL). The combined organic layers were dried over MgSO4, filtered and then 
concentrated in vacuo. The residue was purified by column chromatography to afford 
oxazine 76 (64 mg, 97%) as a colorless solid. 
1
H NMR (600 MHz, CDCl3) δ 7.60 (d, J = 8.1 
Hz, 2H), 7.45 (d, J = 8.0 Hz, 2H), 6.61 – 6.49 (m, 2H), 5.24 (d, J = 12.9 Hz, 1H), 5.18 (d, J 
= 12.9 Hz, 1H), 4.84 – 4.81 (m, 1H), 4.79 – 4.76 (m, 1H), 2.22 (dddd, J = 13.0, 9.4, 3.7, 3.7 
Hz, 1H), 2.13 (dddd, J = 12.8, 9.3, 3.4, 3.4 Hz, 1H), 1.51 (dddd, J = 12.8, 12.8, 3.1, 3.1 Hz, 
1H), 1.44 – 1.36 (m, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 157.9, 140.3, 132.2, 131.9, 
130.5 (q, J = 32.6 Hz), 128.1, 125.7 (q, J = 3.8 Hz), 124.2 (q, J = 272.1 Hz), 71.4, 66.8, 
50.3, 23.6, 20.8 ppm; IR (thin film) 3063, 2942, 1705, 1392, 1126, 1067 cm
-1
; MS (ESI) m/z 
336.10 (336.08 calcd for C15H17NNaO4
+
 [MNa]
+
). 
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(77) 4-Vinylbenzyl 2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxylate 
 
According to the general procedure, CuCl (11 mg, 0.11 mmol, 0.20 equiv) and pyridine 
(2.2μL, 0.027 mmol, 0.05 equiv) were added to 4-vinylbenzyl hydroxycarbamate S-26 (105 
mg, 0.25 mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (57 μL, 0.60 mmol, 1.2 equiv) in 5 
mL THF. The resulting mixture was stirred for 3 h at rt. The reaction was quenched with 10 
mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 10 mL). The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue 
was purified by column chromatography to afford oxazine 77 (139 mg, 94%) as a colorless 
solid. 
1
H NMR (600 MHz, CDCl3) δ 7.38 (d, J = 8.1 Hz, 2H), 7.30 (d, J = 8.1 Hz, 2H), 6.69 
(dd, J = 17.6, 10.9 Hz, 1H), 6.58 – 6.48 (m, 2H), 5.74 (d, J = 17.6 Hz, 1H), 5.24 (d, J = 10.9 
Hz, 1H), 5.17 (d, J = 12.4 Hz, 1H), 5.11 (d, J = 12.4 Hz, 1H), 4.82 – 4.79 (m, 1H), 4.77 – 
4.74 (m, 1H), 2.20 (dddd, J = 13.0, 9.4, 3.7, 3.7 Hz, 1H), 2.11 (dddd, J = 12.8, 9.3, 3.4, 3.4 
Hz, 1H), 1.48 (dddd, J = 12.3, 12.3, 3.1, 3.1 Hz, 1H), 1.41 – 1.33 (m, 1H) ppm; 13C NMR 
(150 MHz, CDCl3) δ 158.2, 137.7, 136.5, 135.6, 132.1, 131.8, 128.5, 126.4, 114.4, 71.2, 
67.6, 50.3, 23.6, 20.7 ppm; IR (thin film) 2967, 2939, 1701, 1513, 1264, 1075 cm
-1
; MS 
(ESI) m/z 294.13 (294.11 calcd for C16H17NNaO3
+
 [MNa]
+
). 
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(78) 2-Oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxamide 
 
According to the general procedure, CuCl (5.9 mg, 0.060 mmol, 0.20 equiv) and pyridine 
(1.2 μL, 0.015 mmol, 0.05 equiv) were added to hydroxyurea S-27 (23 mg, 0.30 mmol, 1.0 
equiv) and cyclohexa-1,3-diene 64 (34 μL, 0.36 mmol, 1.1 equiv) in 3 mL THF. The 
resulting mixture was stirred for 2 h at rt. The reaction was quenched with 6 mL EDTA (0.5 
M, pH 7.0) and extracted with ethyl acetate (3 x 6 mL). The combined organic layers were 
dried over MgSO4, filtered and then concentrated in vacuo. The residue was purified by 
column chromatography to afford oxazine 78 (41 mg, 89%) as a colorless solid. 
1
H NMR 
(600 MHz, CDCl3) δ 6.55 (dd, J = 6.3, 6.3 Hz, 1H), 6.48 (dd, J = 6.5, 6.5 Hz, 1H), 5.33 (bs, 
2H), 4.92 – 4.83 (m, 1H), 4.70 – 4.61 (m, 1H), 2.22 – 2.05 (m, 2H), 1.50 (dd, J = 12.0, 12.0 
Hz, 1H), 1.34 (dd, J = 11.7, 11.7 Hz, 1H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 163.6, 132.5, 
130.7, 71.0, 49.8, 23.9, 20.3 ppm; IR (thin film) 3455, 2938, 2860, 1667, 1371, 1171, 1053 
cm
-1
; MS (ESI) m/z 177.06 (177.06 calcd for C7H10N2NaO2
+
 [MNa]
+
). 
(79) N-phenyl-2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxamide 
 
According to the general procedure, CuCl (6.5 mg, 0.066 mmol, 0.20 equiv) and pyridine 
(1.3 μL, 0.016 mmol, 0.05 equiv) were added to 1-hydroxy-3-phenylurea S-28 (50 mg, 0.33 
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mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (38 μL, 0.39 mmol, 1.2 equiv) in 3 mL THF. 
The resulting mixture was stirred for 4 h at rt. The reaction was quenched with 6 mL EDTA 
(0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 6 mL). The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo. The residue was purified by 
column chromatography to afford oxazine 79 (71 mg, 94%) as a colorless solid. 
1
H NMR 
(600 MHz, CDCl3) δ 7.64 (bs, 1H), 7.44 (d, J = 8.6 Hz, 2H), 7.28 (dd, J = 8.0, 8.0 Hz, 2H), 
7.04 (dd J = 7.4, 7.4 Hz, 1H), 6.59 (ddd, J = 7.4, 5.9, 1.3 Hz, 1H), 6.51 (ddd, J = 7.8, 5.8, 1.7 
Hz, 1H), 5.06 – 4.99 (m, 1H), 4.82 – 4.76 (m, 1H), 2.26 – 2.11 (m, 2H), 1.57 (dddd, J = 
12.3, 12.3, 3.0, 3.0 Hz, 1H), 1.44 – 1.34 (m, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 159.5, 
137.9, 132.8, 130.6, 129.1, 123.7, 119.4, 71.3, 50.1, 24.0, 20.19 ppm; IR(thin film) 3394, 
3059, 2938, 1679, 1527, 1217, 1050 cm
-1
, MS (ESI) m/z 253.12 (253.09 calcd for 
C13H14N2NaO4
+
 [MNa]
+
). 
(80) N-benzyl-2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxamide 
 
According to the general procedure, CuCl (6.0 mg, 0.060 mmol, 0.20 equiv) and pyridine 
(1.2 μL, 0.015 mmol, 0.05 equiv) were added to 1-hydroxy-3-benzylurea S-29 (50 mg, 0.30 
mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (34 μL, 0.36 mmol, 1.2 equiv) in 3 mL THF. 
The resulting mixture was stirred for 5 h at rt. The reaction was quenched with 6 mL EDTA 
(0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 6 mL). The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo. The residue was purified by 
column chromatography to afford oxazine 80 (73 mg, 99%) as a colorless solid. 
1
H NMR 
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(600 MHz, CDCl3) δ 7.30 (t, J = 7.3 Hz, 2H), 7.26 – 7.21 (m, 3H), 6.56 (ddd, J = 8.2, 5.9, 
1.4, 1H), 6.49 (ddd, J = 7.8, 5.8, 1.7, 1H), 6.10 (bs, 1H), 4.97 – 4.93 (m, 1H), 4.66 – 4.63 
(m, 1H), 4.42 – 4.33 (m, 2H), 2.19 – 2.09 (m, 2H), 1.58 – 1.49 (m, 1H), 1.38 – 1.30 (m, 1H) 
ppm; 
13
C NMR (150 MHz, CDCl3) δ 162.5, 138.9, 132.4, 130.5, 128.7, 127.6, 127.4, 70.7, 
50.5, 43.9, 24.1, 20.2 ppm; IR (thin film) 3339, 3061, 2934, 1669, 1524, 1251, 1018 cm
-1
; 
MS (ESI) m/z 267.13 (267.11 calcd for C14H16N2NaO2
+
 [MNa]
+
). 
(81) N-(pyridin-2-ylmethyl)-2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxamide 
 
According to the general procedure, CuCl (3.6 mg, 0.036 mmol, 0.20 equiv) and pyridine 
(0.72 μL, 0.0090 mmol, 0.05 equiv) were added to 1-hydroxy-3-(pyridin-2-ylmethyl)urea S-
30 (30 mg, 0.18 mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (21 μL, 0.22 mmol, 1.2 equiv) 
in 2 mL THF. The resulting mixture was stirred for 3 h at rt. The reaction was quenched with 
4 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 4 mL). The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue 
was purified by column chromatography to afford oxazine 81 (34 mg, 77%) as a colorless 
oil. 
1
H NMR (600 MHz, CDCl3) δ 8.52 (d, J = 4.6 Hz, 1H), 7.63 (ddd, J = 7.7, 7.7, 1.6 Hz, 
1H), 7.24 (d, J = 7.8 Hz, 1H), 7.16 (dd, J = 7.1, 5.2 Hz, 1H), 6.65 (bs, 1H), 6.55 (ddd, J = 
7.9, 6.3, 1.2 Hz, 1H), 6.50 (ddd, J = 7.8, 5.9, 1.7 Hz, 1H), 4.96 – 4.92 (m, 1H), 4.73 – 4.70 
(m, 1H), 4.55 (dd, J = 16.0, 5.7 Hz, 1H), 4.44 (dd, J = 16.0, 5.0 Hz, 1H), 2.22 – 2.10 (m, 
2H), 1.54 (dddd, J = 12.2, 12.2 3.0, 3.0 Hz 1H), 1.39 – 1.32 (m, 1H) ppm; 13C NMR (150 
MHz, CDCl3) δ 162.56, 157.8, 149.3, 136.9, 132.4, 130.7, 122.4, 121.8, 70.8, 50.5, 45.4, 
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24.1, 20.3 ppm; IR (thin film) 3347, 3057, 2936, 1674, 1512, 1260, 1018 cm
-1
; MS (ESI) 
m/z 268.09 (268.11 calcd for C13H15N3NaO2
+
 [MNa]
+
). 
(83) 2-oxa-3-azabicyclo[2.2.2]oct-5-en-3-yldiphenylphosphine oxide 
 
According to the general procedure, CuCl (4.2 mg, 0.043 mmol, 0.20 equiv) and pyridine 
(0.86 μL, 0.011 mmol, 0.05 equiv) were added to N-hydroxy-P,P-diphenylphosphinic amide 
S-31 (50 mg, 0.21 mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (24 μL, 0.26 mmol, 1.2 
equiv) in 2 mL THF. The resulting mixture was stirred for 3 h at rt. The reaction was 
quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 4 mL). The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo. 
The residue was purified by column chromatography to afford oxazine 83 (66 mg, 99%) as a 
colorless solid. 
1
H NMR (600 MHz, CD3OD) δ 7.88 – 7.80 (m, 4H), 7.55 (dddd, J = 20.4, 
7.4, 7.4, 1.3 Hz, 2H), 7.47 (dddd, J = 18.8, 7.6, 7.6, 3.5 Hz, 4H), 6.44 (ddd, J = 7.8, 6.3, 1.3 
Hz, 1H), 6.35 (ddd, J = 7.8, 5.8, 1.4 Hz,1H), 4.55 – 4.50 (m, 1H), 4.02 – 3.96 (m, 1H), 2.25 
– 2.13 (m, 2H), 1.43 – 1.34 (m, 2H) ppm; 13C NMR (150 MHz, CD3OD) δ 133.7 (d, J = 2.7 
Hz), 133.7 (d, J = 9.3 Hz), 133.5 (d, J = 4.7 Hz), 133.4 (d, J = 2.7 Hz), 133.4 (d, J = 9.3 Hz), 
71.5, 49.9, 49.5 (d, J = 2.9 Hz), 24.8, 23.5 (d, J = 11.1 Hz) ppm; 
31
P NMR (162 MHz, 
CD3OD) δ 28.6 ppm; IR (thin film) 3058, 2934, 1440, 1213, 1119 cm
-1
; MS (ESI) m/z 
334.12 (334.10 calcd for C18H18NNaO2P
+
 [MNa]
+
). 
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(84) Diethyl 2-oxa-3-azabicyclo[2.2.2]oct-5-en-3-ylphosphonate 
 
As modified from the general procedure, CuCl (4.1 mg, 0.041 mmol, 0.20 equiv) and 
pyridine (0.83 μL, 0.010 mmol, 0.05 equiv) were added to diethyl 
(trimethylsilyl)oxyphosphoramidate S-32 (50 mg, 0.21 mmol,1.0 equiv) and cyclohexa-1,3-
diene 64 (24 μL, 0.25 mmol, 1.2 equiv) in 2 mL THF. The resulting mixture was stirred for 
5 h at rt. The reaction was filtered through a plug of neutral alumina and then concentrated in 
vacuo. The residue was purified by column chromatography to afford oxazine 84 (25 mg, 
49%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 6.60 (ddd, J = 7.9, 6.8, 1.1 Hz, 1H), 
6.48 (ddd, J = 7.5, 6.4, 1.1 Hz, 1H), 4.59 – 4.56 (m, 1H), 4.32 – 4.28 (m, 1H), 4.18 – 4.12 
(m, 2H), 4.11 – 4.01 (m, 2H), 2.24 – 2.10 (m, 1H), 2.18 – 2.10 (m, 1H), 1.47 – 1.35 (m, 2H), 
1.33 (t, J = 6.7 Hz, 3H), 1.27 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 132.5 
(d, J = 3.7 Hz), 131.0, 70.0, 64.2 (d, J = 7.1 Hz), 63.8 (d, J = 6.4 Hz), 48.9, 23.83 (d, J = 1.6 
Hz), 22.7 (d, J = 12.0 Hz), 16.4 (d, J = 6.5 Hz), 16.4 (d, J = 6.7 Hz) ppm; 
31
P NMR (162 
MHz, CD3OD) δ 5.4 ppm; IR (thin film) 2981, 2934, 1258, 1028, 977 cm
-1
; MS (ESI) m/z 
270.11 (270.09 calcd for C10H18NNaO4P
+
 [MNa]
+
). 
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(85) (E)-tert-butyl (2-oxa-3-azabicyclo[2.2.2]oct-5-en-3-yl((tert 
butoxycarbonyl)imino)methyl) carbamate 
 
As modified from the general procedure, N,N’-di-tert-butoxycarbonyl-N’’hydroxylguanidine 
S-33 (10 mg, 0.036 mmol, 1.0 equiv) was added to a solution of CuCl (0.7 mg, 0.0072 
mmol, 0.20 equiv), pyridine (0.19 μL, 0.0018 mmol, 0.05 equiv) and cyclohexa-1,3- diene 
64 (4 μL, 0.043 mmol, 1.2 equiv) in 1 mL of THF . The reaction was quenched with 2 mL 
EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 2 mL). The combined organic 
layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue was 
purified by column chromatography to afford oxazine 85 (8.4 mg, 66%) as a colorless solid. 
1
H NMR (600 MHz, CDCl3) δ 7.99 (bs, 1H), 6.66 (ddd, J = 7.6, 6.5, 1.1 Hz, 1H), 6.52 (ddd, 
J = 7.5, 6.2, 1.3 Hz, 1H), 5.23 – 5.13 (m, 1H), 4.84 – 4.77 (m, 1H), 2.27 – 2.12 (m, 2H), 1.53 
– 1.45 (m, 20H) ppm; 13C NMR (150 MHz, CDCl3) δ 133.3, 131.4, 72.6, 50.4, 28.3, 28.2, 
23.7, 20.4 ppm (carbonyl and guanidine carbons not observed); IR (thin film) 3282, 2979, 
1720, 1369, 1136, 1059 cm
-1
; MS (ESI) m/z 376.19 (376.18 calcd for C17H27N3NaO5
+
 
[MNa]
+
). 
(86) 3-phenyl-2-oxa-3-azabicyclo[2.2.2]oct-5-ene 
 
  181 
As modified from the general procedure, N-phenylhydroxylamine S-34 (50 mg, 0.46 mmol, 
1.0 equiv) in 1 mL THF was added to a solution of CuCl (9.1 mg, 0.092 mmol, 0.20 equiv), 
pyridine (1.8 μL, 0.023 mmol, 0.05 equiv) and cyclohexa-1,3-diene 64 (261 μL, 2.75 mmol, 
6.0 equiv) in 4 mL THF via syringe pump (0.5 ml/min). After completion of addition, the 
resulting mixture was stirred for 1 h at rt. The reaction was quenched with 10 mL EDTA 
(0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 10 mL). The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo. The residue was purified by 
column chromatography to afford oxazine 86 (72 mg, 84%) as a colorless solid. 
1
H NMR 
(600 MHz, CDCl3) δ 7.21 (dd, J = 7.9 Hz, 2H), 7.01 (d, J = 7.8 Hz, 2H), 6.93 (dd, J = 7.3, 
7.3 Hz, 1H), 6.58 (ddd, J = 7.8, 6.0, 1.5 Hz, 1H), 6.15 (ddd, J = 7.6, 6.5, 1.1 Hz, 1H), 4.73 – 
4.68 (m, 1H), 4.46 – 4.41 (m, 1H), 2.30 (dddd, J = 12.6, 9.6, 3.3, 3.3 Hz, 1H), 2.23 (dddd, J 
= 13.0, 9.5, 3.7, 3.7 Hz, 1H), 1.58 (dddd, J = 12.3, 12.3, 3.0, 3.0 Hz, 1H), 1.37 (dddd, J = 
12.3, 12.3, 3.6, 1.3 Hz, 1H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 152.5, 131.8, 130.1, 128.5, 
122.2, 117.6, 69.3, 56.7, 24.2, 21.6 ppm; IR (thin film) 2961, 2858, 1596, 1490, 1225, 940 
cm
-1
; MS (ESI) m/z 188.10 (188.11 calcd for C12H14NO
+
 [MH]
+
). 
(87) 3-(3,5-dichlorophenyl)-2-oxa-3-azabicyclo[2.2.2]oct-5-ene 
 
As modified from the general procedure, N-(3,5-dichlorophenyl)hydroxylamine S-35 (50 
mg, 0.28 mmol, 1.0 equiv) in 1 mL THF was added to a solution of CuCl (5.6 mg, 0.056 
mmol, 0.20 equiv), pyridine (1.1 μL, 0.014 mmol, 0.05 equiv) and cyclohexa-1,3-diene 64 
  182 
(160 μL, 1.69 mmol, 6.0 equiv) in 2 mL THF via syringe pump (0.5 ml/min). After 
completion of addition, the resulting mixture was stirred for 1 h at rt. The reaction was 
quenched with 6 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 6 mL). The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo. 
The residue was purified by column chromatography to afford oxazine 87 (58 mg, 81%) as a 
colorless solid. 
1
H NMR (600 MHz, CDCl3) δ 6.89 – 6.84 (m, 3H), 6.56 (ddd, J = 7.6, 6.5, 
1.1 Hz, 1H), 6.17 (dd, J = 6.9, 6.9 Hz, 1H), 4.73 – 4.68 (m, 1H), 4.43 – 4.37 (m, 1H), 2.28 – 
2.16 (m, 2H), 1.57 (dddd, J = 12.8, 12.8, 2.9, 2.9 Hz, 1H), 1.39 – 1.32 (m, 1H) ppm; 13C 
NMR (150 MHz, CDCl3) δ 154.7, 135.0, 131.9, 129.9, 121.8, 115.8, 69.8, 56.5, 24.0, 21.2 
ppm; IR (thin film) 2937, 2860, 1583, 1420, 1112, 901 cm
-1
; MS (ESI) m/z 256.02 (100%), 
258.02 (64%) (256.03, 258.03 calcd for C12H12Cl2NO
+
 [MH]
+
). 
(89) 2-oxa-3-azabicyclo[2.2.2]oct-5-en-3-yl((3aR,6S)-8,8-dimethyl-2,2 
dioxidohexahydro-1H-3a,6-methanobenzo[c]isothiazol-1-yl)methanone 
 
According to the general procedure, CuCl (2.2 mg, 0.022 mmol, 0.20 equiv) and pyridine 
(0.44 μL, 0.0055 mmol, 0.05 equiv) were added to (3aR,6S)-N-hydroxy-8,8-
dimethylhexahydro-1H-3a,6-methanobenzo[c]isothiazole-1- carboxamide 2,2-dioxide 88 (30 
mg, 0.11 mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (13 μL, 0.13 mmol, 1.2 equiv) in 1 
mL THF. The resulting mixture was stirred for 6 h at rt. The reaction was quenched with 2 
mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 2 mL). The combined 
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organic layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue 
was purified by column chromatography to afford oxazine 89 (39 mg, 99%, >20:1 dr) as a 
colorless solid. 
1
H NMR (600 MHz, CDCl3) δ 6.58 (ddd, J = 7.7, 5.9, 1.5, 1H), 6.37 (ddd, J 
= 7.6, 6.1, 1.1, 1H), 4.99 – 4.94 (m, 1H), 4.87 – 4.83 (m, 1H), 3.99 (dd, J = 7.7, 4.3 Hz, 1H), 
3.37 (s, 2H), 2.32 – 2.20 (m, 2H), 1.93 – 1.76 (m, 5H), 1.50 – 1.42 (m, 2H), 1.38 – 1.29 (m, 
2H), 1.18 (s, 3H), 0.95 (s, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 154.9, 132.5, 129.6, 
71.8, 65.2, 54.3, 52.9, 48.7, 48.1, 44.9, 37.5, 32.7, 26.9, 23.4, 20.9, 20.6, 20.1 ppm; IR (thin 
film) 2936, 1708, 1336, 1166, 1060 cm
-1
; MS (ESI) m/z 375.17 (375.13 calcd for 
C17H24N2NaO4S
+
 [MNa]
+); [α]D
25
 +63.7° (1.00, CHCl3). 
(90) (3S,5S,8S,9R,10R,13R,14R,17R)-Benzyl 17-((2R,5R,E)-5,6-dimethylhept-3-en-
2-yl)-3-hydroxy-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-8,5 
(epoxyimino)cyclopenta[a]phenanthrene-19-carboxylate 
 
According to the general procedure, CuCl (5.9 mg, 0.060 mmol, 0.20 equiv) and pyridine 
(1.2 μL, 0.015 mmol, 0.05 equiv) were added to benzyl hydroxycarbamate 16 (50 mg, 0.30 
mmol, 1.0 equiv) and ergosterol S-39 (143 mg, 0.36 mmol, 1.2 equiv) in 3 mL THF. The 
resulting mixture was stirred for 2 h at rt. The reaction was quenched with 6 mL EDTA (0.5 
M, pH 7.0) and extracted with ethyl acetate (3x 6 mL). The combined organic layers were 
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dried over MgSO4, filtered and then concentrated in vacuo. The residue was purified by 
column chromatography to afford oxazine 90 (168 mg, 99%, 16:1 mixture of regioisomers, 
inseparable) as a colorless solid. 
1
H NMR (600 MHz, CDCl3) δ 7.32 – 7.21 (m, 5H), 6.25 (d, 
J = 8.3 Hz, 1H), 6.20 (d, J = 8.4 Hz, 1H), 5.24 – 5.10 (m, 3H), 4.95 (d, J = 12.8 Hz, 1H), 
4.17 – 4.08 (m, 1H), 3.27 (dd, J = 13.4, 3.0 Hz, 1H), 2.07 – 1.80 (m, 7H), 1.78 – 1.66 (m, 
3H), 1.66 – 1.56 (m, 2H), 1.50 – 1.41 (m, 3H), 1.40 – 1.29 (m, 2H), 1.26 – 1.08 (m, 3H), 
0.98 (d, J = 6.5 Hz, 3H), 0.91 (d, J = 6.8 Hz, 3H), 0.88 (s, 3H), 0.85 – 0.76 (m, 9H) ppm; 13C 
NMR (150 MHz, CDCl3) δ 159.3, 136.9, 136.6, 135.5, 132.4, 128.5, 127.9, 127.7, 127.4, 
79.7, 67.4, 67.3, 67.1, 56.6, 53.7, 53.1, 44.4, 43.0, 40.0, 39.7, 39.1, 36.6, 35.1, 33.3, 30.0, 
28.7, 24.2, 21.1, 21.0, 20.2, 19.8, 18.1, 17.9, 13.3 ppm; MS (ESI) m/z 584.38 (584.37 calcd 
for C36H51NNaO4
+
 [MNa]
+); [α]D
25
 -4.1° (1.00, CHCl3). 
(91) (3S,5S,8S,9R,10R,13R,14R,17R)-benzyl 3-acetoxy-17-((2R,5R,E)-5,6-
dimethylhept-3-en-2- yl)-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-
1H-8,5-(epoxyimino)cyclopenta[a]phenanthrene-19-carboxylate 
 
According to the general procedure, CuCl (5.9 mg, 0.060 mmol, 0.20 equiv) and pyridine 
(1.2 μL, 0.015 mmol, 0.05 equiv) were added to benzyl hydroxycarbamate 16 (50 mg, 0.30 
mmol, 1.0 equiv) and ergosteryl acetate S-40 (158 mg, 0.36 mmol, 1.2 equiv) in 3 mL THF. 
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The resulting mixture was stirred for 3 h at rt. The reaction was quenched with 6 mL EDTA 
(0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 6 mL). The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo. The residue was purified by 
column chromatography to afford oxazine 91  (155 mg, 86%, 35:1 mixture of regioisomers, 
inseparable) as a colorless solid. 
1
H NMR (600 MHz, CDCl3) δ 7.33 – 7.21 (m, 5H), 6.25 (d, 
J = 8.4 Hz, 1H), 6.21 (d, J = 8.5 Hz, 1H), 5.23 – 5.11 (m, 4H), 4.96 (d, J = 12.7 Hz, 1H), 
3.32 (dd, J = 13.6, 3.6 Hz, 1H), 2.15 – 2.08 (m, 1H), 2.08 – 1.96 (m, 5H), 1.96 – 1.88 (m, 
2H), 1.88 – 1.80 (m, 1H), 1.77 – 1.64 (m, 3H), 1.63 – 1.54 (m, 2H), 1.49 – 1.40 (m, 3H), 
1.39 – 1.28 (m, 2H), 1.27 – 1.08 (m, 3H), 0.98 (d, J = 6.6 Hz, 3H), 0.93 – 0.86 (m, 6H), 0.86 
– 0.74 (m, 9H) ppm; 13C NMR (150 MHz, CDCl3) δ 170.3, 159.4, 136.6, 136.6, 135.5, 
132.4, 128.7, 128.5, 127.9, 127.6, 79.6, 70.4, 67.4, 67.0, 56.6, 53.7, 53.0, 44.4, 43.0, 40.0, 
39.7, 39.0, 34.7, 33.3, 32.8, 28.6, 26.8, 24.2, 21.6, 21.1, 21.0, 20.2, 19.8, 17.9, 17.9, 13.3 
ppm; IR (thin film) 2957, 2872, 1737, 1457, 1245, 1030 cm
-1
; (ESI) m/z 626.38 (626.38 
calcd for C38H53NNaO5
+
 [MNa]
+); [α]D
25
 +5.6° (1.00, CHCl3). 
(95) 3-Methylbut-2-en-1-yl 2-oxa-3-azabicyclo[2.2.1]hept-5-ene-3-carboxylate 
 
According to the general procedure, CuCl (14 mg, 0.14 mmol, 0.20 equiv) and pyridine (2.9 
μL, 0.036 mmol, 0.05 equiv) were added to 3-methylbut-2-en-1-yl hydroxycarbamate 1 (104 
mg, 0.72 mmol, 1.0 equiv) and cyclopentadiene S-36 (66 μL, 0.79 mmol, 1.1 equiv) in 7 mL 
THF. The resulting mixture was stirred for 3 h at rt. The reaction was quenched with 14 mL 
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EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 14 mL). The combined organic 
layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue was 
purified by column chromatography to afford oxazine 95 (117 mg, 78%) as a colorless solid. 
1
H NMR (600 MHz, CDCl3) δ 6.42 – 6.39 (m, 1H), 6.37 – 6.33 (m, 1H), 5.33 – 5.26 (m, 
1H), 5.19 (s, 1H), 5.00 (s, 1H), 4.59 (dd, J = 12.1, 7.3 Hz, 1H), 4.54 (dd, J = 12.1, 7.3 Hz, 
1H), 1.96 (ddd, J = 8.6, 1.8, 1.8 Hz, 1H), 1.72 (d, J = 9.2 Hz, 1H), 1.70 (s, 3H), 1.66 (s, 3H) 
ppm; 
13
C NMR (150 MHz, CDCl3) δ 159.7, 139.6, 134.6, 133.1, 118.5, 83.9, 65.1, 63.3, 
48.3, 25.9, 18.1 ppm; IR (thin film) 3019, 2968, 1701, 1444, 1178, 1032 cm
-1
; MS (ESI) m/z 
232.09 (232.09 calcd for C11H15NNaO3
+
 [MNa]
+
). 
(96) 3-Methylbut-2-en-1-yl 2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxylate 
 
According to the general procedure, CuCl (5.9 mg, 0.060 mmol, 0.20 equiv) and pyridine 
(1.2 μL, 0.015 mmol, 0.05 equiv) were added to 3-methylbut-2-en-1-yl hydroxycarbamate 1 
(44 mg, 0.30 mmol, 1.0 equiv) and cyclohexa-1,3-diene 64 (34 μL, 0.36 mmol, 1.1 equiv) in 
3 mL THF. The resulting mixture was stirred for 4 h at rt. The reaction was quenched with 6 
mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 6 mL). The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue 
was purified by column chromatography to afford oxazine 96 (61 mg, 91%) as a colorless 
oil. 
1
H NMR (600 MHz, CDCl3) δ 6.57 (dd, J = 6.7, 6.7 Hz, 1H), 6.52 (ddd, J = 7.3, 6.0, 1.3 
Hz, 1H), 5.34 (t, J = 7.2 Hz, 1H), 4.83 – 4.77 (m, 1H), 4.77 – 4.72 (m, 1H), 4.64 (dd, J = 
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12.0, 7.4 Hz, 1H), 4.58 (dd, J = 12.1, 7.3 Hz, 1H), 2.20 (dddd, J = 12.9, 9.0, 3.6, 3.6 Hz, 
1H), 2.11 (dddd, J = 12.7, 9.5, 3.2, 3.2 Hz, 1H), 1.73 (s, 3H), 1.69 (s, 3H), 1.49 (dddd, J = 
12.9, 12.9, 2.9, 2.9 Hz, 1H), 1.41 – 1.34 (m, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 158.6, 
139.3, 132.2, 131.8, 118.8, 71.2, 63.3, 50.2, 26.0, 23.7, 20.8, 18.3 ppm; IR (thin film) 2937, 
2862, 1701, 1447, 1264, 1075 cm
-1
; MS (ESI) m/z 246.11 (246.11 calcd for C12H17NNaO3
+
 
[MNa]
+
). 
 
6.2 Chapter 3 Supporting Information 
6.2.1 Supporting Information for the N-Selective Nitrosocarbonyl Aldol Reaction 
Materials and Methods.  Unless stated otherwise, reactions were conducted in flame-dried 
glassware under an atmosphere of air using reagent grade solvents. All commercially 
obtained reagents were used as received. Reaction temperatures were controlled using a 
Heidolph temperature modulator, and unless stated otherwise, reactions were performed at 
room temperature (rt, approximately 23 ºC). Thin-layer chromatography (TLC) was 
conducted with E. Merck silica gel 60 F254 pre-coated plates, (0.25 mm) and visualized by 
exposure to UV light (254 nm) or stained with potassium permanganate.  Flash column 
chromatography was performed using normal phase silica gel (60 Å, 230-240 mesh, 
Geduran®).  
1
H NMR spectra were recorded on Varian Spectrometers (at 400, 500 and 600 
MHz) and are reported relative to deuterated solvent signals.  Data for 
1
H NMR spectra are 
reported as follows: chemical shift ( ppm), multiplicity, coupling constant (Hz) and 
integration.  
13
C NMR spectra were recorded on Varian Spectrometers (125 and 150 MHz).  
Data for 
13
C NMR spectra are reported in terms of chemical shift.  IR spectra were recorded 
on a Perkin Elmer Spectrum Two FT/IR and are reported in terms of frequency of absorption 
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(cm
-1
). Low resolution mass spectra and X-Ray analyses were obtained from the UC Santa 
Barbara Mass Spectrometry and X-Ray Facilities.  
Starting Materials 
Hydroxycarbamates S-5, S-6, S-7, and S-8 were prepared according to literature 
precedent.
4
 Hydroxycarbamates S-4 and 30 were prepared according to literature precedent. 
Hydroxycarbamates 2, and 42 were purchased from commercial sources. β-Keto esters S-9, 
S-12, S-13, S-14, S-15, and S-16 were prepared by acylation of ethyl propionate with the 
corresponding N-methoxy-N-methylamides.
9
 β-Keto esters S-1, S-2, and S-3 were prepared 
by alkylation of the corresponding acetoacetate with methyl iodide.
10
 β-Keto esters S-10 and 
S-11 were prepared from ethyl-2-bromopropionate and the corresponding nitrile.
11
 β-Keto 
esters 1, S-17, S-18, and S-19 were purchased from commercial sources. Copper(II) 
trifluoromethanesulfonate was used as received. Copper(I) chloride was purified prior to use 
according to literature precedent.
12
 Note, the use of commercially available copper(I) 
chloride can result in extended reaction times. The crystal structure data for tert-butyl 2-
(((benzyloxy)carbonyl)(hydroxy)amino)-2-methyl-3-oxobutanoate 9 and ethyl 4,5-dimethyl-
3-((4-nitrobenzoyl)oxy)-2-oxooxazolidine-4-carboxylate S-23 can be obtained free of charge 
from the Cambridge Crystallographic Data Centre with deposition numbers CCDC 883296 
and CCDC 891932 respectively.  
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Substrate Scope 
(3) Ethyl 2-(((benzyloxy)carbonyl)(hydroxy)amino)-2-methyl-3-oxobutanoate 
 
 To a round bottom flask containing hydroxycarbamate 2 (47 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester 1 (49 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (24 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 3 (80 mg, 92%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.40 – 7.28 (m, 5H), 6.62 (s, 1H), 5.22 (d, J = 12.0 Hz, 1H), 
5.17 (d, J = 12.1 Hz, 1H), 4.20 (q, J = 7.0 Hz, 2H), 2.24 (s, 3H), 1.73 (s, 3H), 1.23 (t, J = 7.1 
Hz, 3H) ppm; 
 13
C NMR (150 MHz, CDCl3) δ 199.4, 168.9, 158.6, 134.9, 128.6, 128.4, 78.3, 
68.9, 62.5, 25.3, 18.7, 13.9 ppm; IR (thin film) 3365, 2984, 1725, 1326, 1264, 1100 cm
-1
; 
MS (ESI) m/z 332.11 (332.11 calcd for C15H19NNaO6
+ 
[MNa]
+
) 
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(7) Methyl 2-(((benzyloxy)carbonyl)(hydroxy)amino)-2-methyl-3-oxobutanoate 
 
To a round bottom flask containing hydroxycarbamate 2 (47 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester S-1 (44 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (24 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
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the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 7 (72 mg, 87%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.38 – 7.30 (m, 5H), 6.64 (s, 1H), 5.22 (d, J = 12.1 Hz, 1H), 
5.18 (d, J = 12.1 Hz, 1H), 3.72 (s, 3H), 2.24 (s, 3H), 1.73 (s, 3H) ppm; 
13
C NMR (150 MHz, 
CDCl3) δ 199.4, 169.4, 158.6, 134.9, 128.6, 128.6, 128.4, 78.2, 68.9, 53.1, 25.3, 18.8 ppm; 
IR (thin film) 3396, 2955, 1748, 1270, 1216, 1085, 795 cm
-1
; MS (ESI) m/z 318.09 (318.09 
calcd for C14H17NNaO6
+ 
[MNa]
+
). 
 
(8) Allyl 2-(((benzyloxy)carbonyl)(hydroxy)amino)-2-methyl-3-oxobutanoate 
 
To a round bottom flask containing hydroxycarbamate 2 (47 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester S-2 (53 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (20 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
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residue was purified by column chromatography to afford 8 (81 mg, 90%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.40 – 7.29 (m, 5H), 6.55 (s, 1H), 5.85 (ddd, J = 16.6, 11.0, 
5.7 Hz, 1H), 5.32 (d, J = 17.2 Hz, 1H), 5.24 (d, J = 11.1 Hz, 1H), 5.22 (d, J = 12.2 Hz, 1H), 
5.17 (d, J = 12.1 Hz, 1H), 4.63 (d, J = 5.5 Hz, 2H), 2.24 (s, 3H), 1.75 (s, 3H) ppm; 
13
C NMR 
(150 MHz, CDCl3) δ 199.2, 168.6, 158.6, 134.9, 131.0, 128.6, 128.4, 119.1, 78.4, 68.9, 66.8, 
25.3, 18.8 ppm;  IR (thin film) 3364, 2950, 1724, 1498, 1455, 1393, 1325 cm
-1
; MS (ESI) 
m/z 344.12 (344.11 calcd for C16H19NNaO6
+ 
[MNa]
+
). 
(9) Tert-butyl 2-(((benzyloxy)carbonyl)(hydroxy)amino)-2-methyl-3-oxobutanoate 
 
To a round bottom flask containing hydroxycarbamate 2 (47 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester S-3 (59 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (24 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 9 (78 mg, 82%) as a colorless 
solid. 
1
H NMR (600 MHz, CDCl3) δ 7.39 – 7.29 (m, 5H), 6.61 (s, 1H), 5.19 (s, 2H), 2.22 (s, 
3H), 1.68 (s, 3H), 1.45 (s, 9H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 199.5, 167.8, 158.6, 
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135.0, 128.5, 128.5, 128.4, 83.7, 78.7, 68.7, 27.7, 25.4, 18.7 ppm;  IR (thin film) 3365, 2979, 
1722, 1499, 1456, 1326 cm
-1
; MS (ESI) m/z 360.13 (360.14 calcd for C17H23NNaO6
+ 
[MNa]
+
). 
(10) Ethyl 2-((tert-butoxycarbonyl)(hydroxy)amino)-2-methyl-3-oxobutanoate 
 
To a round bottom flask containing hydroxycarbamate 42 (37 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester 1 (49 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (23 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 10 (61 mg, 79%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 6.26 (s, 1H), 4.27 (q, J = 7.1 Hz, 2H), 2.29 (s, 3H), 1.72 (s, 
3H), 1.47 (s, 9H), 1.30 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 199.7, 
168.9, 157.9, 84.5, 78.4, 62.2, 27.9, 25.2, 19.1, 14.0 ppm; IR (thin film) 3363, 2982, 2936, 
1747, 1752, 1449, 1370, 1260 cm
-1
; MS (ESI) m/z 298.13 (298.13 calcd for C12H21NNaO6
+ 
[MNa]
+
). 
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(11) Ethyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)(hydroxy)amino)-2-methyl-3-
oxobutanoate 
 
To a round bottom flask containing hydroxycarbamate S-4 (72 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester 1 (49 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (27 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 11 (98 mg, 87%) as a colorless 
solid. 
1
H NMR (600 MHz, CDCl3) δ 7.75 (d, J = 7.6 Hz, 2H), 7.61 (t, J = 8.1 Hz, 2H), 7.39 
(t, J = 7.5 Hz, 2H), 7.30 (tdd, J = 7.5, 2.4, 0.9 Hz, 2H), 6.28 (s, 1H), 4.53 (dd, J = 10.6, 6.9 
Hz, 1H), 4.47 (dd, J = 10.6, 7.0 Hz, 1H), 4.28 – 4.19 (m, 3H), 2.19 (s, 3H), 1.69 (s, 3H), 
1.26 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 199.0, 169.0, 158.6, 143.3, 
143.3, 141.3, 127.9, 127.2, 127.2, 125.1, 125.0, 120.0, 78.4, 68.8, 62.6, 46.8, 25.1, 18.5, 
14.0 ppm; IR (thin film) 3373, 2982, 2257, 1744, 1726, 1527, 1376 1355 cm
-1
; MS (ESI) 
m/z 420.15 (420.14 calcd for C22H23NNaO6
+ 
[MNa]
+
). 
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(12) Ethyl 2-(hydroxy((2,2,2-trichloroethoxy)carbonyl)amino)-2-methyl-3-
oxobutanoate 
 
To a round bottom flask containing hydroxycarbamate 33 (58 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester 1 (49 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (26 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 12 (89 mg, 90%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 6.55 (s, 1H), 4.84 (d, J = 11.9 Hz, 1H), 4.77 (d, J = 11.9 Hz, 
1H), 4.33 – 4.24 (m, 2H), 2.33 (s, 3H), 1.80 (s, 3H), 1.31 (t, J = 7.1 Hz, 3H) ppm; 13C NMR 
(150 MHz, CDCl3) δ 198.9, 168.7, 156.8, 94.3, 78.5, 75.8, 62.8, 25.3, 18.8, 14.0 ppm; IR 
(thin film) 3373, 2985, 2955, 1729, 1447, 1391, 1357, 1327, 1267 cm
-1
; MS (ESI) m/z 
371.98 (100%), 373.98 (100%), 375.98 (34%) (371.98, 373.98, 375.97 calcd for 
C10H14Cl3NNaO6
+
 [MNa]
+
). 1 gram scale at 5 mol % catalyst loading: To a round bottom 
flask containing hydroxycarbamate 33 (1.00g, 4.80 mmol, 1.0 equiv), Cu(OTf)2 (87 mg, 0.24 
mmol, 0.05 equiv), and CuCl (24 mg, 0.24 mmol, 0.05 equiv), was added a solution of β-
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ketoester 1 (804 mg, 5.76 mmol, 1.2 equiv) in MeOH (34 mL). The reaction was stirred at 
room temperature open to the atmosphere, using a 24-gauge needle, until completion as 
indicated by TLC (26 h). Upon completion, solvent removal in vacuo and dilution with ethyl 
acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and the solution was stirred 
until color no longer persisted in the organic layer (approx. 30 min). The reaction was 
extracted with ethyl acetate three times and the combined organic layers were dried over 
MgSO4. The product was filtered and then concentrated in vacuo. The residue was purified 
by column chromatography to afford 12 (1.45 g, 86%) as a colorless oil. Spectral data was 
consistent with 12. 1 gram scale at 1 mol % catalyst loading: To a round bottom flask 
containing hydroxycarbamate 33 (1.00 g, 4.80 mmol, 1.0 equiv), Cu(OTf)2 (17.4 mg, 0.048 
mmol, 0.05 equiv), and CuCl (4.8 mg, 0.048 mmol, 0.05 equiv), was added a solution of β-
ketoester 1 (804 mg, 5.76 mmol, 1.2 equiv) in MeOH (34 mL). The reaction was stirred at 
room temperature open to the atmosphere, using a 24-gauge needle, until completion as 
indicated by TLC (240 h). Upon completion, solvent removal in vacuo and dilution with 
ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and the solution was 
stirred until color no longer persisted in the organic layer (approx. 30 min). The reaction was 
extracted with ethyl acetate three times and the combined organic layers were dried over 
MgSO4. The product was filtered and then concentrated in vacuo. The residue was purified 
by column chromatography to afford 12 (1.38 g, 82%) as a colorless oil. Spectral data was 
consistent with 12.  
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(13) Ethyl 2-(hydroxy((2-(2-nitrophenyl)propoxy)carbonyl)amino)-2-methyl-3-
oxobutanoate 
 
To a round bottom flask containing hydroxycarbamate S-5 (67 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester 1 (49 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (36 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 13 (104 mg, 96%, 1;1 dr, 
inseparable mixture) as a yellow oil. 
1
H NMR (600 MHz, CDCl3) δ 7.76 (td, J = 8.1, 1.1 Hz, 
1H), 7.56 (t, J = 7.6 Hz, 1H), 7.47 (d, J = 7.9 Hz, 1H), 7.37 (td, J = 7.6, 1.1 Hz, 1H), 6.52 (d, 
J = 8.7 Hz, 1H), 4.37 – 4.29 (m, 2H), 4.25 – 4.17 (m, 2H), 3.74 – 3.67 (m, 1H), 2.16 (d, J = 
6.0 Hz, 3H), 1.66 (d, J = 4.5 Hz, 3H), 1.34 (d, J = 7.0 Hz, 3H), 1.26 (t, J = 7.1 Hz, 3H), 1.25 
(t, J = 7.1 Hz, 3H ppm; 
13
C NMR (150 MHz, CDCl3) δ 199.2, 199.2, 168.7, 168.7, 158.4, 
150.3, 150.2, 136.9, 136.8, 132.8, 132.8, 128.2, 128.2, 127.6, 124.3, 124.2, 78.1, 78.1, 70.7, 
70.6, 62.5, 62.4, 33.3, 33.3, 25.1, 25.1, 18.5, 17.7, 17.7, 13.9 ppm; IR (thin film) 3373, 2982, 
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2257, 1744, 1726, 1609, 1527, 1447, 1355 cm
-1
; MS (ESI) m/z 405.13 (405.13 calcd for 
C17H22N2NaO8
+ 
[MNa]
+
). 
(14) Ethyl 2-(hydroxy(((4-methoxybenzyl)oxy)carbonyl)amino)-2-methyl-3-
oxobutanoate 
To a round bottom flask containing hydroxycarbamate S-6 (55 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester 1 (49 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (24 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 14 (65 mg, 69%) as a colorless oil 
after. 
1
H NMR (600 MHz, CDCl3) δ 7.28 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.7 Hz, 2H), 5.15 
(d, J = 11.8 Hz, 1H), 5.09 (d, J = 11.8 Hz, 1H), 4.19 (q, J = 7.1 Hz, 2H), 3.79 (s, 3H), 2.22 
(s, 3H), 1.71 (s, 3H), 1.23 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 199.4, 
168.9, 159.8, 158.7, 130.4, 127.1, 113.9, 78.2, 68.7, 62.4, 55.3, 25.3, 18.7, 13.9 ppm; IR 
(thin film) 3346, 2981, 2841, 1743, 1716, 1600, 1456, 1259 cm
-1
; MS (ESI) m/z 362.13 
(362.12 calcd for C16H21NNaO7
+ 
[MNa]
+
). 
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(15) Ethyl 2-(hydroxy(((4-vinylbenzyl)oxy)carbonyl)amino)-2-methyl-3-
oxobutanoate 
 
To a round bottom flask containing hydroxycarbamate S-7 (54 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester 1 (49 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (48 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 15 (88 mg, 86%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.40 (d, J = 8.1 Hz, 2H), 7.32 (d, J = 8.1 Hz, 2H), 6.71 (dd, J 
= 17.6, 10.9 Hz, 1H), 6.29 (s, 1H), 5.76 (d, J = 17.6 Hz, 1H), 5.27 (d, J = 10.9 Hz, 1H), 5.21 
(d, J = 12.1 Hz, 1H), 5.16 (d, J = 12.1 Hz, 1H), 4.22 (qd, J = 7.1, 2.4 Hz, 2H), 2.25 (s, 3H), 
1.74 (s, 3H), 1.25 (t, J = 7.1 Hz, 3H)  ppm; 
13
C NMR (150 MHz, CDCl3) δ 199.2, 168.9, 
158.5, 137.9, 136.2, 134.4, 128.7, 126.4, 114.5, 78.4, 68.6, 62.5, 25.3, 18.7, 13.9  ppm; IR 
(thin film) 3375, 3090, 3983, 2257, 1744, 1725, 1515, 1448, 1328, 1264 cm
-1
; MS (ESI) m/z 
358.13 (358.13 calcd for C17H21NNaO6
+ 
[MNa]
+
). 
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(16) Ethyl 2-(hydroxy(((4-(trifluoromethyl)benzyl)oxy)carbonyl)amino)-2-methyl-3-
oxobutanoate 
 
To a round bottom flask containing hydroxycarbamate S-8 (66 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester 1 (49 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (36 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 16 (93 mg, 87%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.60 (d, J = 8.1 Hz, 2H), 7.46 (d, J = 8.0 Hz, 2H), 6.75 (s, 
1H), 5.25 (d, J = 12.7 Hz, 1H), 5.22 (d, J = 12.8 Hz, 1H), 4.24 – 4.18 (m, 2H), 2.25 (s, 3H), 
1.74 (s, 3H), 1.23 (t, J = 7.2 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 199.4, 168.9, 
158.4, 139.0, 130.6 (q, J = 32.5 Hz), 128.2, 125.5 (q, J = 3.7 Hz), 124.7 (q, J = 271.6 Hz), 
78.2, 67.6, 62.6, 25.3, 18.8, 13.8 ppm; IR (thin film) 3373, 2986, 2950, 1726, 1623, 1448, 
1420, 1326, 1166, 1126 cm
-1
; MS (ESI) m/z 400.11 (400.10 calcd for C16H18F3NNaO6
+ 
[MNa]
+
). 
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(19) Ethyl 2-(((benzyloxy)carbonyl)(hydroxy)amino)-2-methyl-3-oxopentanoate 
 
To a round bottom flask containing hydroxycarbamate 2 (47 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester S-9 (54 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (30 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 19 (78 mg, 86%%) as a colorless 
oil. 
1
H NMR (600 MHz, CDCl3) δ 7.38 – 7.29 (m, 5H), 6.80 (s, 1H), 5.20 (d, J = 12.1 Hz, 
1H), 5.15 (d, J = 12.1 Hz, 1H), 4.19 (qd, J = 7.1, 1.7 Hz, 2H), 2.65 – 2.52 (m, 2H), 1.72 (s, 
3H), 1.23 (t, J = 7.1 Hz, 3H), 1.01 (t, J = 7.2 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 
202.7, 169.2, 158.7, 135.0, 128.5, 128.5, 128.4, 78.0, 68.8, 62.4, 30.8, 19.1, 13.9, 8.0 ppm; 
IR (thin film) 3375, 3066, 3034, 1745, 1722, 1587, 1456, 1187 cm
-1
; MS (ESI) m/z 362.12 
(362.10 calcd for C16H21KNO6
+
 [MK]
+
). 
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(20) Ethyl 2-(((benzyloxy)carbonyl)(hydroxy)amino)-2-methyl-3-oxo-4-
phenylbutanoate 
 
To a round bottom flask containing hydroxycarbamate 2 (47 mg, 0.28 mmol, 1.0), Cu(OTf)2 
(5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was added a 
solution of β-ketoester S-10 (75 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The reaction 
was stirred at room temperature open to the atmosphere, using a 24-gauge needle, until 
completion as indicated by TLC (96 h). Upon completion, solvent removal in vacuo and 
dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and the 
solution was stirred until color no longer persisted in the organic layer (approx. 30 min). The 
reaction was extracted with ethyl acetate three times and the combined organic layers were 
dried over MgSO4. The product was filtered and then concentrated in vacuo. The residue 
was purified by column chromatography to afford 20 (97 mg, 90%) as a colorless oil. 
1
H 
NMR (600 MHz, CDCl3) δ 7.38 – 7.32 (m, 5H), 7.30 – 7.21 (m, 3H), 7.17 (d, J = 7.1 Hz, 
2H), 6.61 (s, 1H), 5.22 (d, J = 12.0 Hz, 1H), 5.19 (d, J = 12.1 Hz, 1H), 4.19 – 4.08 (m, 2H), 
3.94 (d, J = 16.5 Hz, 1H), 3.90 (d, J = 16.5 Hz, 1H), 1.79 (s, 3H), 1.19 (t, J = 7.1 Hz, 3H) 
ppm; 
13
C NMR (150 MHz, CDCl3) δ 198.9, 168.9, 158.7, 134.9, 133.8, 129.7, 128.6, 128.6, 
128.5, 128.3, 126.9, 78.5, 69.0, 62.6, 43.8, 18.7, 13.8 ppm; IR (thin film) 3379, 3064, 2983, 
1726, 1586, 1497, 1455, 1263, 1028 cm
-1
; MS (ESI) m/z 408.15 (408.14 calcd for 
C21H23NNaO6
+ 
[MNa]
+
). 
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(21) Ethyl 2-(((benzyloxy)carbonyl)(hydroxy)amino)-2,4-dimethyl-3-oxopentanoate 
 
To a round bottom flask containing hydroxycarbamate 2 (47 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β -ketoester S-11 (59 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (32 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 21 (87 mg, 91%) as a colorless. 
1
H 
NMR (600 MHz, CDCl3) δ 7.37 – 7.28 (m, 5H), 6.70 (s, 1H), 5.19 (d, J = 12.1 Hz, 1H), 5.17 
(d, J = 12.1 Hz, 1H), 4.16 (qd, J = 7.1, 3.0 Hz, 2H), 3.11 (h, J = 6.6 Hz, 1H), 1.79 (s, 3H), 
1.22 (t, J = 7.2 Hz, 3H), 1.14 (d, J = 6.7 Hz, 3H), 1.08 (d, J = 6.7 Hz, 3H) ppm; 
13
C NMR 
(150 MHz, CDCl3) δ 207.4, 169.2, 158.6, 135.1, 128.5, 128.4, 128.4, 78.3, 68.6, 62.4, 36.3, 
20.5, 20.5, 19.1, 13.9 ppm; IR (thin film) 3375, 2980, 2875, 1722, 1499, 1456, 1326, 1261, 
1010 cm
-1
; MS (ESI) m/z 360.15 (360.14 calcd for C17H23NNaO6
+ 
[MNa]
+
). 
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(22) Ethyl 2-(((benzyloxy)carbonyl)(hydroxy)amino)-2-methyl-3-oxo-3-
phenylpropanoate 
 
To a round bottom flask containing hydroxycarbamate 2 (47 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester S-12 (70 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (72 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 22 (90 mg, 87%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 8.10 (dd, J = 8.4, 1.1 Hz, 2H), 7.52 (t, J = 7.4 Hz, 1H), 7.39 
(t, J = 7.9 Hz, 2H), 7.30 – 7.25 (m, 3H), 7.18 (d, J = 3.6 Hz, 2H), 6.66 (s, 1H), 5.15 (d, J = 
12.1 Hz, 1H), 5.08 (d, J = 12.1 Hz, 1H), 4.24 (qd, J = 7.1, 1.2 Hz, 2H), 1.92 (s, 3H), 1.21 (t, 
J = 7.1 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 190.6, 169.8, 158.4, 134.8, 134.5, 
133.0, 129.3, 128.4, 128.4, 128.3, 128.3, 78.3, 68.9, 62.6, 19.9, 13.9 ppm; IR (thin film) 
3363, 3066, 2983, 1744, 1715, 1688, 1578, 1498, 1264 cm
-1
; MS (ESI) m/z 394.13 (394.13 
calcd for C20H21NNaO6
+ 
[MNa]
+
). 
  206 
(23) Ethyl 2-(((benzyloxy)carbonyl)(hydroxy)amino)-3-(4-methoxyphenyl)-2-
methyl-3-oxopropanoate 
 
To a round bottom flask containing hydroxycarbamate 2 (47 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester S-13 (80 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (96 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 23 (101 mg, 90%) as a colorless 
solid. 
1
H NMR (600 MHz, CDCl3) δ 8.09 (d, J = 9.0 Hz, 2H), 7.27 – 7.21 (m, 3H), 7.15 (s, 
2H), 6.82 (d, J = 9.0 Hz, 2H), 5.13 (d, J = 12.1 Hz, 1H), 5.05 (d, J = 12.2 Hz, 1H), 4.21 (q, J 
= 7.1 Hz, 2H), 3.81 (s, 3H), 1.91 (s, 3H), 1.20 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (150 MHz, 
CDCl3) δ 189.8, 170.0, 163.4, 158.8, 135.0, 131.8, 128.5, 128.4, 128.4, 127.4, 113.6, 78.4, 
68.9, 62.6, 55.5, 20.3, 14.0 ppm; IR (thin film) 3364, 2958, 2839, 1745, 1725, 1587, 1516, 
1251 cm
-1
; MS (ESI) m/z 424.14 (424.14 calcd for C21H23NNaO7
+ 
[MNa]
+
). 
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(24) Ethyl 2-(((benzyloxy)carbonyl)(hydroxy)amino)-3-(4-(tert-butyl)phenyl)-2-
methyl-3-oxopropanoate 
 
To a round bottom flask containing hydroxycarbamate 2 (47 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester S-14 (89 mg, 0.34 mmol, 0.05 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (96 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 24 (104 mg, 87%) as a colorless 
solid. 
1
H NMR (600 MHz, CDCl3) δ 8.04 (d, J = 8.6 Hz, 2H), 7.39 (d, J = 8.6 Hz, 2H), 7.28 
– 7.22 (m, 3H), 7.17 (s, 2H), 6.69 (s, 1H), 5.16 (d, J = 12.1 Hz, 1H), 5.07 (d, J = 12.1 Hz, 
1H), 4.23 (q, J = 7.1 Hz, 2H), 1.92 (s, 3H), 1.32 (s, 9H), 1.21 (t, J = 7.1 Hz, 3H) ppm; 
13
C 
NMR (150 MHz, CDCl3) δ 190.5, 169.9, 158.5, 156.7, 134.9, 131.7, 129.3, 128.4, 128.3, 
128.3, 125.3, 78.4, 7.8, 62.6, 35.1, 31.0, 20.2, 13.9 ppm; IR (thin film) 3358, 2965, 1745, 
1716, 1685, 1321, 1268 cm
-1
; MS (ESI) m/z 450.19 (450.19 calcd for C24H29NNaO6
+ 
[MNa]
+
). 
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(25) Ethyl 2-(((benzyloxy)carbonyl)(hydroxy)amino)-3-(4-bromophenyl)-2-methyl-
3-oxopropanoate 
 
To a round bottom flask containing hydroxycarbamate 2 (47 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester S-15 (97 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (72 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 25 (100 mg, 79%) as a colorless 
oil. 
1
H NMR (600 MHz, CDCl3) δ 7.94 (d, J = 8.7 Hz, 2H), 7.48 (d, J = 8.7 Hz, 2H), 7.30 – 
7.24 (m, 3H), 7.14 (d, J = 6.7 Hz, 2H), 6.87 (s, 1H), 5.14 (d, J = 12.0 Hz, 1H), 5.04 (d, J = 
12.0 Hz, 1H), 4.22 (qd, J = 7.1, 0.8 Hz, 2H), 1.88 (s, 3H), 1.20 (t, J = 7.1 Hz, 3H) ppm; 
13
C 
NMR (150 MHz, CDCl3) δ 189.6, 169.5, 158.4, 134.6, 133.3, 131.6, 130.7, 128.5, 128.5, 
128.4, 128.2, 78.2, 69.0, 62.8, 19.7, 13.9 ppm; IR (thin film) 3358, 3034, 2982, 1744, 1713, 
1691, 1583, 1264 cm
-1
; MS (ESI) m/z 472.06 (100%), 474.06 (100%) (472.04, 474.03 calcd 
for C20H20BrNNaO6
+ 
[MNa]
+
). 
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(26) Ethyl 2-(((benzyloxy)carbonyl)(hydroxy)amino)-2-methyl-3-(4-nitrophenyl)-3-
oxopropanoate  
 
To a round bottom flask containing hydroxycarbamate 2 (47 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester S-16 (85 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (72 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford  26 (74 mg, 63%) as a colorless 
oil. 
1
H NMR (600 MHz, CDCl3) δ 8.22 (d, J = 9.0 Hz, 2H), 8.18 (d, J = 9.0 Hz, 2H), 7.33 – 
7.26 (m, 3H), 7.19 (d, J = 6.8 Hz, 2H), 6.54 (s, 1H), 5.15 (d, J = 12.0 Hz, 1H), 5.07 (d, J = 
12.0 Hz, 1H), 4.25 (q, J = 7.1 Hz, 2H), 1.91 (s, 3H), 1.55 (s, 3H), 1.22 (t, J = 7.1 Hz, 3H) 
ppm; 
13
C NMR (150 MHz, CDCl3) δ 188.4, 169.1, 158.3, 149.9, 139.5, 134.5, 130.1, 128.7, 
128.5, 128.5, 123.4, 78.2, 69.2, 63.1, 19.1, 13.9 ppm; IR (thin film) 3373, 2984, 1744, 1699, 
1525, 1348 cm
-1
; MS (ESI) m/z 439.12 (439.11 calcd for C20H20N2NaO8
+ 
[MNa]
+
). 
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(27) Ethyl 2-(((benzyloxy)carbonyl)(hydroxy)amino)-2-ethyl-3-oxobutanoate 
 
To a round bottom flask containing hydroxycarbamate 2 (47 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester S-17 (54 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (48 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 27 (76 mg, 84%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.38 – 7.29 (m, 5H), 6.71 (s, 1H), 5.19 (d, J = 12.1 Hz, 1H), 
5.17 (d, J = 12.1 Hz, 1H), 4.18 (q, J = 7.1 Hz, 2H), 2.26 (dq, J = 14.8, 7.5 Hz, 1H), 2.24 (s, 
3H), 2.16 (dq, J = 14.8, 7.5 Hz, 1H), 1.22 (t, J = 7.1 Hz, 3H), 1.04 (t, J = 7.5 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 199.2, 168.5, 158.5, 135.1, 128.5, 128.5, 128.4, 81.1, 68.7, 
62.3, 26.6, 26.6, 13.9, 9.2 ppm  ; IR (thin film) 3374, 3066, 3034, 1722, 1456, 1393, 1326, 
1243 cm
-1
; MS (ESI) m/z 346.15 (346.13 calcd for C16H21NNaO6
+ 
[MNa]
+
). 
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(28) Ethyl 2-benzyl-2-(((benzyloxy)carbonyl)(hydroxy)amino)-3-oxobutanoate 
 
To a round bottom flask containing hydroxycarbamate 2 (47 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (5 mg, 0.014 mmol, 0.05 equiv), and CuCl (1.4 mg, 0.014 mmol, 0.05 equiv), was 
added a solution of β-ketoester S-18 (75 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (120 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 28 (85 mg, 79%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.38 – 7.31 (m, 5H), 7.30 (d, J = 7.5 Hz, 2H), 7.24 – 7.19 (m, 
3H), 6.46 (s, 1H), 4.93 (d, J = 12.0 Hz, 1H), 4.87 (d, J = 12.0 Hz, 1H), 4.25 – 4.15 (m, 2H), 
3.64 (d, J = 14.1 Hz, 1H), 3.49 (d, J = 14.1 Hz, 1H), 2.13 (s, 3H), 1.24 (t, J = 7.1 Hz, 3H) 
ppm; 
13
C NMR (150 MHz, CDCl3) δ 197.1, 167.4, 157.4, 134.9, 131.0, 128.6, 128.6, 128.5, 
128.1, 127.2, 82.4, 68.5, 62.8, 36.2, 26.4, 13.8  ppm; IR (thin film) 3388, 3033, 2983, 1718, 
1497, 1455, 1310, 1117 cm
-1
; MS (ESI) m/z 408.15 (408.14 calcd for C21H23NNaO6
+ 
[MNa]
+
). 
  212 
(29) Ethyl 2-acetyl-2-(((benzyloxy)carbonyl)(hydroxy)amino)-3-methylbutanoate 
 
To a round bottom flask containing hydroxycarbamate 2 (47 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (20 mg, 0.056 mmol, 0.20 equiv), and CuCl (5.5 mg, 0.056 mmol, 0.20 equiv), 
was added a solution of β-ketoester S-19 (59 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). 
The reaction was stirred at room temperature open to the atmosphere, using a 24-gauge 
needle, until completion as indicated by TLC (96 h). Upon completion, solvent removal in 
vacuo and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 
7.0), and the solution was stirred until color no longer persisted in the organic layer (approx. 
30 min). The reaction was extracted with ethyl acetate three times and the combined organic 
layers were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 29 (40 mg, 42%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.40 – 7.30 (m, 5H), 6.65 (s, 1H), 5.19 (s, 2H), 4.26 – 4.17 
(m, 2H), 2.79 (h, J = 6.9 Hz, 1H), 2.22 (s, 3H), 1.25 (t, J = 7.1 Hz, 3H), 1.12 (d, J = 7.0 Hz, 
3H), 1.05 (d, J = 6.8 Hz, 3H)  ppm; 
13
C NMR (150 MHz, CDCl3) δ 197.9, 168.8, 157.7, 
135.2, 128.5, 128.5, 128.4, 83.2, 68.5, 62.3, 32.7, 27.6, 19.2, 18.6, 13.9  ppm; IR (thin film) 
3385, 2975, 1721, 1498, 1456, 1393, 1323 cm
-1
; MS (ESI) m/z 360.16 (360.14 calcd for 
C17H23NNaO6
+ 
[MNa]
+
). 
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(30) Ethyl 1-(((benzyloxy)carbonyl)(hydroxy)amino)-2-oxocyclohexanecarboxylate 
 
To a round bottom flask containing hydroxycarbamate 2 (47 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (20 mg, 0.056 mmol, 0.20 equiv), and CuCl (5.5 mg, 0.056 mmol, 0.20 equiv), 
was added a solution of β-ketoester 72 (58 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). The 
reaction was stirred at room temperature open to the atmosphere, using a 24-gauge needle, 
until completion as indicated by TLC (120 h). Upon completion, solvent removal in vacuo 
and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 7.0), and 
the solution was stirred until color no longer persisted in the organic layer (approx. 30 min). 
The reaction was extracted with ethyl acetate three times and the combined organic layers 
were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 30 (40 mg, 43%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.37 – 7.30 (m, 5H), 6.38 (s, 1H), 5.24 (d, J = 12.1 Hz, 1H), 
5.17 (d, J = 12.1 Hz, 1H), 4.25 – 4.15 (m, 2H), 2.75 (td, J = 12.4, 6.1 Hz, 1H), 2.70 – 2.64 
(m, 1H), 2.46 (dt, J = 12.8, 4.2 Hz, 1H), 2.26 (ddd, J = 15.0, 11.6, 3.4 Hz, 1H), 2.04 – 1.97 
(m, 1H), 1.94 – 1.85 (m, 1H), 1.84 – 1.74 (m, 1H), 1.72 – 1.65 (m, 1H), 1.23 (t, J = 7.1 Hz, 
3H)  ppm; 
13
C NMR (151 MHz, CDCl3) δ 202.3, 168.7, 159.3, 135.0, 128.6, 128.5, 128.5, 
79.9, 68.9, 62.3, 39.9, 34.7, 28.2, 20.6, 14.0  ppm; IR (thin film) 3364, 2947, 1724, 1324 cm
-
1
; MS (ESI) m/z 358.11 (358.13 calcd for C17H21NNaO6
+ 
[MNa]
+
). 
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(31) Ethyl 2-(((benzyloxy)carbonyl)(hydroxy)amino)-1-oxo-1,2,3,4-
tetrahydronaphthalene-2-carboxylate 
 
To a round bottom flask containing hydroxycarbamate 2 (47 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (20 mg, 0.056 mmol, 0.20 equiv), and CuCl (5.5 mg, 0.056 mmol, 0.20 equiv), 
was added a solution of β-ketoester S-20 (74 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). 
The reaction was stirred at room temperature open to the atmosphere, using a 24-gauge 
needle, until completion as indicated by TLC (144 h). Upon completion, solvent removal in 
vacuo and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 
7.0), and the solution was stirred until color no longer persisted in the organic layer (approx. 
30 min). The reaction was extracted with ethyl acetate three times and the combined organic 
layers were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 29 (75 mg, 70%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.87 (d, J = 7.2 Hz, 1H), 7.46 (td, J = 7.6, 1.3 Hz, 1H), 7.36 – 
7.26 (m, 6H), 7.21 (d, J = 7.7 Hz, 1H), 6.52 (s, 1H), 5.18 (d, J = 12.4 Hz, 1H), 5.16 (d, J = 
12.8 Hz, 1H), 4.20 – 4.09 (m, 2H), 3.19 – 3.11 (m, 1H), 2.97 – 2.89 (m, 2H), 2.71 – 2.64 (m, 
1H), 1.15 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (151 MHz, CDCl3) δ 190.6, 168.5, 159.0, 
142.7, 135.0, 133.6, 132.0, 128.5, 128.4, 128.4, 128.2, 126.8, 76.4, 68.8, 62.3, 31.2, 25.6, 
13.8  ppm; IR (thin film) 3373, 3066, 1743, 1701, 1297 cm
-1
; MS (ESI) m/z 406.15 (406.13 
calcd for C21H21NNaO6
+ 
[MNa]
+
). 
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(32) Ethyl 2-(((benzyloxy)carbonyl)(hydroxy)amino)-2-methoxy-3-oxobutanoate 
 
To a round bottom flask containing hydroxycarbamate 2 (47 mg, 0.28 mmol, 1.0 equiv), 
Cu(OTf)2 (20 mg, 0.056 mmol, 0.20 equiv), and CuCl (5.5 mg, 0.056 mmol, 0.20 equiv), 
was added a solution of β-ketoester S-21 (44 mg, 0.34 mmol, 1.2 equiv) in MeOH (2 mL). 
The reaction was stirred at room temperature open to the atmosphere, using a 24-gauge 
needle, until completion as indicated by TLC (72 h). Upon completion, solvent removal in 
vacuo and dilution with ethyl acetate was followed by quenching with EDTA (0.5 M, pH 
7.0), and the solution was stirred until color no longer persisted in the organic layer (approx. 
30 min). The reaction was extracted with ethyl acetate three times and the combined organic 
layers were dried over MgSO4. The product was filtered and then concentrated in vacuo. The 
residue was purified by column chromatography to afford 32 (51 mg, 61%) as a colorless oil. 
1
H NMR (600 MHz, CD3OD) δ 7.38 – 7.28 (m, 5H), 5.11 (d, J = 12.8 Hz, 1H), 5.08 (d, J = 
12.3 Hz, 1H), 4.27 – 4.17 (m, 2H), 3.25 (s, 3H), 2.30 (s, 3H), 1.22 (t, J = 7.1 Hz, 3H)  ppm; 
13
C NMR (151 MHz, CD3OD) δ 200.6, 165.9, 155.2, 136.3, 128.1, 127.8, 127.6, 89.4, 66.7, 
62.6, 50.3, 24.0, 12.7  ppm; IR (thin film) 3378, 2983, 1730, 1273 cm
-1
; MS (ESI) m/z 
332.13 (332.11 calcd for C15H19NNaO6
+ 
[MNa]
+
). 
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Post–Functionalization of N-Aldol Products 
(35) Ethyl 2-(hydroxyamino)-2-methyl-3-oxobutanoate 
 
To a stirred solution of oxobutanoate 3 (59 mg, 0.192 mmol, 1.0 equiv) in methanol (2 mL), 
was added Pd/C (10%) (10 mg, 0.096 mmol, 0.05 equiv). The flask was charged with 
hydrogen gas and left to stir until complete as indicated by TLC (15 min). Filtration and 
removal of the solvent in vacuo was followed with column chromatography to afford 35 (25 
mg, 73%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 4.25 (q, J = 7.1 Hz, 2H), 2.26 (s, 
3H), 1.56 (s, 3H), 1.29 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 203.9, 
170.2, 75.0, 62.1, 26.1, 17.8, 14.0 ppm; IR (thin film) 3280, 2986, 2939, 1718, 1448, 1359 
cm
-1
; MS (ESI) m/z 198.07 (198.07 calcd for C7H13NNaO4
+ 
[MNa]
+
). 
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(35) Ethyl 2-(hydroxyamino)-2-methyl-3-oxobutanoate 
 
To a stirred solution of oxobutanoate 10 (26 mg, 0.094 mmol, 1.0 equiv) in dichloromethane 
(0.94 mL) at 0 
°
C, was added trifluoroacetic acid (0.08 mL, 1.13 mmol, 12.0 equiv) 
dropwise. The reaction was left to stir until complete as indicated by TLC (10 min). The 
reaction was transferred to a separatory funnel containing dichloromethane and saturated 
NaHCO3. The reaction was extracted with dichloromethane (3 x 5 mL) and the combined 
organic layers were dried over Na2SO4. Filtration and removal of the solvent in vacuo was 
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followed with the isolation of 35 (16 mg, 95%) as a colorless oil. 
1
H NMR (600 MHz, 
CD3OD) δ 4.21 (q, J = 7.1 Hz, 2H), 2.24 (s, 3H), 1.48 (s, 3H), 1.27 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (151 MHz, CD3OD) δ 204.5, 170.1, 75.0, 61.4, 24.6, 16.6, 12.9 ppm. Additional 
spectral data were consistent with the previous entry.  
(36) Ethyl 2-(((benzyloxy)carbonyl)amino)-2-methyl-3-oxobutanoate 
 
Oxobutanoate 3 (192 mg, 0.62 mmol, 1.0 equiv) was heated under reflux in 2 M HCl (4.30 
mL) with powdered zinc (203 mg, 3.1 mmol, 5 equiv) for 2 hours and 15 minutes. The 
reaction was transferred to a separatory funnel containing dichloromethane and saturated 
NaHCO3. The reaction was extracted with dichloromethane (7 x 10 mL) and the combined 
organic layers were dried over Na2SO4. After filtration and solvent removal in vacuo, the 
crude material was purified by column chromatography to afford 36 (144 mg, 79%) as a 
colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.38 – 7.28 (m, 5H), 6.38 (s, 1H), 5.10 (d, J = 
12.0 Hz, 1H), 5.07 (d, J = 12.4 Hz, 1H), 4.21 (dd, J = 11.9, 6.9 Hz, 2H), 2.19 (s, 3H), 1.73 
(s, 3H), 1.21 (t, J = 6.9 Hz, 3H) ppm; 
13
C NMR (151 MHz, CDCl3) δ 199.9, 169.0, 154.5, 
136.2, 128.5, 128.2, 128.1, 68.6, 66.9, 62.7, 24.1, 20.4, 13.9 ppm; IR (thin film) 3408, 3034, 
2984, 1722, 1492, 1269, 1065 cm
-1
; MS (ESI) m/z 316.13 (316.12 calcd for C15H19NNaO5
+ 
[MNa]
+
).  
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(37) Ethyl 2-amino-2-methyl-3-oxobutanoate 
 
To a stirred solution of oxobutanoate 36 (92 mg, 0.31 mmol, 1.0 equiv) in methanol (2 mL), 
was added Pd/C (10%) (25 mg, 0.016 mmol, 0.05 equiv). The flask was charged with 
hydrogen gas and left to stir until complete as indicated by TLC (10 min). Filtration and 
removal of the solvent in vacuo was followed with the isolation of 37 (44 mg, 90%) as a 
colorless oil. 
1
H NMR (600 MHz, CD3OD) δ 4.22 (q, J = 7.1 Hz, 2H), 2.23 (s, 3H), 1.48 (s, 
3H), 1.27 (t, J = 7.1 Hz, 3H).; 
13
C NMR (151 MHz, CD3OD) δ 205.4, 172.1, 66.9, 61.6, 
23.5, 20.8, 12.9.; IR (thin film) 3279, 2926, 1717, 1263, 1106 cm
-1
; MS (ESI) m/z 182.07 
(182.09 calcd for C7H13NNaO3
+ 
[MNa]
+
). 
(38) Ethyl 3-hydroxy-4,5-dimethyl-2-oxooxazolidine-4-carboxylate 
 
To a round bottom flask was added oxobutanoate 12 (105 mg, 0.30 mmol, 1.0 equiv) and 
flushed with nitrogen gas, followed by the addition of methanol (4 mL). A solution of 
sodium borohydride (13 mg, 0.33 mmol, 1.1 equiv) in methanol (1 mL) was then added at 0 
o
C and stirred for 20 min, followed by the addition of silica gel (1 g) and stirred for 2 hr. The 
solvent was removed in vacuo and the sample was loaded for column chromatography to 
afford 38 (43mg, 71%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.52 (s, 1H), 4.56 
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(q, J = 6.5 Hz, 1H), 4.27 (qd, J = 7.1, 1.1 Hz, 2H), 1.48 (s, 3H), 1.43 (d, J = 6.5 Hz, 3H), 
1.31 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 170.7, 157.8, 74.7, 68.9, 62.5, 
14.8, 14.0, 13.2 ppm; IR (thin film) 3269, 2988, 2943, 1770, 1465, 1388 cm
-1
; MS (ESI) m/z 
242.05 (242.04 calcd for C8H13KNO5
+ 
[MK]
+
).  
(S-23) Ethyl 4,5-dimethyl-3-((4-nitrobenzoyl)oxy)-2-oxooxazolidine-4-carboxylate 
 
To a stirred solution of 38 (40.0 mg, 0.20 mmol, 1.0 equiv), 4-dimethylaminopyridine (0.24 
mg, 0.002 mmol, 0.01 equiv), and triethylamine (22.2 mg, 0.22 mmol, 1.1 equiv) in 
dichloromethane (6 mL) at 0 
o
C was slowly added 4-nitrobenzoylchloride S-22 (41 mg, 0.22 
mmol, 1.1 equiv), under nitrogen gas. Removal of the solvent in vacuo was then followed by 
column chromatography to afford S-23 (57 mg, 88%) as a colorless solid. 
1
H NMR (600 
MHz, CDCl3) δ 8.34 (d, J = 8.9 Hz, 2H), 8.25 (d, J = 8.9 Hz, 2H), 4.92 (q, J = 6.5 Hz, 1H), 
4.23 (q, J = 7.1 Hz, 2H), 1.59 (s, 3H), 1.56 (d, J = 6.5 Hz, 3H), 1.22 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (151 MHz, CDCl3) δ 168.8, 161.6, 154.9, 151.1, 132.3, 131.2, 123.8, 75.1, 68.8, 
62.6, 14.8, 13.9, 13.8 ppm; IR (thin film) 1807, 1780, 1739, 1529, 1387, 1347, 1249 cm
-1
; 
MS (ESI) m/z 375.09 (375.08 calcd for C15H16N2NaO8
+ 
[MK]
+
).  
6.2.2. Supporting Information for the O-Selective Nitrosocarbonyl Aldol Reaction 
Materials and Methods. Unless stated otherwise, reactions were conducted in flame-dried 
glassware under an atmosphere of air using reagent grade solvents. All commercially 
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obtained reagents were used as received. Reaction temperatures were controlled using a 
Heidolph temperature modulator, and unless stated otherwise, reactions were performed at 
room temperature (rt, approximately 23 ºC). Thin-layer chromatography (TLC) was 
conducted with E. Merck silica gel 60 F254 pre-coated plates, (0.25 mm) and visualized by 
exposure to UV light (254 nm) or stained with potassium permanganate.  Flash column 
chromatography was performed using normal phase silica gel (60 Å, 230-240 mesh, 
Geduran®). 
1
H NMR spectra were recorded on Varian Spectrometers (at 500 and 600 MHz) 
and are reported relative to deuterated solvent signals. Data for 
1
H NMR spectra are reported 
as follows: chemical shift ( ppm), multiplicity, coupling constant (Hz) and integration. 13C 
NMR spectra were recorded on Varian Spectrometers (125 and 150 MHz). Data for 
13
C 
NMR spectra are reported in terms of chemical shift, and where relevant, multiplicity and 
coupling constant (Hz). IR spectra were recorded on a Perkin Elmer Spectrum Two FT/IR 
and are reported in terms of frequency of absorption (cm
-1
). High resolution mass spectra 
and X-Ray analyses were obtained from the UC Santa Barbara Mass Spectrometry and X-
Ray Facilities.  
Starting Materials 
Hydroxycarbamates 2, 42, S-5, S-6, S-7, and S-8 were purchased from commercial sources, 
or prepared according to literature precedent.
1
 β-Ketoesters 1, 72, S-17, S-18, S-19, S-24, S-
25, and S-26 were purchased from commercial sources and used as received. β-Ketoesters S-
1, S-2, and S-3 were prepared by alkylation of the corresponding acetoacetate with methyl 
iodide.
10
 β-Ketoesters S-9, S-10, and S-11 were prepared from ethyl-2-bromopropionate and 
the corresponding nitrile. β-Ketoesters S-20, and S-27 were prepared by acylation of the 
ketone with the corresponding carbonate.
13
 β-Ketoesters S-28 and S-29 were prepared by 
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esterification from the corresponding acid.
14
 β-Ketoester S-30 was prepared according to 
literature precedent. Annulation reagent S-32 was purchased from commercial vendors and 
used as received. Annulation reagent S-33 was prepared according to the Aggarwal 
method.
15
 The crystal structures of compounds 85 and S-31 are available free of charge from 
the Cambridge Crystallographic Data Centre via www.cdcc.cam.ac.uk/data_request/cif 
CCDC 907696 (85) and CCDC 932616 (S-31). 
Substrate Scope for the O-Selective Nitrosocarbonyl Aldol 
(44) Ethyl 2-(((tert-butoxycarbonyl)amino)oxy)-2-methyl-3-oxobutanoate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and tert-butyl 
hydroxycarbamate 42 (40 mg, 0.30 mmol, 1 equiv) were added to ethyl 2-methyl-3-
oxobutanoate 1 (52 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 0.015 mmol, 0.05 
equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of isopropyl alcohol. 
The reaction was stirred for 17 h at rt, and the solvent was removed in vacuo. The reaction 
was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 4 mL). 
The combined organic layers were dried over MgSO4, filtered and then concentrated in 
vacuo. The residue was purified by column chromatography to afford aldol product 44 (70 
mg, 84%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.67 (s, 1H), 4.26 (q, J = 7.1 Hz, 
2H), 2.31 (s, 3H), 1.65 (s, 3H), 1.47 (s, 9H), 1.30 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (150 
MHz, CDCl3) δ 202.9, 169.4, 156.5, 91.4, 82.5, 62.4, 28.3, 25.3, 18.5, 14.3 ppm; IR (thin 
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film) 3297, 2958, 1727, 1370, 1248, 1131 cm
-1
; HRMS (ESI) m/z 298.1259 (298.1261 calcd 
for C12H21NNaO6
+ 
[MNa]
+
). A minor amount of the N-selective product was also isolated (8 
mg, 10%). 
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(45) Ethyl 2-(((tert-butoxycarbonyl)amino)oxy)-2-methyl-3-oxo-4-phenylbutanoate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and tert-butyl 
hydroxycarbamate 42 (40 mg, 0.30 mmol, 1 equiv) were added to ethyl 2-methyl-3-oxo-4-
phenylbutanoate S-10 (133 mg, 0.60 mmol, 2.0 equiv), Cu(OAc)2·H2O (3.0 mg, 0.015 
mmol, 0.05 equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of 
isopropyl alcohol. The reaction was stirred for 14 h at rt, and the solvent was removed in 
vacuo. The reaction was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with 
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ethyl acetate (3 x 4 mL). The combined organic layers were dried over MgSO4, filtered and 
then concentrated in vacuo. The residue was purified by column chromatography to afford 
aldol product 45 (77 mg, 73%) as a colorless solid. 
1
H NMR (600 MHz, CDCl3) δ 7.79 (s, 
1H), 7.30 (t, J = 7.3 Hz, 2H), 7.24 (t, J = 7.3 Hz, 1H), 7.19 (d, J = 7.2 Hz, 2H), 4.21 (q, J = 
7.1 Hz, 2H), 4.10 (d, J = 17.1 Hz, 1H), 3.97 (d, J = 17.1 Hz, 1H), 1.10 (s, 3H), 1.48 (s, 9H), 
1.26 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 202.4, 169.4, 156.5, 133.5, 
130.0, 128.6, 127.2, 91.4, 82.5, 62.4, 43.6, 28.3, 18.6, 14.2 ppm; IR (thin film) 3301, 2982, 
1729, 1456, 1370, 1249, 1135 cm
-1
; HRMS (ESI) m/z 374.1571 (374.1574 calcd for 
C18H25NNaO6
+ 
[MNa]
+
). A minor amount of the N-selective product was also isolated (16 
mg, 15%). 
(46) Ethyl 2-(((tert-butoxycarbonyl)amino)oxy)-2-methyl-3-oxopentanoate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and tert-butyl 
hydroxycarbamate 42 (40 mg, 0.30 mmol, 1 equiv) were added to ethyl 2-methyl-3-
oxopentanoate S-9 (95 mg, 0.60 mmol, 2.0 equiv), Cu(OAc)2·H2O (3.0 mg, 0.015 mmol, 
0.05 equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of isopropyl 
alcohol. The reaction was stirred for 14 h at rt, and the solvent was removed in vacuo. The 
reaction was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 
x 4 mL). The combined organic layers were dried over MgSO4, filtered and then 
concentrated in vacuo. The residue was purified by column chromatography to afford aldol 
product 46 (54 mg, 62%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.68 (s, 1H), 4.24 
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(qd, J = 7.1, 1.0 Hz, 2H), 2.76 (dq, J = 18.6, 7.2 Hz, 1H), 2.65 (dq, J = 18.6, 7.2 Hz, 1H), 
1.63 (s, 3H), 1.45 (s, 9H), 1.28 (t, J = 7.1 Hz, 3H), 1.04 (t, J = 7.2 Hz, 3H) ppm; 
13
C NMR 
(150 MHz, CDCl3) δ 205.7, 169.6, 156.5, 91.4, 82.4, 62.3, 30.6, 28.3, 18.6, 14.2, 7.6 ppm; 
IR (thin film) 3300, 2982, 1726, 1370, 1247, 1131 cm
-1
; HRMS (ESI) m/z 312.1417 
(312.1418 calcd for C13H23NNaO6
+ 
[MNa]
+
). A minor amount of the N-selective product 
was also isolated (13 mg, 19%). 
(47) Ethyl 2-(((tert-butoxycarbonyl)amino)oxy)-2,4-dimethyl-3-oxopentanoate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and tert-butyl 
hydroxycarbamate 42 (40 mg, 0.30 mmol, 1 equiv) were added to ethyl 2,4-dimethyl-3-
oxopentanoate S-11 (103 mg, 0.60 mmol, 2.0 equiv), Cu(OAc)2·H2O (3.0 mg, 0.015 mmol, 
0.05 equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of isopropyl 
alcohol. The reaction was stirred for 14 h at rt, and the solvent was removed in vacuo. The 
reaction was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 
x 4 mL). The combined organic layers were dried over MgSO4, filtered and then 
concentrated in vacuo. The residue was purified by column chromatography to afford aldol 
product 47 (52 mg, 57%) as a colorless oil.
 1
H NMR (600 MHz, CDCl3) δ 7.63 (s, 1H), 4.24 
(q, J = 7.1 Hz, 2H), 3.28 (h, J = 6.8 Hz, 1H), 1.66 (s, 3H), 1.46 (s, 9H), 1.29 (t, J = 7.1 Hz, 
3H), 1.12 (d, J = 6.8 Hz, 3H), 1.06 (d, J = 6.7 Hz, 3H) ppm;
 13
C NMR (150 MHz, CDCl3) δ 
209.7, 169.6, 156.5, 91.9, 82.4, 62.3, 35.5, 28.3, 19.9, 19.2, 18.8, 14.3 ppm; IR (thin film) 
3300, 2980, 1754, 1370, 1248, 1133 cm
-1
; HRMS (ESI) m/z 326.1574 (326.1574 calcd for 
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C14H25NNaO6
+ 
[MNa]
+
). A minor amount of the N-selective product was also isolated (17 
mg, 19%). 
(54) Ethyl 2-(((tert-butoxycarbonyl)amino)oxy)-2-ethyl-3-oxobutanoate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and tert-butyl 
hydroxycarbamate 42 (40 mg, 0.30 mmol, 1 equiv) were added to ethyl 2-ethyl-3-
oxobutanoate S-17 (142 mg, 0.90 mmol, 3.0 equiv), Cu(OAc)2·H2O (3.0 mg, 0.015 mmol, 
0.05 equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of isopropyl 
alcohol. The reaction was stirred for 15 h at rt, and the solvent was removed in vacuo. The 
reaction was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 
x 4 mL). The combined organic layers were dried over MgSO4, filtered and then 
concentrated in vacuo. The residue was purified by column chromatography to afford aldol 
product 54 (78 mg, 90%) as a colorless oil.
 1
H NMR (600 MHz, CDCl3) δ 7.82 (s, 1H), 4.26 
(qd, J = 7.1, 1.5 Hz, 2H), 2.29 (s, 3H), 2.13 (dq, J = 14.7, 7.4 Hz, 1H), 2.06 (dq, J = 14.7, 7.5 
Hz, 1H), 1.44 (s, 9H), 1.29 (t, J = 7.1 Hz, 3H), 0.95 (t, J = 7.4 Hz, 3H) ppm; 
13
C NMR (150 
MHz, CDCl3) δ 203.5, 169.1, 156.2, 94.3, 82.4, 62.2, 28.3, 26.1, 26.1, 14.3, 8.0 ppm; IR 
(thin film) 3297, 2981, 1725, 1370, 1248, 1148 cm
-1
; HRMS (ESI) m/z 312.1414 (312.1418 
calcd for C13H23NNaO6
+ 
[MNa]
+
). Less than 2% of the N-selective product was observed. 
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(55) Ethyl 2-(((tert-butoxycarbonyl)amino)oxy)-2-benzyl-3-oxobutanoate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and tert-butyl 
hydroxycarbamate 42 (40 mg, 0.30 mmol, 1 equiv) were added to ethyl 2-benzyl-3-
oxobutanoate S-18 (198 mg, 0.90 mmol, 3.0 equiv), Cu(OAc)2·H2O (3.0 mg, 0.015 mmol, 
0.05 equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of isopropyl 
alcohol. The reaction was stirred for 15 h at rt, and the solvent was removed in vacuo. The 
reaction was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 
x 4 mL). The combined organic layers were dried over MgSO4, filtered and then 
concentrated in vacuo. The residue was purified by column chromatography to afford aldol 
product 55 (102 mg, 96%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.90 (s, 1H), 
7.28 – 7.18 (m, 5H), 4.36 – 4.01 (m, 2H), 3.41 (d, J = 14.6 Hz, 1H), 3.30 (d, J = 14.6 Hz, 
1H), 2.25 (s, 3H), 1.45 (s, 9H), 1.21 (t, J = 7.2 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 
202.9, 168.5, 155.9, 134.0, 130.4, 128.2, 127.2, 93.5, 82.3, 62.0, 38.7, 28.1, 25.9, 13.9 ppm; 
IR (thin film) 3297, 2982, 1725, 1369, 1246, 1161 cm
-1
; HRMS (ESI) m/z 374.1580 
(374.1574 calcd for C18H25NNaO6
+ 
[MNa]
+
). Less than 2% of the N-selective product was 
observed. 
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(56) Tert-butyl (3-acetyl-2-oxotetrahydrofuran-3-yl)oxycarbamate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and tert-butyl 
hydroxycarbamate 42 (40 mg, 0.30 mmol, 1 equiv) were added to 3-acetyldihydrofuran-
2(3H)-one S-24 (46 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 0.015 mmol, 0.05 
equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of isopropyl alcohol. 
The reaction was stirred for 16 h at rt, and the solvent was removed in vacuo. The reaction 
was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 4 mL). 
The combined organic layers were dried over MgSO4, filtered and then concentrated in 
vacuo. The residue was purified by column chromatography to afford aldol product 56 (73 
mg, 93%) as a colorless solid. 
1
H NMR (600 MHz, CDCl3) δ 7.65 (s, 1H), 4.43 (ddd, J = 
8.7, 7.5, 4.7 Hz, 1H), 4.33 (q, J = 8.5 Hz, 1H), 2.71 – 2.61 (m, 2H), 2.38 (s, 3H), 1.47 (s, 
9H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 202.1, 170.9, 156.8, 92.1, 83.3, 66.2, 29.3, 28.2, 
26.0 ppm; IR (thin film) 3277, 2982, 1723, 1371, 1250, 1162 cm
-1
; HRMS (ESI) m/z 
282.0945 (282.0948 calcd for C11H17NNaO6
+ 
[MNa]
+
). Less than 2% of the N-selective 
product was observed. 
(57) Ethyl 2-(((tert-butoxycarbonyl)amino)oxy)-2-fluoro-3-oxobutanoate 
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According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and tert-butyl 
hydroxycarbamate 42 (40 mg, 0.30 mmol, 1 equiv) were added to ethyl 2-fluoro-3-
oxobutanoate S-25 (53 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 0.015 mmol, 
0.05 equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of isopropyl 
alcohol. The reaction was stirred for 16 h at rt, and the solvent was removed in vacuo. The 
reaction was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 
x 4 mL). The combined organic layers were dried over MgSO4, filtered and then 
concentrated in vacuo. The residue was purified by column chromatography to afford aldol 
product 57 (81 mg, 96%) as a colorless oil.
 1
H NMR (600 MHz, CDCl3) δ 7.58 (s, 1H), 4.32 
(qq, J = 8.1, 3.6 Hz, 2H), 2.40 (d, J = 1.7 Hz, 3H), 1.48 (s, 9H), 1.32 (t, J = 7.2 Hz, 3H) 
ppm; 
13
C NMR (150 MHz, CDCl3) δ 195.9 (d, J = 29 Hz), 162.4 (d, J = 35 Hz), 155.7, 
108.9 (d, J = 252 Hz), 83.7, 63.5, 28.2, 25.4, 14.1 ppm; IR (thin film) 3275, 2984, 1745, 
1371, 1250, 1138 cm
-1
; HRMS (ESI) m/z 302.1013 (302.1010 calcd for C11H18FNNaO6
+ 
[MNa]
+
). Less than 2% of the N-selective product was observed. 
(48) Methyl 2-(((tert-butoxycarbonyl)amino)oxy)-2-methyl-3-oxobutanoate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and tert-butyl 
hydroxycarbamate 42 (40 mg, 0.30 mmol, 1 equiv) were added to methyl 2-methyl-3-
oxobutanoate S-1 (47 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 0.015 mmol, 0.05 
equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of isopropyl alcohol. 
The reaction was stirred for 14 h at rt, and the solvent was removed in vacuo. The reaction 
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was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 4 mL). 
The combined organic layers were dried over MgSO4, filtered and then concentrated in 
vacuo. The residue was purified by column chromatography to afford aldol product 49 (67 
mg, 86%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.70 (s, 1H), 3.78 (s, 3H), 2.29 
(s, 3H), 1.63 (s, 3H), 1.44 (s, 9H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 202.8, 169.8, 156.5, 
91.5, 82.5, 53.1, 28.3, 25.2, 18.5 ppm; IR (thin film) 3230, 2981, 1728, 1370, 1248, 1131 
cm
-1
; HRMS (ESI) m/z 284.1103 (284.1105 calcd for C11H19NNaO6
+ 
[MNa]
+
). A minor 
amount of the N-selective product was also isolated (8 mg, 10%). 
(50) Allyl 2-(((tert-butoxycarbonyl)amino)oxy)-2-methyl-3-oxobutanoate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and tert-butyl 
hydroxycarbamate 42 (40 mg, 0.30 mmol, 1 equiv) were added to allyl 2-methyl-3-
oxobutanoate S-2 (56 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 0.015 mmol, 0.05 
equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of isopropyl alcohol. 
The reaction was stirred for 15 h at rt, and the solvent was removed in vacuo. The reaction 
was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 4 mL). 
The combined organic layers were dried over MgSO4, filtered and then concentrated in 
vacuo. The residue was purified by column chromatography to afford aldol product 50 (70 
mg, 81%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.69 (s, 1H), 5.90 (ddt, J = 16.3, 
11.6, 5.8 Hz, 1H), 5.33 (dq, J = 17.1, 1.3 Hz, 1H), 5.26 (dq, J = 10.4, 1.0 Hz, 1H), 4.67 (dt, J 
= 5.8, 1.2 Hz, 2H), 2.29 (s, 3H), 1.65 (s, 3H), 1.45 (s, 9H) ppm. 
13
C NMR (150 MHz, 
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CDCl3) δ 202.7, 169.0, 156.5, 131.3, 119.4, 91.5, 82.5, 66.7, 28.3, 25.2, 18.5 ppm. IR (thin 
film) 3302, 2982, 1728, 1370, 1248, 1130 cm
-1
; HRMS (ESI) m/z 310.1261 (310.1261 calcd 
for C13H21NNaO6
+ 
[MNa]
+
). A minor amount of the N-selective product was also isolated (8 
mg, 9%). 
(51) Tert-butyl 2-(((tert-butoxycarbonyl)amino)oxy)-2-methyl-3-oxobutanoate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and tert-butyl 
hydroxycarbamate 42 (40 mg, 0.30 mmol, 1 equiv) were added to tert-butyl 2-methyl-3-
oxobutanoate S-3 (62 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 0.015 mmol, 0.05 
equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of isopropyl alcohol. 
The reaction was stirred for 17 h at rt, and the solvent was removed in vacuo. The reaction 
was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 4 mL). 
The combined organic layers were dried over MgSO4, filtered and then concentrated in 
vacuo. The residue was purified by column chromatography to afford aldol product 51 (65 
mg, 71%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 7.71 (s, 1H), 2.27 (s, 3H), 1.59 
(s, 3H), 1.48 (s, 9H), 1.45 (s, 9H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 203.1, 168.5, 156.5, 
91.4, 83.6, 82.3, 28.3, 28.1, 25.3, 18.4 ppm; IR (thin film) 3293, 2981, 1726, 1370, 1248, 
1131 cm
-1
; HRMS (ESI) m/z 326.1566 (326.1574 calcd for C14H25NNaO6
+ 
[MNa]
+
). A 
minor amount of the N-selective product was also isolated (13 mg, 14%). 
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(58) Ethyl 1-(((tert-butoxycarbonyl)amino)oxy)-2-oxocyclopentanecarboxylate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and tert-butyl 
hydroxycarbamate 42 (40 mg, 0.30 mmol, 1 equiv) were added to ethyl 2-
oxocyclopentanecarboxylate S-26 (56 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 
0.015 mmol, 0.05 equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of 
isopropyl alcohol. The reaction was stirred for 16 h at rt, and the solvent was removed in 
vacuo. The reaction was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with 
ethyl acetate (3 x 4 mL). The combined organic layers were dried over MgSO4, filtered and 
then concentrated in vacuo. The residue was purified by column chromatography to afford 
aldol product 58 (77 mg, 89%) as a colorless solid. 
1
H NMR (600 MHz, CDCl3) δ 7.80 (s, 
1H), 4.25 (qd, J = 7.1, 1.1 Hz, 2H), 2.73 – 2.52 (m, 1H), 2.42 – 2.22 (m, 4H), 2.12 – 1.97 
(m, 1H), 1.45 (s, 9H), 1.28 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 208.1, 
169.7, 156.4, 89.0, 82.3, 62.3, 36.9, 33.7, 28.3, 19.0, 14.3 ppm; IR (thin film) 3325, 2980, 
1746, 1369, 1268, 1165 cm
-1
; HRMS (ESI) m/z 310.1245 (310.1261 calcd for 
C13H21NNaO6
+ 
[MNa]
+
). Less than 2% of the N-selective product was observed. 
(59) Ethyl 1-(((tert-butoxycarbonyl)amino)oxy)-2-oxocyclohexanecarboxylate 
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According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and tert-butyl 
hydroxycarbamate 42 (40 mg, 0.30 mmol, 1 equiv) were added to ethyl 2-
oxocyclohexanecarboxylate 72 (61 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 
0.015 mmol, 0.05 equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of 
isopropyl alcohol. The reaction was stirred for 16 h at rt, and the solvent was removed in 
vacuo. The reaction was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with 
ethyl acetate (3 x 4 mL). The combined organic layers were dried over MgSO4, filtered and 
then concentrated in vacuo. The residue was purified by column chromatography to afford 
aldol product 59 (85 mg, 94%) as a colorless oil.
 1
H NMR (600 MHz, CDCl3) δ 8.08 (s, 1H), 
4.33 – 4.13 (m, 2H), 2.95 (ddd, J = 13.8, 11.3, 5.8 Hz, 1H), 2.39 (dt, J = 13.8, 4.9 Hz, 1H), 
2.28 (ddd, J = 15.6, 11.4, 3.9 Hz, 1H), 2.17 – 2.04 (m, 2H), 2.03 – 1.94 (m, 1H), 1.86 – 1.70 
(m, 1H), 1.63 (dt, J = 13.5, 4.6 Hz, 1H), 1.42 (s, 9H), 1.28 (t, J = 7.2 Hz, 3H) ppm; 
13
C 
NMR (150 MHz, CDCl3) δ 205.7, 170.1, 156.2, 90.6, 82.3, 62.1, 39.5, 34.6, 28.3, 27.3, 20.4, 
14.3 ppm; IR (thin film) 3310, 2980, 1726, 1369, 1251, 1160 cm
-1
; HRMS (ESI) m/z 
324.1397 (324.1418 calcd for C14H23NNaO6
+ 
[MNa]
+
). Less than 2% of the N-selective 
product was observed. 
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(60) Ethyl 2-(((tert-butoxycarbonyl)amino)oxy)-1-oxo-1,2,3,4-
tetrahydronaphthalene-2-carboxylate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and tert-butyl 
hydroxycarbamate 42 (40 mg, 0.30 mmol, 1 equiv) were added to ethyl 1-oxo-1,2,3,4-
tetrahydronaphthalene-2-carboxylate S-20 (79 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O 
(3.0 mg, 0.015 mmol, 0.05 equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 
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2 mL of isopropyl alcohol. The reaction was stirred for 15 h at rt, and the solvent was 
removed in vacuo. The reaction was quenched with 4 mL EDTA (0.5 M, pH 7.0) and 
extracted with ethyl acetate (3 x 4 mL). The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo. The residue was purified by column 
chromatography to afford aldol product 60 (102 mg, 97%) as a colorless oil. 
1
H NMR (600 
MHz, CDCl3) δ 8.12 – 7.95 (m, 2H), 7.50 (td, J = 7.5, 1.3 Hz, 1H), 7.31 (t, J = 7.6 Hz, 1H), 
7.25 (d, J = 7.8 Hz, 1H), 4.27 (q, J = 7.1 Hz, 2H), 3.42 (ddd, J = 16.5, 9.6, 4.8 Hz, 1H), 2.89 
(dt, J = 16.9, 5.1 Hz, 1H), 2.69 (ddd, J = 14.4, 9.7, 4.9 Hz, 1H), 2.49 (dt, J = 14.2, 5.1 Hz, 
1H), 1.32 – 1.22 (m, 12H) ppm; 13C NMR (150 MHz, CDCl3) δ 190.8, 169.6, 155.9, 143.8, 
134.3, 131.3, 128.9, 128.2, 127.0, 87.6, 81.9, 62.2, 30.7, 28.0, 24.9, 14.2 ppm; IR (thin film) 
3325, 3068, 2936, 1747, 1368, 1268, 1165 cm
-1
; HRMS (ESI) m/z 372.1436 (372.1418 calcd 
for C18H23NNaO6
+ 
[MNa]
+
). Less than 2% of the N-selective product was observed. 
(64) Methyl 1-((((benzyloxy)carbonyl)amino)oxy)-2-oxocyclohexane-1-carboxylate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and benzyl 
hydroxycarbamate 2 (50 mg, 0.30 mmol, 1 equiv) were added to methyl 2-oxocyclohexane-
1-carboxylate S-27 (56 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 0.015 mmol, 
0.05 equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of isopropyl 
alcohol. The reaction was stirred for 14 h at rt, and the solvent was removed in vacuo. The 
reaction was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 
x 4 mL). The combined organic layers were dried over MgSO4, filtered and then 
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concentrated in vacuo. The residue was purified by column chromatography to afford aldol 
product 64 (71 mg, 74%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 8.34 (s, 1H), 7.41 
– 7.30 (m, 5H), 5.19 (d, J = 12.1 Hz, 1H), 5.12 (d, J = 12.1 Hz, 1H), 3.78 (s, 3H), 2.95 (ddd, 
J = 13.9, 11.2, 5.7 Hz, 1H), 2.42 (dt, J = 13.9, 4.9 Hz, 1H), 2.32 (ddd, J = 15.3, 11.3, 4.5 Hz, 
1H), 2.21 – 2.06 (m, 2H), 2.03 – 1.94 (m, 1H), 1.85 – 1.73 (m, 1H), 1.71 – 1.61 (m, 1H) 
ppm; 
13
C NMR (150 MHz, CDCl3) δ 205.2, 170.2, 156.9, 135.5, 128.8, 128.7, 128.5, 90.9, 
67.9, 52.9, 39.5, 34.5, 27.2, 20.4 ppm; IR (thin film) 3299, 3034, 2954, 1723, 1437, 1226, 
1103 cm
-1
; HRMS (ESI) m/z 344.1106 (344.1105 calcd for C16H19NNaO6
+ 
[MNa]
+
). Less 
than 2% of the N-selective product was observed. 
(65) Ethyl 1-((((benzyloxy)carbonyl)amino)oxy)-2-oxocyclohexanecarboxylate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and benzyl 
hydroxycarbamate 2 (50 mg, 0.30 mmol, 1 equiv) were added to ethyl 2-
oxocyclohexanecarboxylate 72 (61 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 
0.015 mmol, 0.05 equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of 
isopropyl alcohol. The reaction was stirred for 14 h at rt, and the solvent was removed in 
vacuo. The reaction was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with 
ethyl acetate (3 x 4 mL). The combined organic layers were dried over MgSO4, filtered and 
then concentrated in vacuo. The residue was purified by column chromatography to afford 
aldol product 65 (82 mg, 81%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 8.39 (s, 1H), 
7.41 – 7.28 (m, 5H), 5.18 (d, J = 12.1 Hz, 1H), 5.11 (d, J = 12.1 Hz, 1H), 4.28 – 4.20 (m, 
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2H), 2.92 (ddd, J = 14.1, 10.8, 5.7 Hz, 1H), 2.42 (dt, J = 13.9, 5.2 Hz, 1H), 2.33 (ddd, J = 
14.7, 10.8, 3.8 Hz, 1H), 2.17 – 2.04 (m, 2H), 2.00 – 1.91 (m, 1H), 1.84 – 1.72 (m, 1H), 1.69 
– 1.59 (m, 1H), 1.27 (t, J = 7.2 Hz, 3H) ppm; 13C NMR (150 MHz, CDCl3) δ 205.4, 169.5, 
156.9, 135.5, 128.7, 128.6, 128.4, 90.7, 67.8, 62.2, 39.6, 34.4, 27.1, 20.4, 14.2 ppm; IR (thin 
film) 3301, 2944, 1724, 1453, 1225, 1102 cm
-1
; HRMS (ESI) m/z 358.1260 (358.1261 calcd 
for C17H21NNaO6
+ 
[MNa]
+
). Less than 2% of the N-selective product was observed. 
(66) Tert-butyl 1-((((benzyloxy)carbonyl)amino)oxy)-2-oxocyclohexane-1-
carboxylate 
 
According to the general procedure, CuCl (0.8 mg, 0.0075 mmol, 0.05 equiv) and benzyl 
hydroxycarbamate 2 (25 mg, 0.15 mmol, 1 equiv) were added to tert-butyl 2-
oxocyclohexane-1-carboxylate S-28 (36 mg, 0.18 mmol, 1.2 equiv), Cu(OAc)2·H2O (1.5 mg, 
0.0075 mmol, 0.05 equiv), and ethyl oxazoline (0.8 mg, 0.0075 mmol, 0.05 equiv) in 1 mL 
of isopropyl alcohol. The reaction was stirred for 24 h at rt, and the solvent was removed in 
vacuo. The reaction was quenched with 2 mL EDTA (0.5 M, pH 7.0) and extracted with 
ethyl acetate (3 x 2 mL). The combined organic layers were dried over MgSO4, filtered and 
then concentrated in vacuo. The residue was purified by column chromatography to afford 
aldol product 66 (40 mg, 77%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 8.43 (s, 1H), 
7.40 – 7.28 (m, 5H), 5.19 (d, J = 12.1 Hz, 1H), 5.11 (d, J = 12.1 Hz, 1H), 2.86 (ddd, J = 
14.7, 9.6, 5.6 Hz, 1H), 2.45 (dt, J = 13.9, 5.8 Hz, 1H), 2.37 – 2.28 (m, 1H), 2.12 – 2.01 (m, 
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2H), 1.95 – 1.87 (m, 1H), 1.87 – 1.76 (m, 1H), 1.68 – 1.58 (m, 1H), 1.47 (s, 9H) ppm; 13C 
NMR (150 MHz, CDCl3) δ 206.1, 168.7, 156.8, 135.6, 128.8, 128.6, 128.5, 90.8, 83.7, 67.8, 
40.0, 34.7, 28.1, 27.1, 20.8 ppm; IR (thin film) 3329, 3035, 2942, 1724, 1456, 1301, 1223, 
1103 cm
-1
; HRMS (ESI) m/z 386.1587 (386.1574 calcd for C19H25NNaO6
+ 
[MNa]
+
). Less 
than 2% of the N-selective product was observed. 
(67) 2,6-Dimethylphenyl 1-((((benzyloxy)carbonyl)amino)oxy)-2-oxocyclohexane-1-
carboxylate 
 
According to the general procedure, CuCl (0.8 mg, 0.0075 mmol, 0.05 equiv) and benzyl 
hydroxycarbamate 2 (25 mg, 0.15 mmol, 1 equiv) were added to 2,6-dimethylphenyl 2-
oxocyclohexane-1-carboxylate S-29 (44 mg, 0.18 mmol, 1.2 equiv), Cu(OAc)2·H2O (1.5 mg, 
0.0075 mmol, 0.05 equiv), and ethyl oxazoline (0.8 mg, 0.0075 mmol, 0.05 equiv) in 1 mL 
of isopropyl alcohol. The reaction was stirred for 8 h at rt, and the solvent was removed in 
vacuo. The reaction was quenched with 2 mL EDTA (0.5 M, pH 7.0) and extracted with 
ethyl acetate (3 x 2 mL). The combined organic layers were dried over MgSO4, filtered and 
then concentrated in vacuo. The residue was purified by column chromatography to afford 
aldol product 67 (50 mg, 85%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 8.37 (s, 1H), 
7.42 – 7.31 (m, 5H), 7.07 (s, 3H), 5.22 (d, J = 12.0 Hz, 1H), 5.14 (d, J = 12.1 Hz, 1H), 3.12 
(td, J = 13.2, 5.9 Hz, 1H), 2.59 – 2.50 (m, 1H), 2.51 – 2.42 (m, 2H), 2.30 – 2.17 (m, 7H), 
2.16 – 2.07 (m, 1H), 1.90 – 1.76 (m, 2H) ppm; 13C NMR (150 MHz, CDCl3) δ 204.6, 168.2, 
157.1, 147.8, 135.4, 130.4, 129.0, 128.8, 128.8, 128.5, 126.6, 91.0, 68.1, 39.4, 35.0, 27.2, 
  242 
20.2, 16.8 ppm; IR (thin film) 3323, 3034, 2951, 1760, 1473, 1318, 1223, 1099 cm
-1
; HRMS 
(ESI) m/z 434.1570 (434.1574 calcd for C23H25NNaO6
+ 
[MNa]
+
). A minor amount of the N-
selective product was also isolated (2 mg, 3%). 
(68) Ethyl 1-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)oxy)-2-
oxocyclohexanecarboxylate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and (9H-
fluoren-9-yl)methyl hydroxycarbamate S-4 (77 mg, 0.30 mmol, 1 equiv) were added to ethyl 
2-oxocyclohexanecarboxylate 72 (61 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 
0.015 mmol, 0.05 equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of 
isopropyl alcohol. The reaction was stirred for 19 h at rt, and the solvent was removed in 
vacuo. The reaction was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with 
ethyl acetate (3 x 4 mL). The combined organic layers were dried over MgSO4, filtered and 
then concentrated in vacuo. The residue was purified by column chromatography to afford 
aldol product 68 (102 mg, 80%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 8.38 (s, 
1H), 7.76 (d, J = 7.6 Hz, 2H), 7.57 (t, J = 7.6 Hz, 2H), 7.41 (td, J = 7.5, 1.3 Hz, 2H), 7.32 (t, 
J = 7.5 Hz, 2H), 4.51 (d, J = 6.7 Hz, 2H), 4.29 (qd, J = 7.2, 4.9 Hz, 2H), 4.22 (t, J = 6.8 Hz, 
1H), 2.87 – 2.74 (m, 1H), 2.39 (dt, J = 14.0, 4.9 Hz, 1H), 2.33 (ddd, J = 14.7, 10.8, 4.1 Hz, 
1H), 2.17 – 2.09 (m, 1H), 2.03 – 1.89 (m, 2H), 1.83 – 1.70 (m, 1H), 1.65 – 1.57 (m, 1H), 
1.31 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 205.4, 169.8, 157.0, 143.5, 
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143.5, 141.5, 128.0, 127.4, 127.3, 125.1, 125.1, 120.2, 90.7, 67.7, 62.3, 47.1, 39.6, 34.5, 
27.2, 20.4, 14.3 ppm; IR (thin film) 3303, 2929, 1724, 1451, 1224, 1103 cm
-1
; HRMS (ESI) 
m/z 446.1572 (446.1574 calcd for C24H25NNaO6
+ 
[MNa]
+
). Less than 2% of the N-selective 
product was observed. 
(69) Ethyl 2-oxo-1-((((2,2,2-
trichloroethoxy)carbonyl)amino)oxy)cyclohexanecarboxylate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and 2,2,2-
trichloroethyl hydroxycarbamate 33 (63 mg, 0.30 mmol, 1 equiv) were added to ethyl 2-
oxocyclohexanecarboxylate 72 (61 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 
0.015 mmol, 0.05 equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of 
isopropyl alcohol. The reaction was stirred for 19 h at rt, and the solvent was removed in 
vacuo. The reaction was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with 
ethyl acetate (3 x 4 mL). The combined organic layers were dried over MgSO4, filtered and 
then concentrated in vacuo. The residue was purified by column chromatography to afford 
aldol product 69 (101 mg, 89%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 8.64 (s, 
1H), 4.80 (d, J = 11.9 Hz, 1H), 4.71 (d, J = 11.9 Hz, 1H), 4.38 – 4.22 (m, 2H), 2.93 (ddd, J = 
14.1, 10.6, 5.7 Hz, 1H), 2.47 (dt, J = 14.1, 5.3 Hz, 1H), 2.37 (ddd, J = 15.0, 10.9, 4.5 Hz, 
1H), 2.20 – 2.05 (m, 2H), 2.03 – 1.93 (m, 1H), 1.89 – 1.77 (m, 1H), 1.74 – 1.61 (m, 1H), 
1.31 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 205.2, 169.6, 155.1, 94.9, 90.8, 
75.0, 62.5, 39.7, 34.4, 27.1, 20.5, 14.3 ppm; IR (thin film) 3294, 2958, 1726, 1369, 1252, 
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1124 cm
-1
; HRMS (ESI) m/z 397.9937 (397.9935 calcd for C12H16Cl3NNaO6
+ 
[MNa]
+
). Less 
than 2% of the N-selective product was observed. 
(70) Ethyl 1-((((2-(2-nitrophenyl)propoxy)carbonyl)amino)oxy)-2-
oxocyclohexanecarboxylate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and 2-(2-
nitrophenyl)propyl hydroxycarbamate S-5(72 mg, 0.30 mmol, 1 equiv) were added to ethyl 
2-oxocyclohexanecarboxylate 72 (61 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 
0.015 mmol, 0.05 equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of 
isopropyl alcohol. The reaction was stirred for 14 h at rt, and the solvent was removed in 
vacuo. The reaction was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with 
ethyl acetate (3 x 4 mL). The combined organic layers were dried over MgSO4, filtered and 
then concentrated in vacuo. The residue was purified by column chromatography to afford 
aldol product 70 (107 mg, 87%, 1:1 dr, inseparable) as an orange oil. 
1
H NMR (600 MHz, 
CDCl3) δ 8.25 (s, 1H), 8.22 (s, 1H), 7.74 (d, J = 8.1 Hz, 1H), 7.59 – 7.53 (m, 1H), 7.46 – 
7.40 (m, 1H), 7.39 – 7.33 (m, 1H), 4.54 – 4.02 (m, 4H), 3.68 (h, J = 6.7 Hz, 1H), 2.90 – 2.70 
(m, 1H), 2.44 – 2.23 (m, 2H), 2.13 – 2.05 (m, 1H), 2.05 – 1.96 (m, 1H), 1.96 – 1.87 (m, 1H), 
1.81 – 1.70 (m, 1H), 1.66 – 1.57 (m, 1H), 1.33 (d, J = 2.0 Hz, 3H), 1.32 (d, J = 2.0 Hz, 3H), 
1.28 (t, J = 7.2 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 205.3, 205.2, 169.7, 169.6, 
156.7, 150.5, 150.5, 137.0, 137.0, 132.9, 132.9, 128.3, 128.2, 127.7, 127.7, 124.4, 124.4, 
90.7, 90.6, 69.6, 69.6, 62.2, 39.6 , 39.5, 34.4, 34.4, 27.1, 20.4, 20.4, 17.8, 17.8, 14.2 ppm; IR 
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(thin film) 3318, 2962, 1724, 1527, 1355, 1226, 1102 cm
-1
; HRMS (ESI) m/z 431.1418 
(431.1425 calcd for C19H24N2NaO8
+ 
[MNa]
+
). Less than 2% of the N-selective product was 
observed. 
(71) Ethyl 1-(((((4-methoxybenzyl)oxy)carbonyl)amino)oxy)-2-
oxocyclohexanecarboxylate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and 4-
methoxybenzyl hydroxycarbamate S-6 (59 mg, 0.30 mmol, 1 equiv) were added to ethyl 2-
oxocyclohexanecarboxylate 72 (61 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 
0.015 mmol, 0.05 equiv), and ethyl oxazoline (1.5 mg, 0.015 mmol, 0.05 equiv) in 2 mL of 
isopropyl alcohol. The reaction was stirred for 15 h at rt, and the solvent was removed in 
vacuo. The reaction was quenched with 4 mL EDTA (0.5 M, pH 7.0) and extracted with 
ethyl acetate (3 x 4 mL). The combined organic layers were dried over MgSO4, filtered and 
then concentrated in vacuo. The residue was purified by column chromatography to afford 
aldol product 71 (93 mg, 85%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 8.32 (s, 1H), 
7.27 (d, J = 8.7 Hz, 2H), 6.86 (d, J = 8.7 Hz, 2H), 5.11 (d, J = 11.8 Hz, 1H), 5.03 (d, J = 
11.8 Hz, 1H), 4.28 – 4.20 (m, 2H), 3.79 (s, 3H), 2.92 (ddd, J = 14.1, 10.9, 5.7 Hz, 1H), 2.41 
(dt, J = 13.9, 5.1 Hz, 1H), 2.32 (ddd, J = 14.8, 10.9, 3.7 Hz, 1H), 2.18 – 2.03 (m, 2H), 2.00 – 
1.90 (m, 1H), 1.85 – 1.74 (m, 1H), 1.70 – 1.57 (m, 1H), 1.27 (t, J = 7.1 Hz, 3H) ppm; 13C 
NMR (150 MHz, CDCl3) δ 205.4, 169.7, 160.0, 157.0, 130.4, 127.6, 114.1, 90.7, 67.7, 62.2, 
55.4, 39.6, 34.5, 27.1, 20.4, 14.2 ppm; IR (thin film) 3302, 2942, 1725, 1516, 1250, 1101 
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cm
-1
; HRMS (ESI) m/z 388.1364 (388.1367 calcd for C18H23NNaO7
+ 
[MNa]
+
). Less than 2% 
of the N-selective product was observed. 
Asymmetric O-Selective Nitrosocarbonyl Aldol Reaction 
General Procedure for the Asymmetric Aldol Reaction: To a stirred solution of β-
ketoester 4, 5 mol % Cu(OAc)2·H2O, and 6 mol % (+)-2,2′-Isopropylidenebis[(4R)-4-
phenyl-2-oxazoline] in isopropyl alcohol (0.15 M) was added 5 mol % CuCl and benzyl 
hydroxycarbamate 30. The reaction was stirred at room temperature open to the air until 
complete by TLC and the isopropyl alcohol was removed in vacuo. The reaction was 
quenched with EDTA (0.5 M, pH 7.0), diluted with ethyl acetate and stirred until color no 
longer persisted in organic layer (approx 30 mins). The reaction was extracted with ethyl 
acetate three times and the combined organic layers were dried over MgSO4. The product 
was filtered and then concentrated in vacuo. The residue was purified by column 
chromatography to afford the corresponding aldol product.  
(75) Methyl 2-((((benzyloxy)carbonyl)amino)oxy)-2-methyl-3-oxobutanoate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and benzyl 
hydroxycarbamate 2 (50 mg, 0.30 mmol, 1 equiv) were added to methyl 2-methyl-3-
oxobutanoate S-1 (47 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 0.015 mmol, 0.05 
equiv), and (+)-2,2′-isopropylidenebis[(4R)-4-phenyl-2-oxazoline] (6.0 mg, 0.018 mmol, 
0.06 equiv) in 2 mL of isopropyl alcohol. The reaction was stirred for 8 h at rt, and the 
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solvent was removed in vacuo. The reaction was quenched with 4 mL EDTA (0.5 M, pH 
7.0) and extracted with ethyl acetate (3 x 4 mL). The combined organic layers were dried 
over MgSO4, filtered and then concentrated in vacuo. The residue was purified by column 
chromatography to afford aldol product 75 (69 mg, 78%, 93:7 er) as a colorless oil. 
Enantiomeric ratio determined by chiral HPLC (Chiralpak IA column, 4.6 mm x 250 mm, 
step gradient (95.5/0.5 hexanes/i-PrOH, 30 min; 97/3 hexanes/i-PrOH, 30 min), 1 mL/min, 
(X) Rt = 43.3 min (major), (X) Rt = 45.0 min (minor)); [α]D
25
 +3.8° (c 1.00, CHCl3);
 1
H 
NMR (600 MHz, CDCl3) δ 7.99 (s, 1H), 7.40 – 7.30 (m, 5H), 5.17 (s, 2H), 3.77 (s, 3H), 2.29 
(s, 3H), 1.66 (s, 3H) ppm;
 13
C NMR (150 MHz, CDCl3) δ 199.4, 169.7, 158.8, 135.2, 128.8, 
128.8, 128.7, 78.7, 69.2, 53.4, 25.5, 19.0 ppm; IR (thin film) 3289, 2956, 1727, 1456, 1232, 
1106 cm
-1
; HRMS (ESI) m/z 318.0945 (318.0948 calcd for C14H17NNaO6
+ 
[MNa]
+
).  
(76) Ethyl 2-((((benzyloxy)carbonyl)amino)oxy)-2-methyl-3-oxobutanoate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and benzyl 
hydroxycarbamate 2 (50 mg, 0.30 mmol, 1 equiv) were added to ethyl 2-methyl-3-
oxobutanoate 1 (52 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 0.015 mmol, 0.05 
equiv), and (+)-2,2′-isopropylidenebis[(4R)-4-phenyl-2-oxazoline] (6.0 mg, 0.018 mmol, 
0.06 equiv) in 2 mL of isopropyl alcohol. The reaction was stirred for 8 h at rt, and the 
solvent was removed in vacuo. The reaction was quenched with 4 mL EDTA (0.5 M, pH 
7.0) and extracted with ethyl acetate (3 x 4 mL). The combined organic layers were dried 
over MgSO4, filtered and then concentrated in vacuo. The residue was purified by column 
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chromatography to afford aldol product 76 (69 mg, 74%, 92:8 er) as a colorless oil. 
Enantiomeric ratio determined by chiral HPLC (Chiralpak IA column, 4.6 mm x 250 mm, 
step gradient (95.5/0.5 hexanes/i-PrOH, 30 min; 97/3 hexanes/i-PrOH, 30 min), 1 mL/min, 
(X) Rt = 38.4 min (major), (X) Rt = 41.2 min (minor)); [α]D
25
 +2.8° (c 1.00, CHCl3);
  1
H 
NMR (600 MHz, CDCl3) δ 7.99 (s, 1H), 7.39 – 7.29 (m, 5H), 5.17 (s, 2H), 4.24 (q, J = 7.1 
Hz, 2H), 2.28 (s, 3H), 1.65 (s, 3H), 1.28 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (150 MHz, 
CDCl3) δ 202.4, 169.1, 157.3, 135.5, 128.8, 128.8, 128.5, 91.6, 68.1, 62.5, 25.3, 18.4, 14.2 
ppm; IR (thin film) 3290, 2985, 1727, 1456, 1231, 1105 cm
-1
; HRMS (ESI) m/z 332.1107 
(332.1105 calcd for C15H19NNaO6
+ 
[MNa]
+
). 
(78) Tert-butyl 2-((((benzyloxy)carbonyl)amino)oxy)-2-methyl-3-oxobutanoate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and benzyl 
hydroxycarbamate 2 (50 mg, 0.30 mmol, 1 equiv) were added to tert-butyl 2-methyl-3-
oxobutanoate S-3 (62 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 0.015 mmol, 0.05 
equiv), and (+)-2,2′-isopropylidenebis[(4R)-4-phenyl-2-oxazoline] (6.0 mg, 0.015 mmol, 
0.06 equiv) in 2 mL of isopropyl alcohol. The reaction was stirred for 8 h at rt, and the 
solvent was removed in vacuo. The reaction was quenched with 4 mL EDTA (0.5 M, pH 
7.0) and extracted with ethyl acetate (3 x 4 mL). The combined organic layers were dried 
over MgSO4, filtered and then concentrated in vacuo. The residue was purified by column 
chromatography to afford aldol product 78 (77 mg, 76%, 99:1 er) as a colorless oil. 
Enantiomeric ratio determined by chiral HPLC (Chiralpak IA column, 4.6 mm x 250 mm, 
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step gradient (95.5/0.5 hexanes/i-PrOH, 30 min; 97/3 hexanes/i-PrOH, 30 min), 1 mL/min, 
(X) Rt = 29.5 min (major), (X) Rt = 31.9 min (minor)); [α]D
25
 +3.3° (c 1.00, CHCl3); 
1
H 
NMR (600 MHz, CDCl3) δ 8.03 (s, 1H), 7.41 – 7.29 (m, 5H), 5.19 – 5.13 (m, 2H), 2.26 (s, 
3H), 1.60 (s, 3H), 1.46 (s, 9H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 202.5, 168.2, 157.2, 
135.5, 128.8, 128.7, 128.5, 91.5, 83.7, 68.0, 28.0, 25.3, 18.3 ppm; IR (thin film) 3290, 2979, 
1725, 1456, 1227, 1104 cm
-1
; HRMS (ESI) m/z 360.1420 (360.1418 calcd for 
C17H23NNaO6
+ 
[MNa]
+
). 
(77) 2,6-Dimethylphenyl 2-((((benzyloxy)carbonyl)amino)oxy)-2-methyl-3-
oxobutanoate 
 
According to the general procedure, CuCl (0.7 mg, 0.0075 mmol, 0.05 equiv) and benzyl 
hydroxycarbamate 2 (25 mg, 0.15 mmol, 1 equiv) were added to 2,6-dimethylphenyl 2-
methyl-3-oxobutanoate S-30 (40 mg, 0.18 mmol, 1.2 equiv), Cu(OAc)2·H2O (1.5 mg, 0.0075 
mmol, 0.05 equiv), and (+)-2,2′-isopropylidenebis[(4R)-4-phenyl-2-oxazoline] (3.0 mg, 
0.0090 mmol, 0.06 equiv) in 1 mL of isopropyl alcohol. The reaction was stirred for 8 h at rt, 
and the solvent was removed in vacuo. The reaction was quenched with 2 mL EDTA (0.5 M, 
pH 7.0) and extracted with ethyl acetate (3 x 2 mL). The combined organic layers were dried 
over MgSO4, filtered and then concentrated in vacuo. The residue was purified by column 
chromatography to afford aldol product 77 (49 mg, 85%, 99:1 er) as a colorless oil. 
Enantiomeric ratio determined by chiral HPLC (Chiralpak IA column, 4.6 mm x 250 mm, 
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step gradient (95.5/0.5 hexanes/i-PrOH, 30 min; 97/3 hexanes/i-PrOH, 30 min), 1 mL/min, 
(X) Rt = 39.7 min (major), (X) Rt = 42.2 min (minor)); [α]D
25
 +16.5° (c 1.00, CHCl3); 
1
H 
NMR (600 MHz, CDCl3) δ 8.03 (s, 1H), 7.42 – 7.30 (m, 5H), 7.12 – 7.00 (m, 3H), 5.20 (s, 
2H), 2.41 (s, 3H), 2.15 (s, 6H), 1.89 (s, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 202.1, 
167.3, 157.4, 147.8, 135.4, 130.2, 129.0, 128.9, 128.8, 128.6, 126.6, 92.1, 68.2, 25.4, 19.0, 
16.6 ppm; IR (thin film) 3281, 3034, 2927, 1728, 1456, 1231, 1101 cm
-1
; HRMS (ESI) m/z 
408.1415 (408.1418 calcd for C21H23NNaO6
+ 
[MNa]
+
). 
(79) Methyl 1-((((benzyloxy)carbonyl)amino)oxy)-2-oxocyclohexane-1-carboxylate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and benzyl 
hydroxycarbamate 2 (50 mg, 0.30 mmol, 1 equiv) were added to methyl 2-oxocyclohexane-
1-carboxylate S-27 (56 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 0.015 mmol, 
0.05 equiv), and (+)-2,2′-isopropylidenebis[(4R)-4-phenyl-2-oxazoline] (6.0 mg, 0.018 
mmol, 0.06 equiv) in 2 mL of isopropyl alcohol. The reaction was stirred for 8 h at rt, and 
the solvent was removed in vacuo. The reaction was quenched with 4 mL EDTA (0.5 M, pH 
7.0) and extracted with ethyl acetate (3 x 4 mL). The combined organic layers were dried 
over MgSO4, filtered and then concentrated in vacuo. The residue was purified by column 
chromatography to afford aldol product 79 (78 mg, 81%, 91:9 er) as a colorless oil. 
Enantiomeric ratio determined by chiral HPLC (Chiralpak IA column, 4.6 mm x 250 mm, 
step gradient (95.5/0.5 hexanes/i-PrOH, 30 min; 97/3 hexanes/i-PrOH, 30 min), 1 mL/min, 
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(X) Rt = 43.2 min (major), (X) Rt = 45.8 min (minor)); [α]D
25
 +38.5° (c 1.00, CHCl3); 
Spectral data consistent with compound 64. 
(80) Ethyl 1-((((benzyloxy)carbonyl)amino)oxy)-2-oxocyclohexane-1-carboxylate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and benzyl 
hydroxycarbamate 2 (50 mg, 0.30 mmol, 1 equiv) were added to ethyl 2-oxocyclohexane-1-
carboxylate 72 (61 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 0.015 mmol, 0.05 
equiv), and (+)-2,2′-isopropylidenebis[(4R)-4-phenyl-2-oxazoline] (6.0 mg, 0.018 mmol, 
0.06 equiv) in 2 mL of isopropyl alcohol. The reaction was stirred for 8 h at rt, and the 
solvent was removed in vacuo. The reaction was quenched with 4 mL EDTA (0.5 M, pH 
7.0) and extracted with ethyl acetate (3 x 4 mL). The combined organic layers were dried 
over MgSO4, filtered and then concentrated in vacuo. The residue was purified by column 
chromatography to afford aldol product 80 (83 mg, 82%, 90:10 er) as a colorless oil. 
Enantiomeric ratio determined by chiral HPLC (Chiralpak IA column, 4.6 mm x 250 mm, 
step gradient (95.5/0.5 hexanes/i-PrOH, 30 min; 97/3 hexanes/i-PrOH, 30 min), 1 mL/min, 
(X) Rt = 37.7 min (major), (X) Rt = 40.7 min (minor)); [α]D
25
 +35.4° (c 1.00, CHCl3); 
Spectral data consistent with compound 65. 
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(81) Tert-butyl 1-((((benzyloxy)carbonyl)amino)oxy)-2-oxocyclohexane-1-
carboxylate 
 
According to the general procedure, CuCl (0.6 mg, 0.0065 mmol, 0.05 equiv) and benzyl 
hydroxycarbamate 2 (22 mg, 0.13 mmol, 1 equiv) were added to tert-butyl 2-
oxocyclohexane-1-carboxylate S-28 (31 mg, 0.16 mmol, 1.2 equiv), Cu(OAc)2·H2O (1.3 mg, 
0.0065 mmol, 0.05 equiv), and (+)-2,2′-isopropylidenebis[(4R)-4-phenyl-2-oxazoline] (2.6 
mg, 0.0078 mmol, 0.06 equiv) in 1 mL of isopropyl alcohol. The reaction was stirred for 8 h 
at rt, and the solvent was removed in vacuo. The reaction was quenched with 2 mL EDTA 
(0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 2 mL). The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo. The residue was purified by 
column chromatography to afford aldol product 81 (40 mg, 85%. 99:1 er) as a colorless oil. 
Enantiomeric ratio determined by chiral HPLC (Chiralpak IA column, 4.6 mm x 250 mm, 
step gradient (95.5/0.5 hexanes/i-PrOH, 30 min; 97/3 hexanes/i-PrOH, 30 min), 1 mL/min, 
(X) Rt = 27.1 min (major), (X) Rt = 42.2 min (minor)); [α]D
25
 +20.6° (c 1.00, CHCl3); 
Spectral data consistent with compound 66. 
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(82) 2,6-Dimethylphenyl 1-((((benzyloxy)carbonyl)amino)oxy)-2-oxocyclohexane-1-
carboxylate 
 
According to the general procedure, CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and benzyl 
hydroxycarbamate 2 (50 mg, 0.30 mmol, 1 equiv) were added to 2,6-dimethylphenyl 2-
oxocyclohexane-1-carboxylate S-29 (87 mg, 0.36 mmol, 1.2 equiv), Cu(OAc)2·H2O (3.0 mg, 
0.015 mmol, 0.05 equiv), and (+)-2,2′-isopropylidenebis[(4R)-4-phenyl-2-oxazoline] (6.0 
mg, 0.018 mmol, 0.06 equiv) in 2 mL of isopropyl alcohol. The reaction was stirred for 8 h 
at rt, and the solvent was removed in vacuo. The reaction was quenched with 4 mL EDTA 
(0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 4 mL). The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo. The residue was purified by 
column chromatography to afford aldol product 82 (105 mg, 88%, 91:9 er) as a colorless oil. 
Enantiomeric ratio determined by chiral HPLC (Chiralpak IA column, 4.6 mm x 250 mm, 
step gradient (95.5/0.5 hexanes/i-PrOH, 30 min; 97/3 hexanes/i-PrOH, 30 min), 1 mL/min, 
(X) Rt = 41.1 min (minor), (X) Rt = 45.4 min (major)); [α]D
25
 +70.2° (c 1.00, CHCl3); 
Spectral data consistent with compound 67. 
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(S-31) (S,Z)-(S,Z)-4-bromo-N-((1-(2,6-dimethylphenoxy)-2-methyl-1,3-dioxobutan-
2-yl)oxy)benzimidic 4-bromobenzoic anhydride 
      
 
 
Single crystal X-ray crystallography of S-31 was used to determine the absolute 
stereochemistry of asymmetric aldol products. See CDCC 932616 for more information. 
Mechanistic Studies  
General Procedure for the Cu(II) Counterion Screen: 
 
To a stirred solution of ethyl 2-methyl-3-oxobutanoate 1 (52 mg, 0.36 mmol, 1.2 equiv), the 
corresponding Cu(II) source (0.015 mmol, 0.05 equiv), and ethyl oxazoline (1.5 mg, 0.015 
mmol, 0.05 equiv) in 2 mL isopropyl alcohol was added  CuCl (1.5 mg, 0.015 mmol, 0.05 
equiv) and tert-butyl hydroxycarbamate 42 (40 mg, 0.30 mmol, 1 equiv). The reaction was 
stirred at room temperature open to the air until complete as judged by TLC, and the 
isopropyl alcohol was removed in vacuo. The reaction was quenched with 4 mL EDTA (0.5 
M, pH 7.0) and extracted with ethyl acetate (3 x 4 mL). The combined organic layers were 
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dried over MgSO4, filtered and then concentrated in vacuo. The residue was purified by 
column chromatography to afford aldol products 44 and 10. The regioselectivity of the 
reaction was determined by 
1
HNMR analysis of the crude reaction mixture.  
Cu(II) Source Regioselectivity (O:N) 
Cu(OTf)2 1.5:1 
Cu(BF4)2•H2O 1.5:1 
CuCl2 6:1 
CuCO3 8:1 
Cu(OAc)2•H2O 10:1 
Cu(2-EtHex)2 14:1 
 
General Procedure for the Screen of Ethyl Oxazoline Loading: 
 
To a stirred solution of ethyl 2-methyl-3-oxobutanoate 1 (52 mg, 0.36 mmol, 1.2 equiv), 
Cu(OAc)2•H2O (12 mg, 0.060 mmol, 0.20 equiv), and ethyl oxazoline (0–40 mol %) in 2 mL 
isopropyl alcohol was added  CuCl (6 mg, 0.060 mmol, 0.20 equiv) and tert-butyl 
hydroxycarbamate 42 (40 mg, 0.30 mmol, 1 equiv). The reaction was stirred at room 
temperature open to the air until complete as judged by TLC, and the isopropyl alcohol was 
removed in vacuo. The reaction was quenched with 4 mL EDTA (0.5 M, pH 7.0) and 
extracted with ethyl acetate (3 x 4 mL). The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo. The residue was purified by column 
chromatography to afford aldol products 44 and 10. The regioselectivity of the reaction was 
determined by 
1
HNMR analysis of the crude reaction mixture.  
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mol % ethyl oxazoline Regioselectivity (O:N) 
0 3:1 
5 6:1 
10 14:1 
20 18:1 
40 >20:1 
 
General Procedure for the Screen of NaOAc loading: 
 
To a stirred solution of ethyl 2-methyl-3-oxobutanoate 1 (52 mg, 0.36 mmol, 1.2 equiv), 
Cu(OTf)2 (22 mg, 0.060 mmol, 0.20 equiv), and ethyl oxazoline (6 mg, 0.060 mmol, 0.20 
equiv) in 2 mL isopropyl alcohol was added  CuCl (6 mg, 0.060 mmol, 0.20 equiv), NaOAc 
(0–80 mol %)  and tert-butyl hydroxycarbamate 42 (40 mg, 0.30 mmol, 1 equiv). The 
reaction was stirred at room temperature open to the air until complete as judged by TLC, 
and the isopropyl alcohol was removed in vacuo. The reaction was quenched with 4 mL 
EDTA (0.5 M, pH 7.0) and extracted with ethyl acetate (3 x 4 mL). The combined organic 
layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue was 
purified by column chromatography to afford aldol products 44 and 10. The regioselectivity 
of the reaction was determined by 
1
HNMR analysis of the crude reaction mixture.  
mol % NaOAc Regioselectivity (O:N) 
0 2:1 
5 2:1 
10 2:1 
15 2:1 
20 3:1 
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25 4:1 
30 5:1 
35 6:1 
40 7:1 
80 7:1 
 
Post–Functionalization of O-Aldol Products 
(84) 2-(Tert-butyl) 6-ethyl 5,6-dimethyl-3,6-dihydro-2H-1,2-oxazine-2,6-
dicarboxylate 
 
Vinyltriphenylphosphonium bromide S-32 (134 mg, 0.36 mmol, 2.0 equiv) and 1,8-
diazabicyclo[5.4.0]undec-7-ene (54 μL, 0.36 mmol, 2.0 equiv) were added to ethyl 2-(((tert-
butoxycarbonyl)amino)oxy)-2-methyl-3-oxobutanoate 44 (50 mg, 0.18 mmol, 1 equiv) in 1 
mL of isopropyl alcohol. The reaction was heated to reflux, stirred for 2 h and cooled to rt. 
The reaction was quenched with H2O (10 mL) and diluted with ethyl acetate (10 mL). The 
phases were separated, and the aqueous phase was extracted with ethyl acetate (3 x 10 mL). 
The combined organic layers were washed with brine (10 mL), dried over MgSO4, filtered 
and then concentrated in vacuo. The residue was purified by column chromatography to 
afford annulation product 84 (42 mg, 82%) as a colorless oil. 
1
H NMR (600 MHz, CDCl3) δ 
5.61 – 5.57 (m, 1H), 4.24 (dq, J = 10.8, 7.1 Hz, 1H), 4.16 (dq, J = 10.8, 7.1 Hz, 1H), 4.08 
(ddq, J = 16.8, 3.6, 1.7 Hz, 1H), 3.89 (dp, J = 16.8, 2.2 Hz, 1H), 1.82 (q, J = 1.8 Hz, 3H), 
1.54 (s, 3H), 1.47 (s, 9H), 1.28 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 
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171.0, 154.8, 134.7, 119.2, 84.1, 81.6, 61.6, 45.8, 28.5, 20.8, 19.0, 14.3 ppm; IR (thin film) 
2980, 1736, 1367, 1265, 1109 cm
-1
;
 
HRMS (ESI) m/z 308.1469 (308.1468 calcd for 
C14H23NNaO5
+ 
[MNa]
+
). 
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(84) 2-(Tert-butyl) 6-ethyl 5,6-dimethyl-3,6-dihydro-2H-1,2-oxazine-2,6-
dicarboxylate 
 
CuCl (1.5 mg, 0.015 mmol, 0.05 equiv) and tert-butyl hydroxycarbamate 42 (40 mg, 0.30 
mmol, 1 equiv) were added to ethyl 2-methyl-3-oxobutanoate 1 (52 mg, 0.36 mmol, 1.2 
equiv), Cu(OAc)2·H2O (3.0 mg, 0.015 mmol, 0.05 equiv), and ethyl oxazoline (1.5 mg, 
0.015 mmol, 0.05 equiv) in 2 mL of isopropyl alcohol. The reaction was stirred for 17 h at rt, 
and then vinyltriphenylphosphonium bromide S-32 (222 mg, 0.60 mmol, 2.0 equiv) and 1,8-
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diazabicyclo[5.4.0]undec-7-ene (90 μL, 0.60 mmol, 2.0 equiv) were added to the solution. 
The reaction was heated to reflux for an additional 2 h, cooled to rt, and the solvent was 
removed in vacuo. The residue was purified by column chromatography to afford annulation 
product 84 (56 mg, 65%) as a colorless oil. 
(85) 3-(Tert-butyl) 4a-ethyl hexahydro-3H,4aH-benzo[e]oxireno[2,3-d][1,2]oxazine-
3,4a-dicarboxylate 
 
Vinyldiphenylsulfonium triflate S-33 (81 mg, 0.23 mmol, 1.2 equiv) and 1,8-
diazabicyclo[5.4.0]undec-7-ene (56 μL, 0.38 mmol, 2.0 equiv) were added to ethyl 1-(((tert-
butoxycarbonyl)amino)oxy)-2-oxocyclohexanecarboxylate 59 (57 mg, 0.19 mmol, 1 equiv) 
in 1 mL of isopropyl alcohol at 0˚C. The reaction was warmed to room temperature and 
stirred for 24 h. The reaction was quenched with a 10% solution of citric acid (10 mL), the 
phases were separated, and the aqueous phase was extracted with ethyl acetate (3 x 10 mL). 
The combined organic layers were washed with brine (10 mL), dried over MgSO4, filtered 
and then concentrated in vacuo. The residue was purified by column chromatography to 
afford annulation product 85 (43 mg, 63%, >20:1 dr) as a colorless solid. 
1
H NMR (600 
MHz, CDCl3) δ 4.29 (q, J = 7.1 Hz, 2H), 3.86 (s, 2H), 3.21 (t, J = 2.3 Hz, 1H), 2.43 (td, J = 
13.4, 4.9 Hz, 1H), 2.29 (dq, J = 13.6, 3.4 Hz, 1H), 1.90 – 1.81 (m, 2H), 1.80 – 1.73 (m, 1H), 
1.54 (qt, J = 13.3, 3.4 Hz, 1H), 1.47 (s, 9H), 1.43 (dt, J = 12.8, 3.8 Hz, 1H), 1.42 – 1.35 (m, 
1H), 1.32 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 169.4, 155.1, 82.4, 82.0, 
61.7, 59.1, 57.4, 45.5, 33.0, 32.4, 28.4, 24.5, 21.9, 14.4 ppm; IR (thin film) 2939, 1737, 
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1368, 1230, 1162 cm
-1
; HRMS (ESI) m/z 350.1578 (350.1574 calcd for C16H25NNaO6
+ 
[MNa]
+
). 
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(85) 3-(Tert-butyl) 4a-ethyl hexahydro-3H,4aH-benzo[e]oxireno[2,3-d][1,2]oxazine-
3,4a-dicarboxylate 
 
CuCl (0.9 mg, 0.0094 mmol, 0.05 equiv) and tert-butyl hydroxycarbamate 42 (25 mg, 0.19 
mmol, 1 equiv) were added to ethyl 2-methyl-3-oxobutanoate 72 (38 mg, 0.23 mmol, 1.2 
equiv), Cu(OAc)2·H2O (1.9 mg, 0.0094 mmol, 0.05 equiv), and ethyl oxazoline (0.9 mg, 
0.0094 mmol, 0.05 equiv) in 1.3 mL of isopropyl alcohol. The reaction was stirred for 16 h, 
cooled to 0 ˚C, and then vinyldiphenylsulfonium triflate S-33  (81 mg, 0.23 mmol, 1.2 equiv) 
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and 1,8-diazabicyclo[5.4.0]undec-7-ene (56 μL, 0.38 mmol, 2.0 equiv) were added to the 
solution. The reaction was warmed to rt and stirred for an addition 24 h, and the solvent was 
removed in vacuo. The residue was purified by column chromatography to afford annulation 
product 85 (55 mg, 97%) as a colorless solid. 
6.3 Chapter 4 Supporting Information 
6.3.1 Supporting Information for the Photoredox Oxidation of N-Substituted 
Hydroxylamines 
Materials and Methods. Unless stated otherwise, reactions were conducted in flame-dried 
glassware under an atmosphere of air using reagent grade solvents. All commercially 
obtained reagents were used as received. Reaction temperatures were controlled using a 
Heidolph temperature modulator, and unless stated otherwise, reactions were performed at 
room temperature (rt, approximately 23 ºC). Thin-layer chromatography (TLC) was 
conducted with E. Merck silica gel 60 F254 pre-coated plates, (0.25 mm) and visualized by 
exposure to UV light (254 nm) or stained with potassium permanganate. Flash column 
chromatography was performed using normal phase silica gel (60 Å, 230-240 mesh, 
Geduran®). 
1
H NMR spectra were recorded on Varian Spectrometers (at 400, 500 and 600 
MHz) and are reported relative to deuterated solvent signals. Data for 
1
H NMR spectra are 
reported as follows: chemical shift (δ ppm), multiplicity, coupling constant (Hz) and 
integration. 
13
C NMR spectra were recorded on Varian Spectrometers (125 and 150 MHz). 
Data for 
13
C NMR spectra are reported in terms of chemical shift. Fluorescence experiments 
were conducted using a Varian Cary Eclipse Fluorimeter by irradiating the sample at 465 
nm.  
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Starting Materials 
Starting Hydroxylamines 1 and S-3 were purchased from commercial vendors and used as 
received. Starting dienes 2 and S-1, S-2 were purchased from commercial vendors and used 
as received. Starting olefins S-3, S-4, S-5, S-6, and S-7 were purchased from commercial 
vendors and used as received. Ru(bpy)2Cl2 was purchased as the hexahydrate and used as 
received.  
 
General Procedure for the Photoredox Nitrosocarbonyl Hetero–Diels–Alder Reaction: 
To a stirred solution of N-substituted hydroxylamine 4 and 1,3-diene 5 in 1,2-dichloroethane 
(DCE) was added Ru(bpy)3Cl2•6H2O (0.01 equiv) and 2,6-lutidine (3 equiv). The reaction 
was suspended between two 26W white light bulbs which were turned on for the duration of 
the reaction, and left to stir open to the atmosphere until reaction completion, as determined 
by TLC analysis of the reaction mixture. During the reaction, the flask was vigorously 
cooled using compressed air to ensure the reaction temperature remained at rt (approx. 
23°C). After completion, the solution was filtered through a plug of basic alumina and the 
solvent was removed in vacuo. The crude residue was purified by flash column 
chromatography to afford the desired 1,2-oxazine 6. 
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Substrate Scope – Nitrosocarbonyl Hetero–Diels–Alder Reaction 
(3) Benzyl 2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxylate 
.  
According to the general procedure, Ru(bpy)3Cl2•6H2O (1.1 mg, 0.0015 mmol, 0.01 
equiv) and 2,6-lutidine (35 μL, 0.30 mmol, 2.0 equiv) were added to a stirred solution of 
benzyl hydroxycarbamate 1 (25 mg, 0.15 mmol, 1.0 equiv) and cyclohexa-1,3-diene 2 (45 
μL, 0.45 mmol, 3.0 equiv) in 1 mL DCE. The resulting mixture was stirred for 20 h at rt. 
The reaction was filtered through a plug of basic alumina, and the solvent was removed in 
vacuo. The crude residue was purified by flash column chromatography to afford oxazine 3 
(32 mg, 87%) as a colorless solid. Data was consistent with previous literature reports.
16
 
1
H 
NMR (600 MHz, CDCl3) δ 7.40 – 7.27 (m, 5H), 6.53 (ddd, J = 13.7, 7.1, 7.1 Hz, 2H), 5.19 
(d, J = 12.3 Hz, 1H), 5.12 (d, J = 12.3 Hz, 1H), 4.81 (s, 1H), 4.75 (s, 1H), 2.20 (dddd, J = 
13.0, 8.2, 3.6, 3.6 Hz, 1H), 2.11 (dddd, J = 12.7, 9.3, 3.3, 3.3 Hz, 1H), 1.48 (dddd, J = 12.3, 
12.3, 2.9, 2.9 Hz 1H), 1.37 (ddd, J = 12.5, 12.5, 3.2 Hz, 1H) ppm; 
13
C NMR (150 MHz, 
CDCl3) δ 158.3, 136.1, 132.1, 131.8, 128.6, 128.3, 128.2, 71.2, 67.8, 50.3, 23.6, 20.7 ppm. 
(7) Benzyl 2-oxa-3-azabicyclo[2.2.1]hept-5-ene-3-carboxylate 
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According to the general procedure, Ru(bpy)3Cl2•6H2O (1.1 mg, 0.0015 mmol, 0.01 
equiv) and 2,6-lutidine (35 μL, 0.30 mmol, 2.0 equiv) were added to a stirred solution of 
benzyl hydroxycarbamate 1 (25 mg, 0.15 mmol, 1.0 equiv) and cyclopentadiene 18 (38 μL, 
0.45 mmol, 3.0 equiv) in 1 mL DCE. The resulting mixture was stirred for 18 h at rt. The 
reaction was filtered through a plug of basic alumina, and the solvent was removed in vacuo. 
The crude residue was purified by flash column chromatography to afford oxazine 7 (32 mg, 
93%) as a colorless solid. Data was consistent with previous literature reports.
16
 
1
H NMR 
(600 MHz, CDCl3) δ 7.46 – 7.28 (m, 5H), 6.37 (s, 2H), 5.23 (s, 1H), 5.19 (dd, J = 12.3, 1.7 
Hz, 1H), 5.12 (dd, J = 12.3, 1.8 Hz, 1H), 5.04 (s, 1H), 2.00 (dd, J = 8.7, 1.7 Hz, 1H), 1.74 (d, 
J = 8.7 Hz, 1H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 159.4, 135.8, 134.6, 133.1, 128.6, 
128.4, 128.3, 84.0, 67.9, 65.2, 48.3 ppm. 
 (8) Benzyl 3,6-diphenyl-3,6-dihydro-2H-1,2-oxazine-2-carboxylate 
 
According to the general procedure, Ru(bpy)3Cl2•6H2O (1.1 mg, 0.0015 mmol, 0.01 
equiv) and 2,6-lutidine (35 μL, 0.30 mmol, 2.0 equiv) were added to a stirred solution of 
benzyl hydroxycarbamate 1 (25 mg, 0.15 mmol, 1.0 equiv) and (1E,3E)-1,4-diphenylbuta-
1,3-diene S-1 (93 mg, 0.45 mmol, 3.0 equiv) in 1 mL DCE. The resulting mixture was 
stirred for 24 h at rt. The reaction was filtered through a plug of basic alumina, and the 
solvent was removed in vacuo. The crude residue was purified by flash column 
chromatography to afford oxazine 8 (30 mg, 54%) as a colorless oil. Data was consistent 
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with previous literature reports.
16
 
1
H NMR (600 MHz, CDCl3) δ 7.54 (d, J = 7.4 Hz, 2H), 
7.49 – 7.30 (m, 12H), 6.17 (ddd, J = 10.1, 4.3, 2.0 Hz, 1H), 6.09 (d, J = 10.2 Hz, 1H), 5.68 
(s, 1H), 5.63 (s, 1H), 5.33 (d, J = 12.3 Hz, 1H), 5.20 (d, J = 12.4 Hz, 1H) ppm; 
13
C NMR 
(150 MHz, CDCl3) δ 155.0, 138.9, 137.1, 136.3, 129.2, 128.9, 128.8, 128.7, 128.3, 128.3, 
128.2, 128.1, 128.1, 127.9, 126.2, 79.9, 67.8, 29.6 ppm. 
 (9) Tert-butyl 2-oxa-3-azabicyclo[2.2.1]hept-5-ene-3-carboxylate 
 
According to the general procedure, Ru(bpy)3Cl2•6H2O (1.1 mg, 0.0015 mmol, 0.01 
equiv) and 2,6-lutidine (35 μL, 0.30 mmol, 2.0 equiv) were added to a stirred solution of 
tert-butyl hydroxycarbamate S-2 (20 mg, 0.15 mmol, 1.0 equiv) and cyclopentadiene 18 (38 
μL, 0.45 mmol, 3.0 equiv) in 1 mL DCE. The resulting mixture was stirred for 36 h at rt. 
The reaction was filtered through a plug of basic alumina, and the solvent was removed in 
vacuo. The crude residue was purified by flash column chromatography to afford oxazine 9 
(26 mg, 89%) as a yellow oil. Data was consistent with previous literature reports.
16
 
1
H 
NMR (600 MHz, CDCl3) δ 6.42 – 6.38 (m, 2H), 5.20 (s, 1H), 4.97 (s, 1H), 1.98 (dt, J = 8.6, 
1.8 Hz, 1H), 1.72 (d, J = 8.6 Hz, 1H), 1.46 (s, 9H) ppm.  
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 (10) Tert-butyl 2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxylate  
 
According to the general procedure, Ru(bpy)3Cl2•6H2O (1.1 mg, 0.0015 mmol, 0.01 
equiv) and 2,6-lutidine (35 μL, 0.30 mmol, 2.0 equiv) were added to a stirred solution of 
tert-butyl hydroxycarbamate S-2 (20 mg, 0.15 mmol, 1.0 equiv) and cyclohexa-1,3-diene 2 
(45 μL, 0.45 mmol, 3.0 equiv) in 1 mL DCE. The resulting mixture was stirred for 36 h at rt. 
The reaction was filtered through a plug of basic alumina, and the solvent was removed in 
vacuo. The crude residue was purified by flash column chromatography to afford oxazine 10 
(28 mg, 77%) as a yellow oil. Data was consistent with previous literature reports.
16
 
1
H 
NMR (600 MHz, CDCl3) δ 6.56 – 6.45 (m, 2H), 4.75 – 4.64 (m, 2H), 2.15 (dddd, J = 12.9, 
9.3, 3.7, 3.7 Hz, 1H), 2.06 (dddd, J = 12.9, 9.4, 3.5, 3.5 Hz, 1H), 1.48 – 1.40 (m, 9H), 1.35 – 
1.29 (m, 1H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 157.8, 131.9, 131.7, 81.7, 70.8, 50.3, 
28.3, 23.7, 20.7 ppm 
 
General Procedure for the Photoredox Nitrosocarbonyl Ene Reaction: To a stirred 
solution of benzyl hydroxylamine 1 (1.0 equiv) and olefin 11 (3.0 equiv) in 1,2-
dichloroethane (DCE) was added Ru(bpy)3Cl2•6H2O (0.01 equiv) and 2,6-lutidine (2.0 
equiv). The reaction was suspended between two 26W white light bulbs which were turned 
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on for the duration of the reaction, and left to stir open to the atmosphere until reaction 
completion, as determined by TLC analysis of the reaction mixture. During the reaction, the 
flask was vigorously cooled using compressed air to ensure the reaction temperature 
remained at rt (approx. 23°C). After completion, the solution was filtered through a plug a 
basic alumina and the solvent was removed in vacuo. The crude residue was purified by 
flash column chromatography to afford the desired allylic hydroxylamine 12. 
(13) Benzyl (2,3-dimethylbut-3-en-2-yl)(hydroxy)carbamate 
 
According to the general procedure, Ru(bpy)3Cl2•6H2O (2.2 mg, 0.0030 mmol, 0.01 equiv) 
and 2,6-lutidine (70 μL, 0.60 mmol, 2.0 equiv) were added to a stirred solution of benzyl 
hydroxycarbamate 1 (50 mg, 0.30 mmol, 1.0 equiv) and 2,3-dimethylbutene S-4 (107 μL , 
0.90 mmol, 3.0 equiv) in 2 mL DCE. The resulting mixture was stirred for 24 h at rt. The 
reaction was filtered through a plug of basic alumina, and the solvent was removed in vacuo. 
The crude residue was purified by flash column chromatography to afford hydroxycarbamate 
13 (74 mg, 99%) as a colorless oil. Data was consistent with previous literature reports. 
1
H 
NMR (600 MHz, CDCl3) δ 7.37 – 7.29 (m, 5H), 6.77 (bs, 1H), 5.16 (s, 2H), 4.84 (s, 1H), 
4.76 (s, 1H), 1.74 (s, 3H), 1.48 (s, 6H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 158.3, 149.8, 
136.0, 128.6, 128.4, 128.3, 109.5, 68.1, 66.1, 25.7, 19.3 ppm. 
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(14) Benzyl cyclohex-2-en-1-yl(hydroxy)carbamate 
 
According to the general procedure, Ru(bpy)3Cl2•6H2O (2.2 mg, 0.0030 mmol, 0.01 equiv) 
and 2,6-lutidine (70 μL, 0.60 mmol, 2.0 equiv) were added to a stirred solution of benzyl 
hydroxycarbamate 1 (50 mg, 0.30 mmol, 1.0 equiv) and cyclohexene S-5 (91 μL , 0.90 
mmol, 3.0 equiv) in 2 mL DCE. The resulting mixture was stirred for 24 h at rt. The reaction 
was filtered through a plug of basic alumina, and the solvent was removed in vacuo. The 
crude residue was purified by flash column chromatography to afford hydroxycarbamate 14 
(51 mg, 68%) as a colorless solid. Data was consistent with previous literature reports. 
1
H 
NMR (600 MHz, CDCl3) δ 7.37 – 7.31 (m, 5H), 6.48 (bs, 1H), 5.96 – 5.90 (m, 1H), 5.56 
(dd, J = 10.2, 1.4 Hz, 1H), 5.20 (s, 2H), 4.70 – 4.64 (m, 1H), 2.09 – 2.02 (m, 1H), 2.00 – 
1.80 (m, 4H), 1.66 – 1.56 (m, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 157.5, 136.2, 132.2, 
128.8, 128.5, 128.3, 126.6, 68.2, 55.8, 25.9, 24.6, 21.3 ppm. 
(15) Benzyl hydroxy(2-phenylallyl)carbamate 
 
According to the general procedure, Ru(bpy)3Cl2•6H2O (2.2 mg, 0.0030 mmol, 0.01 equiv) 
and 2,6-lutidine (70 μL, 0.60 mmol, 2.0 equiv) were added to a stirred solution of benzyl 
hydroxycarbamate 1 (50 mg, 0.30 mmol, 1.0 equiv) and cyclohexene S-6 (117 μL , 0.90 
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mmol, 3.0 equiv) in 2 mL DCE. The resulting mixture was stirred for 24 h at rt. The reaction 
was filtered through a plug of basic alumina, and the solvent was removed in vacuo. The 
crude residue was purified by flash column chromatography to afford hydroxycarbamate 15 
(63 mg, 85%) as a colorless solid. Data was consistent with previous literature reports. 
1
H 
NMR (600 MHz, CDCl3) δ 7.34 – 7.15 (m, 10H), 6.98 (bs, 1H), 5.39 (s, 1H), 5.18 (s, 1H), 
5.02 (s, 2H), 4.48 (s, 2H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 157.4, 142.5, 138.8, 136.0, 
128.7, 128.6, 128.5, 128.3, 128.1, 126.5, 115.4, 68.3, 54.5 ppm. 
(16) Benzyl (E)-hydroxy(oct-5-en-4- yl)carbamate  
 
According to the general procedure, Ru(bpy)3Cl2•6H2O (2.2 mg, 0.0030 mmol, 0.01 equiv) 
and 2,6-lutidine (70 μL, 0.60 mmol, 2.0 equiv) were added to a stirred solution of benzyl 
hydroxycarbamate 1 (50 mg, 0.30 mmol, 1.0 equiv) and (E)-oct-4-ene S-7 (142 μL , 0.90 
mmol, 3.0 equiv) in 2 mL DCE. The resulting mixture was stirred for 24 h at rt. The reaction 
was filtered through a plug of basic alumina, and the solvent was removed in vacuo. The 
crude residue was purified by flash column chromatography to afford hydroxycarbamate 16 
(65 mg, 78%) as an inseperable 3:1 E:Z mixture as a colorless oil. Data was consistent with 
previous literature reports. 
1
H NMR (600 MHz, CDCl3) δ 7.37 – 7.31 (m, 5H), 7.15 (bs, 1H), 
5.65 (dt, J = 15.5 Hz, 1H), 5.54 – 5.45 (m, 1H), 5.20 (d, J = 12.3 Hz, 1H), 5.16 (d, J = 12.4 
Hz, 1H), 4.79 (apt. q, J = 8.4 Hz, 1H), 4.45 (apt. q, J = 7.2 Hz, 1H), 2.06 – 1.99 (m, 2H), 
1.80 – 1.75 (m, 1H), 1.54 – 1.48 (m, 1H), 1.47 – 1.43 (m, 1H), 1.31 – 1.18 (m, 3H), 0.90 (t, J 
= 7.5 Hz, 3H), 0.83 (t, J = 7.4 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3) δ 157.9, 157.5, 
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136.3, 136.2, 135.1, 134.4, 128.7, 128.4, 128.4, 128.2, 128.2, 126.6, 126.5, 68.0, 68.0, 61.0, 
55.9, 34.5, 33.9, 25.5, 21.3, 19.5, 19.4, 14.3, 14.0, 14.0, 13.6 ppm. 
(17) Benzyl (E)-hydroxy(oct-2-en-1-yl)carbamate 
 
According to the general procedure, Ru(bpy)3Cl2•6H2O (2.2 mg, 0.0030 mmol, 0.01 equiv) 
and 2,6-lutidine (70 μL, 0.60 mmol, 2.0 equiv) were added to a stirred solution of benzyl 
hydroxycarbamate 1 (50 mg, 0.30 mmol, 1.0 equiv) and oct-1-ene S-8 (142 μL , 0.90 mmol, 
3.0 equiv) in 2 mL DCE. The resulting mixture was stirred for 24 h at rt. The reaction was 
filtered through a plug of basic alumina, and the solvent was removed in vacuo. The crude 
residue was purified by flash column chromatography to afford hydroxycarbamate 17 (28 
mg, 34%) as an inseperable 3:1 E:Z mixture as a colorless oil. Data was consistent with 
previous literature reports. 
1
H NMR (600 MHz, CDCl3) δ 7.37 – 7.31 (m, 5H), 6.98 (bs, 1H), 
5.67 (dt, J = 15.0, 6.7 Hz, 1H), 5.64 – 5.58 (m, 1H), 5.51 – 5.45 (m, 1H), 5.18 (s, 2H), 4.20 
(d, J = 5.0 Hz, 1H), 4.18 (d, J = 6.9 Hz, 2H), 4.07 (d, J = 6.3 Hz, 2H), 2.06 (q, J = 7.1 Hz, 
2H), 2.02 (q, J = 7.0 Hz, 2H), 1.38 – 1.22 (m, 6H), 0.88 (t, J = 7.1 Hz, 3H) ppm; 13C NMR 
(150 MHz, CDCl3) δ 157.7, 157.6, 136.1, 136.0, 128.7, 128.7, 128.5, 128.5, 128.3, 128.3, 
123.2, 123.0, 68.3, 68.2, 52.9, 47.7, 32.4, 31.6, 31.6, 29.3, 28.9, 27.5, 22.7, 14.2 ppm. 
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General Procedure for the Nitrosocarbonyl HDA Using TPP: To a stirred solution of 
benzyl hydroxycarbamate 1 (25 mg, 0.15 mmol, 1.0 equiv) and 1,3-cyclohexadiene 2 (45 μL, 
0.45 mmol, 3.0 equiv) in 1,2-dichloroethane (DCE) was added 5,10,15,20-
tetraphenylporphyrin (TPP) (0.90 mg, 0.0015 mmol, 0.010 equiv) and 2,6-lutidine (35 μL, 
0.30 mmol, 2.0 equiv). An additional 3 equiv of 1,3-cyclohexadiene was added every two 
hours up to a total of 9 equiv. The reaction was suspended between two 26W white light 
bulbs which were turned on for the duration of the reaction, and left to stir open to the 
atmosphere until reaction completion, as determined by TLC analysis of the reaction 
mixture. During the reaction, the flask was vigorously cooled using compressed air to ensure 
the reaction temperature remained at rt (approx. 23°C). After completion, the solution was 
filtered through a plug of basic alumina and the solvent was removed in vacuo. The crude 
residue was purified by flash column chromatography to afford the desired 1,2-oxazine 3 (14 
mg, 37%). 
 
General Procedure for the On-Off Studies on the Photoredox Oxidation 
To a stirred solution of benzyl hydroxycarbamate 1 (200 mg, 1.2 mmol, 1.0 equiv) and 
cyclopentadiene 18 (302 μL, 3.6 mmol, 3.0 equiv) in 1,2-dichloroethane (8 mL) was added 
Ru(bpy)3Cl2•6H2O (9.0 mg, 0.012 mmol, 0.01 equiv) and 2,6-lutidine (280 μL, 2.4 mmol, 
2.0 equiv). Dimethylterephthalate (58 mg, 0.30 mmol, 0.25 equiv) was added as an internal 
standard. The reaction was suspended between two 26W white light bulbs which were 
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iteratively turned on and off for designated periods of time while stirring open to the 
atmosphere. During the reaction, the flask was vigorously cooled using compressed air to 
ensure the reaction temperature remained at rt (approx. 23°C). At designated time intervals, 
200 μL aliquots were removed, filtered through a plug of basic alumina and concentrated in 
vacuo. Conversion was determined by NMR analysis of the concentrated aliquots. 
 
General Procedure for the Distance Dependence Studies on the Photoredox Oxidation 
To a stirred solution of benzyl hydroxycarbamate 1 (200 mg, 1.2 mmol, 1.0 equiv) and 
cyclopentadiene 18 (302 μL, 3.6 mmol, 3.0 equiv) in 1,2-dichloroethane (8 mL) was added 
Ru(bpy)3Cl2•6H2O (9.0 mg, 0.012 mmol, 0.01 equiv) and 2,6-lutidine (280 μL, 2.4 mmol, 
2.0 equiv). Dimethylterephthalate (58 mg, 0.30 mmol, 0.25 equiv) was added as an internal 
standard. The reaction was suspended between two 26W white light bulbs which were 
placed at a designated distance from the sidewall of the flask (0 cm, 1 cm, 2 cm) while 
stirring open to the atmosphere. During the reaction, the flask was vigorously cooled using 
compressed air to ensure the reaction temperature remained at rt (approx. 23°C). At 
designated time intervals, 200 μL aliquots were removed, filtered through a plug of basic 
alumina and concentrated in vacuo. Conversion was determined by NMR analysis of the 
concentrated aliquots. 
 
General Procedure for the Fluorescence Quenching of the Photocatalyst: 
A solution of benzyl hydroxycarbamate 1 in acetonitrile was vigorously degassed via freeze-
pump-thaw. The solution was added to a sealed cuvette so that an atmosphere of argon was 
maintained and the cuvette was place in a Varian Cary Eclipse Fluorimeter. The sample was 
irradiated at 465 nm and the fluorescence was monitored. The experiment was repeated 
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iteratively at various concentrations of benzyl hydroxycarbamate 1 (Cbz HA) and 
cyclohexa-1,3-diene 2 (diene).  
 
Fluorescence quenching of Ru(bpy)3Cl2 by benzyl hydroxycarbamate 
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Fluorescence quenching of Ru(bpy)3Cl2 by 1,3-cyclohexadiene 
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General Procedure for Cyclic Voltammetry Experiments 
The experiments were carried out in a conventional three electrode cell using a Potentiostat 
600C (CH Instruments, Austin TX). A glassy carbon disc (diameter: 1 mm) served as a 
working electrode and a platinum wire as counter electrode. The glassy carbon disc was 
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polished using polishing alumina (0.05 μm) before each experiment. As reference a 
Ag/AgNO3 electrode (silver wire in 0.1 M NBu4BF4/MeCN solution; c(AgNO3) = 0.01 M; 
E0 = -87 mV vs. ferrocene redox couple) was used and this compartment was separated from 
the rest of the cell with a Vycor frit. For estimation of the oxidation potentials, the average 
value of three different measurements was formed (typical deviation within the range of 10 
mV). A solution of 1.5 mg of benzyl hydroxycarbamate in 5 ml of electrolyte solution was 
used. 
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